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ABSTRACT 
 
Six studies (three with broilers and three with turkeys) were conducted to 
determine if E. coli lipopolysaccharide (LPS) would enhance the effects of 
aflatoxin B1 (AFB1) and the T-2 toxin (T-2) in chicks and poults fed from hatch 
to 21 days of age.  In mortality rate, there was a toxic synergy between AFB1 and 
LPS in chicks and poults.  In birds exposed to LPS and T-2 alone or in 
combination, LPS did not enhance the effects of T-2.  In poults, a decrease in 
performance observed in birds at 2 mg/kg T-2 alone was atypical.  In birds 
exposed to AFB1, T-2, and LPS singly or in combination, LPS did not enhance 
the effects T-2 and AFB1 on performance.  However, LPS did enhance the effects 
of T-2 on mortality rate and oral lesion in poults and acute mortality rate in broiler 
chicks.  In chicks and poults, LPS-treated groups had lower feed intake 
immediately after treatment when compared to saline groups.  Little or any 
interactions were detected which may be due to the atypical responses observed 
when toxins were fed alone.
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CHAPTER I 
 
INTRODUCTION 
 
Animals are exposed simultaneously to a myriad of stressors resulting in poor 
performance which can lead to high mortality.  Stressors like the presence of low doses of 
mycotoxins in the feed and exposure to unsanitary environments can stimulate the 
immune system to release cytokines and other mediators necessary to overcome the 
problem.  The body enters a catabolic state and shifts nutrients toward recovery of the 
animal.  At this point, the priority is host recovery.  In some cases, antibiotics therapy is 
an efficient alternative to diminish the damaging effects of this constant exposure.  
However, due to the unfavorable public opinion towards the use of antibiotics, other 
alternatives should be found to prevent inefficient production.  Chronic exposure to low 
doses of mycotoxins in the diet does not necessarily increase or cause mortality.  
However, exposure to low doses can render the animal more sensitive to pathogens 
presents in the environment further decreasing performance and increasing mortality rate.  
These effects can increase the cost of production and decrease production efficiency.   
The objective of this research was to clarify the impact that common environmental 
stressors like E. coli endotoxin, aflatoxin B1, and T-2 toxin have on performance of 
chicks and poults fed from hatch to day 21. 
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CHAPTER II 
 
 
LITERATURE REVIEW 
 
 
AFLATOXIN B1 
 
 
 
 Aflatoxins were first identified as the causative agent of Turkey X disease, 
which killed more than 100,000 turkey poults in England in 1960 (Lancaster et al., 1961).  
The two fungi that are major producers of aflatoxin are Aspergillus flavus and A. 
parasiticus, and are found virtually everywhere in the world.  The predominant and most 
toxic aflatoxin produced by A. flavus is aflatoxin B1 (AFB1).  Aspergillus spp. are mainly 
storage fungi which generally do not contaminate grains prior to harvest.  However, 
conditions such as drought stress and insect damage may allow infection by Aspergilli 
and production of aflatoxins in the field before crop harvest (Anderson et al., 1975; 
Fennel et al., 1975; Lillejoh et al., 1976).  For instance, drought stress in the 3 to 4 weeks 
following silking has been correlated with high levels of aflatoxins in corn in the USA 
(Schmitt and Hurburg, 1989; Payne et al., 1986).  In nuts, aflatoxin content is related to 
insect damage (Schatzki and Ong, 2001).  Several publications have suggested that 
almonds free of such damage are not contaminated by the toxin (Schade et al., 1975; 
Fuller et al., 1977; Schatzki, 1996).  Aspergillus species are able to grow on many 
different substrates and most foods and feeds are susceptible to invasion at any stage of 
production, processing, transportation, and/or storage.  Aflatoxins are extremely stable in 
grains and may persist long after mold growth has stopped.  For example, the groundnut 
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meal associated with the outbreak of Turkey X disease was sterile, although it 
contained large amounts of aflatoxins (Austick and Ayerst, 1963). 
 Occurrence of aflatoxins, in foods and feeds worldwide has been documented 
(Jelinek et al., 1989; Wood, 1992).  Survey results, from the Contamination Monitoring 
Program for mycotoxins conducted by the Food and Agriculture Organization, World 
Health Organization, and United Nations Environmental Program from 1976 to 1983, 
showed that much of the monitored grain contained aflatoxins above 5 to 20 µg/kg, the 
regulatory levels for food in most countries, or 20 to 50 µg/kg, the regulatory limits in 
feeds in most countries (Jelinek et al., 1989). The mean levels for aflatoxins in corn and 
corn products ranged from < 0.1 to 321 µg/kg (Jelinek et al., 1989; Chamberlain et al., 
1993).  Aflatoxin B1 has been shown to be prevalent in samples of almonds and peanuts 
at levels of 95 µg/kg and < 10 µg/kg, respectively (Jimenéz et al., 1991).  Other reports 
have shown higher levels ranging from 7 to 11,600 µg AFB1/ kg (Jindal et al., 1993; 
Shetty et al., 1987; Hegazy et al., 1991). 
 The knowledge that mycotoxins can have serious effects on humans and animals 
has led many countries to establish regulations on mycotoxins in food and feed in the last 
four decades (FAO, 2003).  The first limits for mycotoxins were set in the late 1960s for 
the aflatoxins.  By the end of 2003, approximately 100 countries had developed specific 
limits for mycotoxins in foodstuffs, and the number continues to grow (FAO, 2003).   
 On a worldwide basis, at least 99 countries had mycotoxin regulations for food 
and/or feed in 2003, an increase of approximately 30% compared to 1995 (FAO, 2003). 
 The current maximum levels set by the European Commission are 2 µg/kg for 
AFB1, 4 µg/kg total aflatoxins for groundnuts, nuts, dried fruits and cereals, and 0.05 
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µg/kg for aflatoxin M1 in milk (Stroka and Anklam, 2002).  New limits are being 
established for AFB1 in baby food (most probably 0.1 µg/kg) and animal feeds (in 
discussion at 1 µg/kg) (Stroka and Anklam, 2002).  Another 21 countries from Africa, 
Asia/Oceania, Latin America, and some countries in Europe have set their limits at 5 
µg/kg.  The United States and Canada do not have a single limit for aflatoxin (FAO, 
2003).   
Scudamore and Patel (2000) examined 140 samples of imported whole corn into 
the United Kingdom and determined that 92.1% of the samples fell below the 2 µg/kg of 
AFB1. This could indicate a determined attempt by suppliers to meet the regulated level 
for AFB1 (Scudamore and Patel, 2000).  For feed for dairy cattle, the limit set by 29 
countries in the European Union (EU) and European Free Trade Association (EFTA) is 5 
µg/kg (FAO, 2003).  A study conducted by Fayokun and Adegoke (2000) found that, in 
Nigeria, AFB1 contamination in poultry feeds far exceeded the 20 ppb EEC limits for 
feedstuffs (Coker et al., 1984) with results ranging from 31.7 to 66.7 ppb of AFB1.  In 
contrast, Oliveira et al. (1997) analyzed 60 samples of broiler mashed feed from several 
farms in Brazil for the presence of AFB1.  From the 60 samples, AFB1 at a level of 28 
ppb, was confirmed in just one sample (1.66%).  Gunsen and Yaroglu (2002), determined 
the aflatoxin levels in 18 dog and 30 horse feed samples collected from different farms 
from June 2000 to June 2001, in Turkey and found that the minimum and maximum 
levels of total aflatoxins were < 1.75 to 20 µg/kg and < 1.75 to 14 µg/kg, respectively.  
Three out of 18 dog feed samples (16.7%) and two out of 20 (10%) horse feed samples 
exceeded the Turkish tolerance limit of 10 µg/kg for aflatoxins (Gunsen and Yaroglu, 
2002).   
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 Aflatoxins can severely damage animal health.  Aflatoxin B1, the most toxic of 
the aflatoxins, causes a variety of adverse effects in different animal species, including 
chickens.  In poultry, these include liver damage, impaired productivity and reproductive 
efficiency, decreased egg production in hens, inferior egg shell quality, inferior carcass 
quality, and increased susceptibility to disease (Wyatt, 1991). Dietary AFB1 tends to 
infiltrate most of the soft tissues and fat depots of the chicken (Trucksess et al., 1983; 
Sudhakar, 1992).  Furthermore, AFB1 and its metabolites can also be transferred to eggs 
in laying hens (Jacobson and Wiseman, 1974; Sudhakar, 1992; Qureshi et al., 1998; 
Oliveira et al., 2000). Eggs laid soon after AF feeding contained aflatoxicol, the most 
toxic of the known AFB1 metabolites (Trucksess et al., 1983). Results of previous studies 
(Hamilton, 1982; Trucksess et al.,1983; Qureshi et al., 1998; Oliveira et al., 2000) have 
demonstrated that the transmission ratio of AFB1 from layer food into the egg is 1/2000 
to1/2500. Jacobson and Wiseman (1974) have reported that the eggs from hens fed 0.1, 
0.2 and 0.4 mg/kg AFB1 contaminated feeds contained measurable amounts of AFB1. 
They found 9 ng AFB1/egg after 10 days of receiving diets containing 0.l mg/kg dietary 
AFB1, whereas Oliveira et al.(2000) detected 6 ng AFB1/egg in the eggs of layers fed 
diets containing 0.5 mg/kg AFB1 for 8 weeks. However, Sudhakar (1992) found 5 ng 
AFB1/egg in the eggs of layers fed a diet containing 0.6 mg/kg AFB1 for 8 weeks. The 
legal upper limits in Turkey for total AF and AFB1 in layer feed are 20 ppb (20 mg/kg 
food) and 10 ppb (10 mg/kg food), respectively (Ministry of Agriculture of Turkey, 
1997). However, results from surveys have shown that the legal limits were frequently 
exceeded (Kaya, 1982; Tuncer, 1987). 
 In the southern United States, artificial feeding of white-tailed deer (Odocoileus 
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virginianus), wild turkeys (Meleagris gallopova silvestris), and other wildlife species 
has created an opportunity for wildlife to be exposed to aflatoxins (AF), particularly via 
contaminated corn. Aflatoxin levels in 51% of 39 submitted samples of shelled corn 
picked up at deer bait piles in North and South Carolina (USA) (Fischer et al.,1995) 
ranged from < 10 to 750 µg AF/kg feed (parts per billion). More recently, analysis of 
corn offered by retailers in Georgia for use as wildlife feed revealed AF in three of 31 
bags; one bag had 385 µg AF/kg feed (C. Quist, unpubl. data). Corn that is deliberately 
left unharvested for a wildlife food source is another source of AF. Aflatoxin levels found 
in standing corn during a 3-year study on a bobwhite quail plantation ranged from 42 to 
1,210 µg AF/kg feed (Stewart, 1985). Among wildlife species, the effects of AF have 
only been studied in white-tailed deer and bob-white quail. Subclinical liver damage was 
detected in both species (Quist et al., 1997; Stewart, 1985).  
The effect of AF on domestic turkeys has been well documented. Extensive 
mortality was produced in young domestic turkeys that were given 400 µg aflatoxin/kg 
feed or more of dietary aflatoxin (Giambrone et al., 1985b). Lower levels of aflatoxin 
cause blood-clotting abnormalities, immune dysfunction, and decreased feed conversion 
(Witlock and Wyatt, 1981; Giambrone et al., 1985a).  In four-month-old wild turkeys, 
100 µg AF/kg of diet for 2 weeks decreased feed consumption and weight gains as 
compared with control poults. Decreased liver-to-body weight ratios, liver enzyme 
alterations, slightly altered blood coagulation patterns, and mild histological changes 
indicated low-level liver damage. Compromise of cell-mediated immunity was indicated 
by decreased lymphoblast transformation. The authors suggest that exposure of wild 
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turkeys to feeds containing AF levels of 100 µg AF/kg of feed or more should be avoided 
(Quist et al., 2000). 
  In adult ruminants, exposure to AF can depress feed efficiency, 
immunocompetence, and reproductive performance, as shown by studies with dairy cattle 
(Diekman and Green, 1992).  The effects on feed efficiency presumably arise from 
impaired ruminal function, including reduced cellulose digestion, volatile fatty acid 
production, and motility (Diekman and Green, 1992).  In dairy cattle, another problem 
arises from the transformation of AFB1 to a related metabolite, aflatoxin M1 (AFM1) 
which is secreted in the milk.  Calves fed aflatoxin contaminated diets show clinical signs 
of aflatoxicosis at 2 to 14 days post-exposure (Barringer and Doster, 2001).  The toxicity 
of AFM1 is about one order of magnitude less than that of AFB1 (Creppy, 2002). 
 In humans, aflatoxins are now incriminated in neonatal jaundice and there is 
circumstancial evidence that they cause perinatal death and reduced birth weight 
(Hendrickse, 1997).  Aflatoxins have also been implicated in episodes of food poisoning 
that have been associated with serious morbidity and mortality, particularly among young 
children (Hendrickse, 1997). 
 In pigs, acute toxicity caused by the consumption of high doses of aflatoxins is 
characterized by feed refusal, reduced weight gain, changes in hematological and 
biochemical parameters, and liver and kidney lesions (Southern and Clawson, 1979; 
Miller et al., 1981; Harvey et al., 1988).  Marin et al. (2002) suggest that, even when 
present at low doses, aflatoxins alter the immune response, which may predispose pigs to 
infectious disease.  It also alters animal performance (Marin et al., 2002).  Van Heugten 
et al. (1994) reported a 31% decrease in growth of piglets fed a diet contaminated with 
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280 ppb of aflatoxin.  For swine, the maximum tolerable level for aflatoxin is 200 ppb 
(FAO, 1997).  
 Liggett et al. (1986) reported that cornmeal in the ration of dogs presenting with 
icterus, anorexia and listlessness contained 511 µg/kg AFB1 and AFB2. 
Aside from health risks, mycotoxin contamination can also reduce the price paid 
for crops (Wu, 2004).  Losses from mycotoxins in the U. S. and other industrial nations 
are typically associated with market losses as opposed to illnesses or deaths from the 
effects of the toxins (Wu, 2004).  Vardon et al. (2003) calculated the total mycotoxin-
related losses to agriculture in the United States to be as high as $1.4 billion annually 
($630 million to $2.5 billion).  In particular years and regions, aflatoxin can contaminate 
crops so severely that farmers are forced to dispose of more than half of their total corn 
and peanut crop (Robens and Cardwell, 2003).  In addition, there is an increase in 
operational costs from screening for the presence of mycotoxins.  Salay and Mercadante 
(2002) reported that in Brazil the costs for implementing a mycotoxin control program 
were US$ 55,900 capital cost to buy the equipment to screen the grains, and the 
operational costs to be between US$ 0.02 and 0.06/test/month. 
 Several strategies for the reduction or inactivation of aflatoxins have been 
previously evaluated and include diverse physical, chemical, and biological methods 
(Phillips et al., 1994, 2002; Phillips, 1999).  One of the strategies of current interest is the 
inclusion of nonnutritive enteroabsorbents in contaminated feed for the inactivation of 
aflatoxins (Pimpukdee et al., 2004).   
The concentration of AFB1 in feed can be reduced by good manufacturing 
practices and good storage practices.  If preventive measures fail, however, AFB1 can be 
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reduced in feed by blending  a method that is not acceptable in the United States or by 
physical or chemical treatment.  The physical treatments include heat, microwaves, 
gamma-rays, X-rays, ultra-violet light, and adsorption (Creppy, 2002).  Adsorption of 
aflatoxin onto hydrated sodium calcium aluminosilicates and other inert materials can be 
used in the animal feed industry to reduce aflatoxins in the feed.  The most successful 
chemical procedure for degrading aflatoxins in animal feed is ammoniation, which leads 
to decomposition of 95 to 98 % of the AFB1, and this procedure is used in various 
countries (Creppy, 2002).   
TOXIC EFFECTS 
 
 The classical assessment of toxicity of compounds centers on the determination of 
LD50 values which is the medium lethal dose (DMello and MacDonald, 1997).  An LD50 
value of 6.5 to 16.5 mg AFB1/kg was reported for one-day-old chicks by Patterson 
(1973).  Hamilton et al., (1972) reported the LD50 for 3-week-old poults to be 1 mg 
AFB1/kg.  DMello and MacDonald (1997) reported the LD50 values for laboratory 
animals of 1.0 to 17.9 mg/kg BW, and 0.5 mg/kg BW for one-day-old ducklings. 
 The metabolic effects of aflatoxins include: inhibition of DNA, RNA and protein 
synthesis, reduction in activities of miscellaneous enzymes; depression of glucose 
metabolism; inhibition of lipid synthesis, including that of phospholipids, free fatty acids, 
triglycerides and cholesterol and its esters; and depression of clotting-factor synthesis 
(Busby and Wogan, 1981).  Aflatoxins tend to block steroid binding sites in the tissues.  
They are also potent immunosuppressants, as shown by (1) reduced host resistance to a 
wide range of bacteria, viruses and fungi; (2) depressed complement activity; and (3) 
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impaired cell mediated immunity (Richard et al., 1978a, 1978b).  The liver is the main 
target for toxicity, and pathological changes include fatty infiltration, biliary duct 
proliferation and toxic necrosis in acute severe poisoning.  The Krebs cycle and 
phosphorylation of substrates also are inhibited via alterations in mitochondrial functions 
(Cheeke and Shull, 1985). 
 Baker and Green (1987) observed decreased synthesis of clotting factors which 
explains homeostasis deficiency and the presence of disseminated intravascular 
coagulation (DIC) in animals with aflatoxicosis.  Harvey et al. (1988) described 
disturbances in the bone marrow, coagulation and homeostasis, caused by the inhibition 
of protein synthesis.  The increase in prothrombin time is caused by alterations in the 
coagulation factors and also in the depletion of platelets which may inhibit aggregation to 
form the clot and inhibition of the clot enzymes (Parent-Massin and Parchment, 1998). 
 Aflatoxins cause a variety of effects in poultry, including retarded growth rate, 
impaired feed conversion, increased liver weights, immunosuppression, negative effects 
on serum chemistry and hematological parameters, and histopathological lesions.  Huff et 
al. (1986) showed that the most sensitive indicators of aflatoxicosis in young broiler 
chickens are the reduction in serum albumin and total protein levels.  Rastogi et al. 
(2001) reported that administration of 2 mg/kg of AFB1 in rats caused significant increase 
(15 to 75%) in the activites of γ-glutamyl transpeptidase, 5-nucleotidase, acid 
phosphatase and acid ribonuclease in liver, indicating hepatic injury.  In addition, there 
were significant depletions in the contents of reduced glutathione (27%) and glycogen 
(32%) (Rastogi et al., 2001).  The authors also reported a decrease (13 to 27%, 
respectively) in the activities of succinate dehydrogenase and glucose-6-phosphatase, 
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increased levels of lipid peroxides by 87%, and decline in the activities of enzymatic 
antioxidants levels viz. catalase (22%), superoxide dismutase (35%), glutathione-S-
transferase (27%), glutathione reductase (20%), and glutathione peroxidase (16%) 
suggesting that initial changes induced by aflatoxin B1 are due to formation of lipid 
peroxides and toxicity is mediated through antioxidant enzymes as well as glutathione 
metabolism (Rastogi et al., 2001).  As aflatoxicosis progresses, hepatomegaly becomes 
apparent due to lipid accumulation in the liver (Huff et al., 1986).   
Aflatoxin appears to be toxic at < 1 mg/kg for poultry with the liver considered to 
be the target organ, because compared with other organs the relative weight of the liver is 
altered by low levels of aflatoxin (Huff et al., 1986).  Researchers have attributed an 
increase in the relative weight of the liver to an accumulation of lipid in the liver, which 
produces the characteristic, enlarged, friable, fatty liver associated with aflatoxicosis in 
broilers (Smith and Hamilton, 1970).   
 
MECHANISM 
  
Carvalho (1995) classifies aflatoxicosis in three clinical stages.  First, primary 
acute disease observed usually after the ingestion of moderate quantities of AFB1.  
Animals show liver, central nervous system, and kidney lesions.  Second, primary 
chronic disease, after consuming diets contaminated with moderate to low levels of 
AFB1.  Animals show no classical lesions, but there is reduction in growth, in carcass 
quality, and, in cows, in milk production.  Finally, secondary chronic disease at which 
 12
animals ingest very low levels of AFB1.  These very low levels cause no signs of 
intoxication, but render the host susceptible to infectious diseases. 
Aflatoxins are very liposoluble compounds and are readily absorbed from the 
gastrointestinal tract into the bloodstream.  Aflatoxins tend to infiltrate most of the soft 
tissues and fat deposits of the chicken; however, the majority of the accumulation occurs 
in organs involved in the biotransformation of the mycotoxins such as liver and kidney 
(Lesson et al., 1995).  The major reactions in AFB1 metabolism are relatively well 
established.  Aflatoxin B1 exo-8,9-epoxide hydrolyzes rapidly to the dihydrodiol 
(Johnson et al., 1996).  Only the exo epoxide reacts efficiently with DNA, and the 
kinetics of this process have been analyzed in detail (Iyer et al., 1994; Johnson and 
Guengerich, 1997).  The endo epoxide (Raney et al., 1992a) is a product of some P450 
enzyme systems [e.g., P450 1A2 (Ueng et al., 1995)] but does not bind to DNA because 
of intercalation of the coumarin ring system into DNA (Raney et al., 1990; 1992b).  The 
dihydrodiol/dialdehyde equilibrium is complex (pKa 8.2) and both forms are present at 
physiological pH (Johnson et al., 1996).  Aflatoxin B1 aldehyde reductase (AFAR) 
enzymes reduce the dialdehyde (and not the dihydrodiol) (Guengerich et al., 2001).  Only 
the epoxide (and not the dialdehyde) reacts with DNA, as documented by the nearly 
exclusive reaction of the exo epoxide (Iyer et al., 1994).  The epoxide is also a substrate 
for conjugation by several GSH transferase (GST) enzymes (Raney et al., 1992a; Johnson 
et al., 1997).  Aflatoxin B1 dialdehyde is considered to be the major AFB1 derivative 
responsible for the formation of protein adducts (Sabbioni et al., 1987).  
Many effects of aflatoxin are a result of its ability to impair protein synthesis 
(Smith, 1963).  Aflatoxin B1 itself is a relatively innocuous molecule but P450 enzymes 
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(and other oxygenases, to a lesser extent) oxidize it to the 8,9-epoxide, which has a 
central role in all succeeding reactions (Baertschi et al., 1988; Johnson et al., 1996; 
Guengerich et al., 1998; Guengerich and Johnson, 1999).  Aflatoxin B1 requires 
metabolic conversion to its exo-8,9-epoxide (Busby and Wogan, 1984; Miller, 1978) in 
order to damage DNA (Miller, 1978). The AFB1 epoxide reacts with guanine to form a 
number of adducts (Essigmann et al., 1983), and one reasonable model is that these 
adducts, or secondary DNA lesions derived from them, lead to heritable genetic changes 
that help a cell along the pathway toward malignant transformation (Smela et al., 2001).  
The oxidized form can bind to DNA, forming AFB1-guanine adducts, and to protein, 
forming AFB1-albumin adducts (Eaton and Gallagher, 1994).  It may also conjugate to 
glutathione (GSH) by glutathione S-transferase (GST) (Wild et al., 1996) which is an 
important route for detoxification (Hayes et al., 1991). 
 The hepatocyte is the major target cell affected by AFB1.  Aflatoxin B1 induces 
DNA adduct formation, binding mainly to guanine residues in guanine + cytosine-rich 
regions, and induces guanine to thymine substitutions almost exclusively (Kuiper-
`Goodman, 1994).  This characteristic has been extensively demonstrated in several 
species, including fish, birds, rodents, carnivores, and primates.  In these animals, AFB1 
causes hepatocellular carcinomas (HCC), even when ingesting low levels of the toxin 
causing it to be considered one of the most potent hepatocarcinogens (Oliveira and 
Germano, 1997).  Even though the liver is the target organ, pancreatic and intestinal 
tumors have been reported in animals fed diets contaminated with aflatoxins (Busby and 
Wogan, 1984).  Aflatoxins toxicity is expressed principally through its disruption of 
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transcriptional events, mediated by the metabolism of aflatoxin to metabolites that bind 
DNA (Huff et al., 1986). 
 
 15
 T-2 TOXIN 
 
 
 
 The tricothecene mycotoxins (TCT) comprise a vast group of over 100 fungal 
metabolites with the same basic structure.  Several fungal genera are capable of 
producing TCT; however, most of them have been isolated from Fusarium spp.  All 
tricothecenes contain an epoxide at the C12,13 position, which is responsible for their 
toxicological activity.  Based on their chemical structure, TCT can be divided into two 
groups: macrocyclic and non-macrocyclic.  
 The tricothecene mycotoxins occur worldwide in grains and other commodities.  
Toxin production is greatest with high humidity and temperatures of 6 to 24ûC.  Natural 
occurrence of TCT has been reported in Asia, Africa, South America, Europe, and North 
America (Scott, 1989).  Tricothecenes have been detected in corn, wheat, barley, oats, 
rice, rye, vegetables, and other crops (Buck and Côté, 1991).  
Macrocyclic tricothecenes are subdivided into type C and D.  Type C 
tricothecenes (crotocin, baccharin) posses an additional epoxide group at the C7,8 or C9,10 
position.  Type D tricothecenes (satratoxin, roridin) contain a macrocyclic ring between 
the C4,15 positions (Sudakin, 2003).  Macrocyclic TCT have not been studied in poultry 
species; therefore, further discussion here is unnecessary.   
On the other hand, non-macrocyclic TCT are common contaminants of poultry 
feeds and feedstuffs and their adverse effects on poultry health and productivity have 
been studied extensively (Leeson et al., 1995).  Non-macrocyclic TCT are subdivided 
into type A and B, A being more toxic for poultry species than type B (Leeson et al., 
1995) due to the influence of the different radicals on their hydrophilic and lipophylic 
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moieties (Leal and Mejía, 1997).  Examples of type A TCT include T-2 toxin (T-2) and 
HT-2 toxin (HT-2), and diacetoxyscirpenol (DAS).  Fusarenone-X (FUX), 
deoxynivalenol (DON), and nivalenol (NIV) are some of the common naturally occurring 
type B TCT. Type A and B tricothecenes are distinguished by the presence or absence of 
a carbonyl group at the C8 position, respectively.   
Fusarium species reported as major producers of type A TCT are Fusarium 
sporotrichioides, F. sambucinum, F. venenatum, F. acuminatum, and F. compactum 
(Chelkowski, 1989; Chu, 1991, Bosch and Mirocha, 1992; Miller and Trenholm, 1994) 
whereas synthesis of type B trichothecenes occurs principally  by F. culmorum and  F. 
graminearum (Placinta et al., 1999).  F. sporotrichioides is widespread on plants and in 
soil throughout the cold and cool temperate regions of the world (Visconti et al., 1985).  
In Europe, the most frequently encountered Fusarium mycotoxins (associated with 
Fusarium head blight) are DON, and ZEA produced by F. graminearum and F. 
culmorum, with the former more common in southern (warmer) and the latter in northern 
(colder) European areas (Bottalico and Perrone, 2002).  Nivalenol was usually found 
associated with DON and its derivatives (mono-acetyldeoxynivalenols), along with FUX, 
which were produced by F. graminearum, F. cerealis, F. culmorum in the southern areas 
and in northern areas, by F. poae.  Moreover, from central to northern European 
countries, moniliform has been consistently reported, as a consequence of the widespread 
distribution of F. avenaceum, whereas the occurrence of T-2 derivatives, such as T-2 and 
HT-2 , and DAS have been recorded in conjunction with sporadic epidemics of F. 
sporotrichioides and F. poae (Botallico and Perrone, 2002). 
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Epidemiological surveys have demonstrated that tricothecenes are distributed 
worldwide in cereals as natural contaminants, and a number of outbreaks of intoxication 
in humans and animals have been associated with the consumption of foods or feeds 
contaminated by these mycotoxins (WHO, 1990; Beardall and Miller, 1994).  In China, 
53 outbreaks of human food poisoning associated with scabby and moldy cereals took 
place during the period 1960 to 1991 (Luo, 1992).  Huang (1992) reported a 1991 
outbreak in Anhui - a province in China, in which the consumption of foods made from 
wheat and barley harvested during a very wet and cold season intoxicated more than 
130,000 people.  They were affected by gastrointestinal disorders, including abdominal 
pain and fullness, nausea, vomiting, fatigue and fever (Huang, 1992).  Another 
mycotoxicosis outbreak, related to the consumption of corn gruel from moldy corn 
powder, occurred in Guangxi province (China) in April 1989 (He, 1990).  Of 10 
consumers, all were affected and one died (He, 1990).  Deoxynivalenol was found in the 
causative cereals implicated in the intoxications in Anhui and Guangxi provinces (China).  
However, in 1999, Li et al. analyzed the leftover samples of wheat, barley, and corn for 
the presence of mycotoxins and found that, although DON was the predominant toxin, 
the grains also contained NIV and ZEA (Li et al., 1999).  The T-2 toxin was negative in 
all samples analyzed (Li et al., 1999).   
At least two serious cases of mycotoxicoses have been associated with the 
ingestion of fusariotoxin contaminated food and feed (Mateo et al., 2002).  The first is 
alimentary toxic aleukia (ATA) which occurred in Russia during World War II (Yagen 
and Joffe, 1976) when a shortage of manpower for harvesting caused the grains to 
overwinter in the field (Moss, 2002); furthermore, after an acute shortage of food, these 
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cereals were gathered and eaten, leading to the deaths of many thousands of people 
(Moss, 2002).  The other is the bean-hull poisoning of horses in Japan (Ueno et al., 
1972).  In both cases, isolates of F. sporotrichioides isolated from grains and beans were 
found to produce T-2 toxin and its derivatives (Moss, 2002). 
The T-2 toxin is one of the most acutely poisonous of the fusarial toxins and is 
produced by Fusarium acuminatum (Ell. and Kellerm) and F. equiseti (Corda) Sacc.  In 
addition, of particular importance are F. poae (Peck) Wollenw. and F. sporotrichioides 
Sherb which were possibly associated with the devastating outbreaks of alimentary toxic 
aleukia (ATA) in the former Soviet Union during, and immediately after World War II 
(Moss, 2002).  In 1994, powdery F. poae was the most abundant potential producer of 
HT-2 and T-2 toxins in Norwegian cereals (Kosiak et al., 2003). 
A recent evaluation of T-2 in the European diet by JECFA (Joint FAO/WHO 
Expert Committee on Food Additives, 2002) suggested that there could be an incidence 
of contamination as high as 11% in European grain samples, albeit at very low levels 
(Moss, 2002).  Using a lowest observed effect level (LOEL) of 0.029 mg/kg body weight 
per day for a sensitive biological test, and a safety factor of 500, the Committee derived a 
permitted maximum total daily intake of 60 ng/kg body weight which is about eight times 
the estimated mean exposure level in Europe (Moss, 2002).     
Kawamura et al. (1990) carried out a survey of T-2 toxin in cereals randomly 
sampled from 11 countries.  Among 540 samples, 72 (13%) contained over 10 ng/g of T-
2 toxin with an average of 91.5 ng/g.  The content of T-2 toxin was highest (500 ng/g) in 
oat samples from Western Germany, and a relatively high content was observed in 
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barley, wheat, oat, and rye produced in Finland, Norway, Western Germany, and the 
USSR. 
Park et al. (1996) tested 98 corn samples received in late fall and winter of 1992 
and 1993 in Wisconsin after an unusually cold summer (Pratt, 1993) for the presence of 
fusarium mycotoxins.  The authors found frequent contamination with toxic fusaria as 
well as with various fusarium mycotoxins in the 1992 corn.  In contrast to the usual case 
in nature in which F. graminearum is more prevalent and its metabolites, such as DON 
and related toxins, are more common than T-2 toxin (Hagler et al., 1984; Jelinek et al., 
1989; Muller and Schwadorf, 1993; Park and Chu, 1993; Scott et al., 1980; Vesonder and 
Hesseltine, 1981) mycological analysis of the 1992 Wisconsin moldy corn revealed that a  
large population of F. sporotrichioides was also present (Park et al., 1996).  F. 
sporotrichioides has a low optimal temperature (6 to 12û) for T-2 toxin production 
(Cullen et al., 1982; Mirocha, 1984; Park and Chu, 1993) and produces mycotoxin during 
overwintering under snow cover in the field and/or during storage (Park et al., 1996).  
Poor storage of grains contaminated with this mold at mild temperatures (around 20ûC) 
usually during summer and the beginning of autumn in many cereal-producing areas 
might cause an increase in the T-2 content (Mateo et al., 2002).  The problem is not as 
important in countries with hot summers (average temperature around or higher than 
30ûC (Mateo et al., 2002).  Low moisture levels are associated with storage of grains in 
these countries, which decreases the possibility of T-2 toxin production (Mateo et al., 
2002).  In Wisconsin, Park (1993) specifically analyzed twenty two samples of maize, 
wheat, and rice for T-2 toxin (Park, 1995) and found that T-2 toxin accounted for about 
30% (range, 9.5 to 76.7%) of the total type A TCTs (Park et al., 1996).  Haubruge et al. 
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(2003) analyzed barley samples from 25 farms located in Tibet and detect the presence of 
T-2 in 76% of the samples with a range of 1 to 163 mg/kg.   
In 1992, in Poland, Bocarov-Stancic et al. (1995) examined samples of diets and 
feeds that included barley grain and determined that T-2 toxin occurred at 100 to 3750 
µg/kg.  Furthermore, Perkowski and Basinski (2002) determined T-2 and HT-2 
concentrations in 99 naturally contaminated oat grain samples from 12 plant breeding 
stations in different parts of Poland.  The HT-2 toxin was found in 24% of the samples 
(average 21 µg/kg; highest level 47 µg/kg) whereas T-2 was found in 15% of the samples 
(average 60 µg/kg; highest level 703 µg/kg) (Perkowski and Basinski, 2002). 
The 1998 grain growing season in Denmark was colder than normal and there 
were regular and heavy rainfalls from the beginning of July throughout the summer 
(Rasmussen et al., 2003).  The harvest season was generally late and lodging was 
widespread, especially in winter wheat (Landsudvalget for Planteavl, 1999).  The weather 
conditions were considered as being highly favorable for infection with Fusarium spp.  
Rasmussen et al. (2003) investigated the presence of T-2 along with other TCT in flour of 
common wheat, durum wheat, and rye on samples collected during this season and until 
2000 from both mills and the retail market.  The article reports that the incidence of T-2 
toxin was lower in common wheat flour than in durum flour and rye flour (Rasmussen et 
al., 2003).  Most samples of common wheat flour showed levels below the detection limit 
of the method (10 µg/kg) (Rasmussen et al., 2003).  On the other hand, rye flour showed 
T-2 in over 65% of samples collected from the harvest years 1998 and 1999 (Rasmussen 
et al., 2003).  The mean concentration of T-2 toxin in rye samples was 68 µg/kg, with 
five of eighteen samples containing more than 100 µg/kg (Rasmussen et al., 2003).  Both 
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the incidence and concentration of T-2 in rye flour may be considered high when 
compared  with the T-2 content in other cereals and cereal products reported at the 
meeting of the Joint FAO/WHO Expert Committee on Food Additives in Geneva (2001) 
(Rasmussen et al., 2003).  The T-2 toxin could not be detected in samples harvested in 
2000 indicating annual variation for the presence of T-2 in rye flour (Rasmussen et al., 
2003).  For durum wheat, the results form this survey indicate a frequent and relative 
high content of T-2 toxin (Rasmussen et al., 2003).  The T-2 toxin was found in 90% of 
the durum wheat samples (Rasmussen et al., 2003).  The mean T-2 concentration in these 
samples was 90 µg/kg and five of the samples contained more than 100 µg/kg 
(Rasmussen et al., 2003).  In Saudi Arabia, analysis of 843 commercial animal feed and 
foodstuff samples from the years 1997 to 2000 found levels of up to 18.75 µg/kg of HT-2 
and 6.25 µg/kg of T-2 (Al-Julaifi and Al-Falih, 2001). 
 Despite the established toxicity of the fusariotoxins, statutory regulations do not 
exist for any of the Fusarium mycotoxins (DMello et al., 1999).  In contrast, stringent 
directives are in place for the Aspergillus-derived aflatoxins (DMello et al., 1999).  
However, a selection of advisory and tolerance limits for the Fusarium  mycotoxins are 
available in the literature (Table 1.4) (DMello et al., 1999).  Countries like Canada, 
Russia, and the USA have established tolerance limits for DON of 500 to 2000 µg/kg for 
food for human consumption and up to 4000 µg/kg for feed for animal consumption 
(Leal and Mejía, 1997).  In Canada, wheat grain to be used for manufacturing infant food 
is temporarily permitted to contain up to 1000 µg/kg of DON (Egmond, 1989).  
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TOXIC EFFECTS 
 
The adverse effects of a mycotoxicosis result from interactions of the original (or 
metabolically modified) mycotoxin with subcellular organelles in the animal cell (Leeson 
et al., 1995).  The toxicity of the tricothecenes is largely due to their ability to inhibit 
protein synthesis (Ueno, 1983).  The immunotoxicity of A-tricothecenes especially that 
of T-2, was found to be less than that of the B-tricothecenes (Sharma et al., 1983).  
Generally, T-2 toxin and HT-2 toxin exhibit the strongest acute toxicity effects, closely 
followed by NIV.  Deoxynivalenol (DON) is considered to be about 10 times less toxic 
than T-2 and HT-2 toxins (Eriksen and Alexander, 1998).  The illness associated with the 
consumption of cereals contaminated with T-2 includes nausea, vomiting, necrotic 
lesions in the mouth and throat (making it difficult to eat), severe hemorrhagic diarrhea, 
and hemorrhaging in many of the body organs (Moss, 2002).   
The T-2 toxin is also a potent immunosuppressant, causing irreversible damage to 
the bone marrow, leading to a characteristic reduction in white blood cells (aleukia) 
(Moss, 2002).  Animal studies have consistently demonstrated immunomodulatory 
effects, ranging from suppression to stimulation of the immune system (Bondy and 
Pestka, 2000).  The T-2 toxin has been shown to cause necrosis and lymphoid depletion 
in the thymus, spleen, and lymph nodes of laboratory animals (Ueno, 1977).  Necrosis 
and depletion of lymphocytes in the thymus, bursa of Fabricius, and spleen have been 
reported in T-2-toxin treated chickens and turkey poults (Wyatt et al., 1973; Boonchuvit 
et al., 1975; Richard et al., 1978a, 1978b; Hoerr et al., 1981).  Tricothecenes have been 
associated with alterations of serum proteins and immunoglobulin profiles, reduced 
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antibody formation, thymic aplasia, reduced cell mediated immunity but with enhanced 
delayed cutaneous hypersensivity, and impairment of bacterial clearance and acquired 
immunity (Pier and McLaughlin, 1985).   
The immunosuppressive effects of the tricothecenes on both cellular and 
antibody-mediated immunity decrease host resistance to infectious agents.  Mortality 
caused by paratyphoid infection was reported to be increased in chickens exposed to T-2 
toxin (Boonchuvit et al., 1975; Ziprin and Elissalde, 1990).  Antibody responses to sheep 
red blood cells were decreased in mice exposed to T-2 (Lafarge-Frayssinet et al., 1979; 
Rosenstein et al., 1981; Holt and DeLoach, 1988), and in swine vaccinated with necrotic 
enteritis vaccine (Rafai and Tuboly, 1982).  In addition to immunossuppression, 
tricothecenes may induce immunomodulating effects including decreased spontaneous 
antibody producing cells in the spleen, increased IgA production in isolated splenocytes, 
enhanced delayed hypersensitivity, and blastogenic responses of T and B lymphocytes 
(Corrier, 1991).   
The LD50 values of the tricothecenes vary with the particular toxin and the type 
and age of the animal.  For male broiler chicks, Hoerr et al. (1981) reported that for T-2, 
the 72-h single oral LD50 was 4.0 mg/kg.  In addition, T-2 administered as 14 daily oral 
doses had an LD50 of 2.90 mg/kg.  In contrast, according to Nemanič (1992), a quantity 
of 0.5 mg/kg T-2 toxin in food over 2 weeks exposure can cause pathological changes in 
the thymus, bursa of Fabricius, and spleen.  However, it is hard to pinpoint the LD50 for 
these toxins under natural conditions (Konjević et al., 2004).  For instance, Konjević et 
al. (2004) reported necrosis and depletion of lymphocytes in the bursa of Fabricius as 
well as severe multifocal necrosis in the stomach and gut mucous in Brahma poultry 
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eating a diet contaminated with 0.70 mg/kg T-2 plus 0.50 mg/kg DAS.  The chronicity 
factors (ratio of the acute to chronic LD50 doses) for T-2 is 0.73.  Chronicity factors near 
to one are indicative of compounds that are rapidly eliminated and tend not to accumulate 
(Osweiler et al., 1984).   
In vivo experiments with different animal species indicate that orally or 
parenterally administered T-2 does not bioaccumulate.  Short half-lives (less than 30 
minutes) have been reported for T-2 in swine, cattle, and dogs (Yagen and Bialer, 1993).  
Major metabolic pathways for tricothecenes include oxidation, de-epoxidation, 
hydrolysis, and glucuronide conjugation (Yagen and Bialer, 1993).  Enterohepatic re-
circulation of T-2 and its metabolites have been reported in the rat (Coddington et al., 
1989).  In vitro studies of human blood suggest that carboxylases may be important in the 
hydrolysis of T-2 to more polar and less toxic metabolites (Johnsen et al., 1988). 
In pigs, T-2 has also been implicated in both feed refusal and anorexia (Rafai et 
al., 1995), reduced weight gain, diarrhea, hemorrhaging, skin lesions, and 
immunosuppresion (Rasmussen et al., 2003).  The authors observed dose-related 
depressions in feed intake within one-week of feeding diets contaminated with T-2.  By 
the end of the three-week study, pigs fed T-2 toxin at 3 mg/kg had feed intakes, which 
were only 0.59 of control values (DMello et al., 1999).  Furthermore, in sows, T-2 may 
cause infertility, and after parenteral administration during the last trimester of gestation, 
is able to precipitate abortion within 48 h (Weaver et al., 1986).  The T-2 toxin also 
induces oral lesions in pigs, specifically on the mucosa of the pars oesophageal region, 
the incidence being dose related (Rafai et al., 1995).  In addition, T-2 can cause 
dermatitis of the snout, nose and buccal comissures in the pig (Rafai et al., 1995). 
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In poultry, NIV, T-2, and DAS induce gizzard erosions and oral lesions (Kubena 
et al., 1995; Kubena et al., 1997; Neiger et al., 1994; Vanyi et al., 1994a; and Vanyi et 
al., 1994b), longer prothrombin time and suppression of factor VIII and fibrinogen 
activities, as well as depletion and necrosis in the lymphopoetic organs and multifocal 
necrosis in the intestinal epithelium (Terao et al., 1978; Bitay et al., 1981; Hoerr et al., 
1982; Čonková et al., 2003).  Chicken macrophage viability may be reduced by exposure 
to T-2 tetraol, a derivative of T-2 (Kidd et al., 1997). According to Mézes et al. (1999), 
the most sensitive poultry species to T-2 toxin are geese, followed by ducks and chickens. 
Dvorska and Surai (2001) reported the effect of T-2 on the antioxidant systems of the 
liver of growing quail fed 8.1 mg T-2/kg for 30 days.  The authors reported that inclusion 
of T-2 in the quail diet was associated with a decrease in concentrations of the 
antioxidants alpha- and gamma-tocopherols, ascorbic acid, retinol, and retinyl esters.  In 
addition, they reported that liver susceptibility to lipid peroxidation was increased 
(Dvorska and Surai, 2001). 
In a murine model, oral doses of 10 mg/kg of T-2 resulted in lymphocyte 
apoptosis in thymus tissue, mesenteric lymph nodes, and Peyers patches (Nagata et al., 
2001).  The lowest-observable effect level for changes in immune parameters was 0.029 
mg/kg body weight per day for T-2, based upon a 3-week dietary study in pigs (Rafai et 
al., 1995).   
In pregnant mice, oral or intraperitoneal administration of T-2 produces maternal 
toxicity, fetal death, and fetal malformations (Hood et al., 1978; Rousseaux et al., 1985, 
1987; Stanford et al., 1975).  Likewise, Lafarge-Frayssinet et al. (1990) reported that T-2 
given to dams by oral, intraperitoneal or intravenous route readily crossed the placenta 
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and was distributed to the fetal spleen, thymus and liver, resulting in inhibition of T- and 
B- cells in the spleen and thymus.  Thymic atrophy (Holladay et al., 1993), a decrease in 
the viability of hematopoietic progenitor cells in the liver, and a decrease in the number 
of B cells were also reported in fetuses after the dams were exposed to T-2 (Holladay et 
al., 1995).  Ishigami et al. (1999) also reported that the damage in mouse embryos 
obtained from dams exposed to T-2 at 11 days of gestation might be produced by 
apoptosis.  Furthermore, Ishigami et al. (2001) studied apoptosis in mouse fetuses from 
dams exposed to T-2 at different days of gestation and concluded that T-2 toxin-induced 
apoptosis in the developing mouse fetuses might be a direct effect of T-2 on fetuses. 
In human tissues, cytotoxic effects of tricothecenes on megakaryocyte progenitor 
cells, as well as on red and white blood cell progenitors, have been reported in vitro 
(Froquet et al., 2001; Lautraite et al., 1997; Rio et al., 1997).   
In rabbits, ingestion of 0.5 mg of T-2 toxin/kg/day for 21 days reduced packed 
cell volume, total white blood cells, leukocyte and neutrophil counts and serum alkaline 
phosphatase activity (Aziz  et al., 1995).  Moreover, residues of T-2 toxin were found in 
the liver, kidney, and adrenal glands of animals that ingested food contaminated with T-2 
(Aziz et al., 1995).  The authors also reported degenerative changes and fibrosis of the 
liver, nephrosis of the kidneys, hemorrhages in the heart and lymphocyte depletion in the 
spleen (Aziz et al., 1995).  Likewise, Guerre et al. (2000) reported damaging effects from 
ingestion of 0.5 mg T-2/kg/day for five days on body weight gain and mortality of New 
Zealand white rabbits.  The authors also reported that a weak decrease in body weight 
gain and moderate signs of toxicity occurred in rabbits receiving 0.25 mg/kg/day.  Guerre 
et al. (2000) also reported that toxin administration became difficult in all experimentally 
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intoxicated rabbits because of feed refusal, whereas it was easier in the animals from the 
control group which is indicative of feed refusal seen in other species.  Furthermore, the 
authors described the signs of T-2 mycotoxicosis observed in these animals, which 
included reduced spontaneous movements, excessive salivation, and peribucal necrosis.  
In addition, the fur around the mouth, the nose, and on the foreleg was wet and tan-
stained (Guerre et al., 2000). 
In young, growing rainbow trout, feeding 5 mg/kg or more of dietary T-2 
significantly decreases growth rate and feed efficiency (Poston et al., 1982).  However, 
the observed anorexia or refusal of feed by fish continuously fed the mycotoxin at a 
concentration of 5 mg/kg or greater suggests that these were caused by inanition rather 
than by inefficient use of nutrients ingested (Poston et al., 1982).  In addition, feeding of 
graded levels of T-2 resulted in depressed hematocrit and blood hemoglobin 
concentration and feeding of 15 mg/kg T-2 toxin to adult trout caused hemorrhaging in 
the intestines and regurgitation of subsequently intubated feed regardless of T-2 toxin 
content (Poston et al., 1982).  Likewise, feeding fingerling rainbow trout a single acute 
dose (6.5 mg/kg body wt) caused extensive shedding of intestinal mucosa, severe edema 
with fluid in the body cavities (including those behind the eyes), and eventual death 
(Marasas et al., 1969). 
In juvenile channel catfish Ictalurus punctatus, feeding 1.25, 2.5, and 5.0 mg T-
2/kg diet for 8 weeks adversely affected growth and hematocrit values.  Survivability was 
adversely affected when levels of 2.5 and 5.0 mg/kg were fed.  Significantly poorer feed 
conversion was found only for the highest level of T-2.  In addition, histopathological 
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studies reviewed anomalies of stomach, head, and trunk kidneys when fish received the 
three highest levels of T-2 (Manning et al., 2003). 
 
MECHANISM 
 
The T-2 toxin affects synthesis of proteins resulting in immunossuppression.  In 
addition to immunosuppression, it has immunomodulatory effects and may induce lipid 
perroxidation.   
Toxicodynamic studies have demonstrated that the tricothecenes function as 
inhibitors of eukaryotic protein synthesis (Sudakin, 2003).  In eukaryotic cells, initiation 
of protein synthesis, elongation, and termination of the polypeptide chain takes place on 
ribosomes and requires peptidyltransferase (Corrier, 1991).  Tricothecenes bind to the 
60S ribosomal subunit and interact with the enzyme peptidyltranferase which is involved 
in elongation and termination steps of protein synthesis (Leeson et al., 1995).  The C12, 13 
epoxide group common to tricothecene is necessary for protein synthesis inhibition, while 
certain substitutions of the ring structure at the C3 and C4 positions lead to additional 
effects (Feinberg and Mc Laughlin, 1989).  This interaction leads to varying degrees of 
inhibition of peptide bond formation depending upon the chemical structure of the 
specific tricothecene (Cundliffe and Davies, 1977).  The more potent tricothecenes - 
including T-2  may inhibit the initiation of protein synthesis as well as the elongation 
and termination (Murthy et al., 1985).  Inhibition of protein synthesis also acts to inhibit 
RNA synthesis as an indirect secondary effect.  In addition, cells require newly 
synthesized protein for DNA synthesis and to complete mitosis (Mitchison, 1971).  
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Therefore, the cytotoxic-radiomimetric-like effects of T-2 toxin on rapidly dividing cells 
are caused by impaired DNA and RNA synthesis resulting indirectly from inhibition of 
peptidyltransferase and protein synthesis (Corrier, 1991).  A comparison of the 
molecular-cellular basis of protein synthesis inhibition by aflatoxin, ochratoxin and the 
tricothecene toxins indicates that while the site and primary event may differ, the 
immunosuppressive effects are ultimately caused by a common mechanism resulting 
directly or indirectly from inhibition of protein synthesis (Corrier, 1991).  Cells most 
susceptible to the action of tricothecenes are those having a high rate of regeneration such 
as lymphoid, erythroid, intestinal cryptal cells, and cells of parenchymal organs like liver, 
kidney, and pancreas (Leeson et al., 1995).  This implies that leukocytes and the immune 
system are the primary targets for T-2 (Bondy and Pestka, 2000). 
The mechanism of action by which T-2 appears to modulate the immune system 
may be due to the fact that T-2 causes depletion of T-lymphocytes and the failure of 
sensitized T cells and T-cell dependent immune-activated macrophages to accumulate at 
the centers of infection (Corrier and Ziprin, 1986b) to fight off the bacteria.  Masuko et 
al. (1977) and later on Otokawa et al. (1979) reported that T-2 interferes with at least one 
subset of T cells, T suppressor cells (Ts), which suppress immune responses (Roitt et al., 
1989) causing cell-mediated resistance against infectious agents.  To illustrate, Corrier 
and Ziprin (1986a, 1986b) evaluated the immunotoxic effects of T-2 and cyclosphamide 
(Cy) - a well known cytotoxic drug - on cell-mediated resistance in mice exposed to 
Listeria monocytes infection.  The authors found that necrosis and depletion of lymphoid 
tissue, a condition called lymphopenia, significantly decreased the influx and number of 
lymphocytes and macrophages occurring in Listeria-elicited peritoneal exudates and at 
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sites of infection in the liver and spleen of the toxin- and cyclophosphamide-treated mice.  
Furthermore, the authors concluded that the immunotoxic effects of T-2 and Cy were 
comparable and attributed primarily to the depletion of T lymphocytes and the 
subsequent failure of surviving immunologically committed T cells and T-cell dependent 
immune-activated macrophages to clear the host of bacteria (Corrier and Ziprin, 1986a, 
1986b).   
The sequence by which this mechanism occurs is: 1) bacteria are removed by T-
lymphocyte dependent immune-activated macrophages (Cheers and McKenzie, 1978; 
Mackaness, 1961; North, 1973; Koster et al., 1971); 2) Phagocytes may be recruited from 
circulating monocytes and neutrophils (North, 1970; Czuprynski et al., 1984) or from 
granulocyte/macrophage precursor cells (Luster et al., 1981; Bennett and Baker, 1977).  
Functional expression of resistance is further dependent on the accumulation of sensitized 
T cells at sites of Listeria infection where they promote the influx and activation of 
macrophages (Koster et al., 1971; McGregor and Logie, 1973, 74; North, 1974).  
Peritoneal exudates elicited by intraperitoneal inoculation of Listeria are especially rich 
in sensitized T lymphoblasts (Koster et al., 1971; McGregor and Logie, 1974; North, 
1974), which will trigger the immune response via signaling other immune cells 
(macrophages) - via secretion of macrophage-activating factor (interleukin-2) and other 
lymphokines - to migrate to the sites of infection to fight off the bacteria, which is 
characterized by the influx and accumulation of lymphocytes and macrophages in the 
peritoneal cavity and at centers of infection in the liver and spleen.  When the immune 
response was negatively altered, the influx of mononuclear cells markedly decreased and 
the cells failed to populate the sites of infection; therefore, there was failure to clear the 
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host of infection, which explains why Corrier and Ziprin (1986a, 1986b) reported rapid 
growth of Listeria in the spleen, increased numbers of Listeria colonies at the foci of 
infection in the liver and spleen, and ultimately in the higher mortality that occurred in 
the T-2- and Cy-treated mice. 
Second, the tricothecenes may induce other immunomodulating effects in addition 
to immunosuppression (Corrier, 1991).  Oral gavage of mice with T-2 toxin was observed 
to increase spontaneous antibody producing cells in the spleen (Pestka and Bondy, 1990).  
The same researchers reported increased IgA production in splenocytes isolated from 
vomitoxin-treated mice (Corrier, 1991).  T-2 toxin was also reported to enhance the 
delayed hypersensitivity response to sheep erythrocytes in mice (Masuko et al., 1977; 
Otokawa et al., 1979).  The authors suggested that T-2 toxin might have depleted or 
interfered with suppressor cells that may regulate the cell-mediated response.  Low 
dosages of T-2 were reported to enhance the blastogenic responses of T and B-
lymphocytes (LaFarge-Frayssinet et al., 1979; Holt et al., 1988a, 1988b).  In addition, 
superinduction of cellular proteins such as IL-1 and IL-2, that regulate intercellular 
communications in the immune system, have been reported using tricothecenes (Miller 
and Atkinson, 1986; Holt et al., 1988a, 1988b).  Proposed mechanisms that may account 
for these effects include interference with high turnover proteins that limit translation of 
mRNA for interleukin synthesis or impaired degradation of intracellular interleukins 
(Miller and Arkinson, 1986). 
The T-2 toxin has been observed to suppress or enhance macrophage activity 
(Corrier, 1991).  However, this activity was dependent on time of toxin treatment and the 
immune challenge (Corrier, 1991).  For instance, post treatment of mice with Listeria 
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challenge suppressed resistance to listeriosis (Corrier and Ziprin, 1986b; Corrier et al., 
1987).  In contrast, pretreatment with T-2 toxin prior to challenge markedly enhanced 
resistance to listeriosis (Corrier and Ziprin, 1986a).  Enhanced resistance was associated 
with increased migration of macrophages and enhanced phagocytic activity (Corrier et 
al., 1987).  Enhanced resistance was also accompanied by necrosis and depletion of 
lymphocytes in the thymus and spleen, leukocytopenia, and lymphopenia.  Increased 
resistance to listeriosis in thymus-deprived mice (Cheers and Waller, 1975; Newborg and 
North, 1980) and in mice treated with the cytotoxic drug cyclophosphamide (Tripathy 
and Mackaness, 1969a, 1969b; Luster et al., 1981) was attributed to the removal of a 
radiosensitive population of regulatory T-cells.  Supressor T cell are short lived 
lymphocytes that are more susceptible to cytotoxic agents than are other subpopulations 
of lymphocytes (Mitsuoka et al., 1976; Chan et al., 1977).  Enhanced host resistance in 
mice exposed to T-2 prior to Listeria challenge may have been caused by the depletion or 
impaired function of regulatory T suppressor cell population and subsequent 
enhancement of macrophage activity (Corrier, 1991).  The results of in vivo studies on  
T-2 toxin modulation of host resistance to listeriosis further demonstrate that the 
immunomodulating effects of the mycotoxins on host resistance may be influenced by 
numerous contributing factors that may not be present or detected during in vitro studies 
(Corrier, 1991).  Likewise, the well-demonstrated inflammatory and irritant action of T-2 
toward the gastrointestinal tract (Marasas et al., 1969; Wyatt et al., 1973) suggests that 
the natural barriers to invasion by the intestinal pathogen Salmonella (Perry et al., 1972) 
may be more readily breached during T-2 toxicosis.  The resulting bacteremia would 
normally be combated by the phagocytic cells, but the smaller spleen caused by T-2 and 
 33
the negative interaction on spleen size by T-2 suggest that the phagocytic cells of the 
reticuloendothelial system are impaired (Boonchuvit et al., 1975).   
To conclude, inhibition of synthesis of proteins will lead to immunosuppression 
because secretion of macrophage-activating factor (interleukin-2) and other lymphokynes 
by sensitized T lymphoblasts requires the induction of specific messenger RNA and new 
protein synthesis (Granelli-Piperno et al., 1984).  The T-2 toxin inhibits 
peptidyltransferase activity necessary for new protein synthesis (Schindler, 1974).  
Although speculative, a mechanism may exist whereby T-2 may cause functional 
impairment of surviving lymphocytes by inhibiting the synthesis of lymphokine proteins 
that activate macrophages (Corrier and Ziprin, 1986a,1986b).  For animal production, the 
implication of a suppressed immune system is the inhibition of vaccine efficacy and of 
resistance to different agents (Palyusik and Bitay, 1992) resulting in increased mortality 
(Boonchuvit et al., 1975). 
In addition, T-2 may also stimulate lipid peroxidation.  It has been concluded that 
T-2 primarily causes damage to the membrane systems of liver cells, and that 
peroxidation of the membrane lipids is secondarily stimulated (Karppanen et al., 1989).  
The T-2 toxin can be incorporated into the lipid or protein components of the cell 
membranes due to its amphipathic character (Leeson et al., 1995).  Several reports 
indicate that T-2 is able to induce a dose-dependent stimulation of lipid peroxidation in 
rat and mice liver (Tsuchida et al., 1984; Ahmed and Ram, 1986; Chang and Mar, 1988; 
Karppanen et al., 1989; Suneja et al., 1989).  Lipid peroxidation is one of the factors 
responsible for the damage and necrosis of liver induced by chemicals and mycotoxins 
(Plaa and Witschi, 1976).  Lipid peroxidation is believed to be caused by depletion of 
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hepatic gluthanione (GSH) and/or production of free radicals (Leeson et al., 1995).  
Guerre et al. (2000) demonstrated that total liver microsomal cytochrome P450 content 
and monooxygenase activities were decreased when 0.25 mg T-2/kg/day was given to 
rabbits.  At this dose, the authors reported that T-2 exposure also produced microsomal 
oxidative damages (Guerre et al., 2000) which impaired the P450 microsomal 
environment, leading to increased protein denaturation and degradation (Serbinova et al., 
1989; Kitada et al., 1989; Mori et al., 1991).   
Karppanen et al. (1989) suggests that when toxic agents stimulate lipid 
peroxidation, the peroxidation reaction results in disturbances in the functioning and 
structure of the cell membranes.  The nonenzymatic auto oxidation of the polyunsaturated 
fatty acids produces a complex mixture of products that have the same biological 
reactivities of the tricothecenes such as a strong inhibition of various enzyme reactions 
(4-hydroxyoctenal) and a strong inhibitory effect on protein synthesis (4-
hydroxypentenal).  When the tricotechenes trigger lipid peroxidation, their toxic effect is 
enhanced and continue even after the toxins have been metabolized and excreted 
(Karppanen et al., 1989). 
The epoxy group of T-2 competes with the substrates for gluthaniones-s-
transferases (Ueno, 1977).  This may result in a decreased content of GSH.  Prevention of 
lipid peroxidation is primarily connected with GSH metabolism and with the ability of 
hepatic glutathione peroxidase to remove hydrogen peroxides (H2O2) and organic 
peroxides in the compartments where catalase is absent (Sies et al., 1972).  It is possible 
that T-2 reduces the level of GSH which is required for the elimination of peroxide 
radicals.  The level of GSH is affected by the activities of the GSH-shuttle enzymes  
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glutathione peroxidase, glutathione reductase, and glucose-6-phosphate - (Plaa and 
Witschi, 1976; Giri et al., 1983).  Agents that cause lung damage by generating reactive 
oxygen species stimulate a protective antioxidant cellular defense mechanism for 
detoxifying O2 and lipid peroxides (Giri et al., 1983) by enhancing lung lipid 
peroxidation and simultaneously raising the activities of glutathione-shuttle enzymes and 
catalase.  Suneja et al. (1989) reported an increase in the activities of liver GSH-shuttle 
enzymes after short term T-2 feeding (2.0 mg/kg) and long term T-2 feeding (0.75 
mg/kg) in rats and concluded that T-2 may be generating reactive oxygen radicals.  In 
addition, it has been shown that T-2 administered to mice cause a significant increase in 
respiratory burst of macrophages, which lead to release of reactive oxygen species into 
the blood stream (Cooray and Jonsson, 1990).   
In conclusion, antioxidants are of primary value biologically in restricting the 
damage that reactive free radicals can cause to cells and cellular components.  The bodys 
antioxidant defense mechanisms normally keep free radicals in check, protecting the 
body from oxidative damage.  However, during exposure to high concentrations of 
toxicants, free radicals may overwhelm the cellular defense mechanism, causing 
excessive oxidative stress with consequent cell- and tissue damage (Rizzo et al., 1994).  
To illustrate, when Rizzo et al. (1994) fed male rats a diet deficient in vitamins C, E, and 
selenium, after administration of T-2 (3.6 mg/kg BW), there was an increase in lipid 
peroxidation by 307% as detected by analysis of thiobarbituric acid-reactive substances 
in liver samples when compared to the animals fed diets sufficient in these antioxidants.   
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 E. coli lipopolysaccharide(LPS) 
 
Bacterial endotoxin or lipopolysaccharide (LPS) is a major component of the cell 
wall of Gram-negative bacteria and is one of the features that distinguish these bacteria 
from Gram-positive bacteria (Hewett and Roth, 1993).  Examples of gram negative 
bacteria include Escherichia coli and Salmonella typhimurium.   The LPS molecule can 
be divided into three parts: the lipid moiety, the R-core, and the O-polysaccharide (Elin 
and Wolff, 1976).  The lipid moiety consists of an insoluble fraction called lipid A and a 
soluble fraction which contains polysaccharides.  Lipid A refers to all chemical 
compounds that become insoluble after acid hydrolysis of LPS whereas the R-core is the 
middle part of the LPS molecule linking the lipid moiety to the O-polysaccharide moiety.  
Finally, the O-polysaccharide portion is made of a regular sequence of either linear or 
branched sugars (Hellerqvist et al., 1969).  The O-polysaccharides determines the O-
antigenic specificity of the bacterium (Hewett and Roth, 1993).   
Exposure to LPS may occur as a result of infection by gram negative bacteria or 
in the absence of bacterial infection (Figure 2.1). First, as an integral part of Gram 
negative bacteria, LPS is not normally released into the extracellular fluid in a free form; 
however, it can be liberated from dividing or dead bacteria during infection by Gram 
negative bacteria (Hewett and Roth, 1993).  LPS exposure can also occur through 
increased absorption of LPS from the gastrointestinal tract (GIT), and in the absence of 
bacterial infection via the respiratory tract by breathing of dust contaminated with 
endotoxin (Figure 2.1). 
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LPS is released from dividing and dead bacteria during infection by Gram-negative 
bacteria (1); LPS derived from endogenous Gram-negative bacterial flora is absorbed 
from the gastrointestinal tract (GI, 2); by breathing endotoxin-contaminated dust (4); and 
is transported to the liver or to the systemic circulation by the portal vein (3a) or 
lymphatic system (3b), respectively (Hewett and Roth, 1993). 
 
Figure 2.1. Means of exposure to LPS (Adapted from Hewett and Roth, 1993) 
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The GIT, particularly the colon, normally contains a large concentration of LPS 
that is derived from endogenous Gram-negative flora of the gut (Ditter et al., 1983).  
Under normal conditions, the intestinal wall acts as a formidable barrier to the passage of 
LPS from the GIT into the blood stream.  However, disruption of this barrier during 
certain pathophysiological conditions, such as T-2 exposure, can lead to systemic 
endotoxaemia (Hewett and Roth, 1976) by increasing LPS absorption from the GIT.  To 
illustrate, increased absorption of LPS has been associated with chemically induced liver 
injury (Grun et al., 1976), partial hepatectomy (Cornell, 1985; Van Leeuwen et al., 1991) 
and intestinal ischemia/reperfusion (Gathiram et al., 1986; Caty et al., 1990). 
Lipopolysaccharide exposure can also occur in the absence of bacterial infection.  
For instance, endotoxin can be present in the house dust (Michel et al., 1991; Peterson et 
al., 1964).  In humans, the level of this exposure is an important determinant of asthma 
severity (Michel et al., 1996).  Endotoxin may increase asthma severity by extending 
airway inflammation since inhalation of endotoxin contaminated dust increases the 
neutrophil number in bronchoalveolar lavage fluid (Sandstrom et al., 1992).    In horses, 
inhaled endotoxin and organic dust particulates have synergistic proinflammatory effects 
in equine heaves (a condition called organic dust-induced asthma).  This condition is 
characterized by airway neutrophilia, mucus hypersecretion and obstructive lung 
dysfunction (Pirie et al., 2003).    
When a challenge occurs, the normal metabolism is altered and its priority is 
shifted to mechanisms that support the immune system.  In rodent models, the 
physiological response includes a depression in peripheral tissue glucose uptake and 
insulin sensitivity (Ling et al., 1994) and an increase in circulating triglycerides and 
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cholesterol (Grunfeld and Feingold, 1992).    During sepsis and infection, cytokines are 
released to ensure adequate nutrient supply to the tissues with a large number of 
inflammatory cells resulting in an increase in muscle protein breakdown (Flores et al., 
1989), an increase in hepatic glucose output (Westfall and Sayeed, 1988; Filkins et al., 
1989), and a redistribution of infused glucose away from skeletal muscle (Ling et al., 
1994).  Thus, this cytokine-regulated process is both essential for normal host defense, 
and detrimental to bodily functions (Wenzel et al., 1996).   
Nolan and co-workers noted a relationship between exposure to endotoxin and 
modification of liver injury (Nolan, 1981; Nolan and Camara, 1989; Nolan 1989) in that 
exposure of LPS augments the hepatoxicity of xenobiotic agents.  The first studies were 
conducted with carbon tetrachloride (CCl4) (Roth et al., 1997).  The hepatotoxic effects 
of CCl4 are reduced in animal in which LPS exposure is prevented  e.g. by the use of the 
antibiotic polymyxin B  and in animals rendered insensitive to LPS (Leach and Forbes, 
1941; Nolan and Ali, 1973).  Finally, Formal et al. (1960) co-administered LPS with 
CCl4 and concluded that LPS increases the toxicity of CCl4 (Roth et al., 1997).   
In addition to CCl4, concurrent exposure to LPS markedly increases the liver 
injury and/or lethality produced by a number of hepatotoxicants.  Co-administration of 
LPS markedly increases the severity of ethanol hepatitis (Bhagwandeen et al., 1987), and 
it potentiates liver injury from T-2 toxin (Tai and Pestka, 1988) as well as from halothane 
exposure in hypoxic rats (Lind et al., 1984).  The hepatotoxic effects of allyl alcohol are 
magnified by LPS co administration, and this occur at LPS doses that  are three to four 
orders of magnitude smaller than those which produce liver injury when LPS is given 
alone.  Roth et al. (1997) reported that treatment of rats with modest doses of LPS results 
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in liver injury upon co-administration of chlorpromazine, ethionine, deoxyvalenol, 
monocrotaline, or AFB1 at doses that are otherwise not hepatotoxic. 
It is also possible that hepatotoxicity from some chemicals arise indirectly from 
primary damage to the GIT which increases translocation of LPS into portal venous 
circulation (Roth et al., 1997).  Under these conditions, the liver is exposed to injurious 
amounts of this bacterial product, and the hepatotoxicity resembles liver injury seen in 
response to relatively large doses of LPS (Roth et al., 1997).  For example, both cadmium 
and T-2 damage the GIT.  As a result, there is an increase in concentration of LPS in 
portal venous blood and the genesis of a liver lesion which resembles that produced by 
large noninjurious doses of LPS (Roth et al., 1997). 
Roth et al. (1997) proposed a hypothesis of how LPS exposure may be an 
important determinant of susceptibility to intoxication from certain xenobiotic agents.  
Hepatotoxic agents initiate tissue injury through a variety of mechanisms: lipid 
peroxidation, covalent binding of reactive metabolites to cellular macromolecules, DNA 
damage, and altered gene expression.  At large xenobiotic doses, these mechanisms are so 
pronounced that they are sufficient to cause overt tissue injury.  At smaller doses, the 
same mechanisms may initiate an alteration in cellular homeostasis that by itself is 
insufficient to lead to injury.  However, the presence of additional host derived factors 
may force progression of such cellular alterations to tissue damage.  These host factors 
can arise from the inflammatory response invoked by LPS exposure, caused either by 
action of the xenobiotic agent itself on the GIT or by independent events, such as locus of 
infection or a concurrent disease or dietary alteration that increases GI translocation of 
LPS.  Diseases that impair hepatic clearance of LPS may further enhance its effects.   
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When activated by LPS, inflammatory cells such as Kupffer cells and neutrophils 
release numerous soluble mediators that may act on parenchymal cells stressed by 
xenobiotic exposure, leading to overt hepatocellular injury (Roth et al., 1997). 
Animals are naturally exposed to high levels of LPS, with poultry operations 
being the most contaminated, followed by swine operations (Simpson et al., 1999).  
Endotoxin is ubiquitous and from a commercial stand-point, this means that performance 
may be affected.  For instance, commercial pork producers are only able to achieve 
approximately 65% of the pigs genetic potential for growth rate as compared to the 
performance at a genetic nucleus farm.  There is no doubt disease challenge is one of the 
factors contributing tremendously to this reduction in performance (Frank, 2003). 
Besides exposure to high levels of endotoxin, animals are sometimes exposed to 
continuous low levels of mycotoxins in feed.  Mycotoxins, such as aflatoxin B1 (AFB1) 
and the T-2 toxin (T-2) are immunosuppressive and hepatotoxic, and in combination with 
endotoxin can render the animal more susceptible to infections resulting in lower feed 
intake, lower body weight gain, and poor feed conversion.  In fact, the possible 
interactions between mycotoxins and infectious disease have been the subject of concern 
in animal husbandry and veterinary medicine ever since reports of aflatoxicosis by Siller 
and Ostler (1961) described the isolation of Salmonella from the internal organs of 
turkeys during field outbreaks of the disease (Cooray and Jonsson, 1990). 
Barton et al. (2001) reported that exposure to a non-toxic dose of bacterial 
endotoxin potentiates the hepatotoxicity of AFB1 in rats.  Exposure to smaller doses of 
LPS initiates a more modest and noninjurious inflammatory response.  However, 
exposure to such doses can render the liver more sensitive to injury from hepatotoxic 
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chemicals, including AFB1.  A small dose of LPS can convert an otherwise nontoxic 
dose of AFB1 into one that is markedly hepatotoxic (Barton et al., 2001). 
In 1988, Tai and Pestka investigated the synergistic interaction between the 
tricothecene T-2 toxin and S. typhimurium LPS in both LPS-susceptible (C3H/HeN) and 
LPS-resistant (C3H/HeJ) mice.  They found that the LD50 values for LPS decreased by 
14-fold and 4.5-fold upon co-administration with T-2 at a level of 1 mg/kg in both 
C3H/HeN and C3H/HeJ mice, respectively and increased mortality due to impaired 
splenic function in the C3H/HeN mice.   
Inhibition of protein synthesis by tricothecenes may increase susceptibility to 
microbial infections, because host defense is ultimately dependent upon the production of 
specific proteins in sufficient quantities to combact an infectious process as well as to 
repair cellular damage (Beisel, 1977).   
 
TOXICITY 
 
 A number of factors influence the response to LPS in vivo, including species 
differences (Kuida et al., 1961; McCuskey et al., 1984), routes of exposure (Jacobson and 
Farrar, 1963), dosing protocols (e.g. bolus injection or infusion) (DOrio et al., 1987), 
timing of exposure (Elliott et al., 1991), and age of the animal (Durham et al., 1990).  In 
addition, LPS from different strains and species of gram-negative bacteria expresses large 
differences in potencies (Sanchez-Cantu et al., 1991).  Although the outcomes of LPS 
exposure may vary under different conditions, it is clear that many of the adverse effects 
of LPS are dependent on endogenous mediators generated by the host in response to LPS 
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(Morrison and Ulevitch, 1979).  Some of the mediators are lipid mediators such as 
arachidonic acid metabolites and platelet activating factor (PAF), cytokines such as tumor 
necrosis factor-α (TNF-α), interferon-γ (IFN- γ), interleukins (ILs), and reactive oxygen 
metabolites, particularly superoxide, nitric oxide (NO), and their derivatives (Hewett and 
Roth, 1993).  Factors derived from the coagulation and complement systems may 
contribute to tissue injury under certain circumstances (Hewett and Roth, 1993).   
Lipopolysaccharide is cytotoxic to cells in vitro under certain conditions.  For 
example, marked degenerative morphological changes occurred after exposure of 
cultured vascular endothelial cells to LPS (Gartner et al., 1988), and were accompanied 
by increased cell detachment, leakage of cytoplasmatic contents and decreased DNA, 
RNA, and protein synthesis.  Moreover, injury to cultured endothelial cells was both dose 
(> 0.1 µg/ml) and duration of LPS exposure (> 4 h) dependent and was enhanced by the 
presence of serum, suggesting that it could be modified by the presence of 
lipopolysaccharide binding proteins (LBP) (Harlan et al., 1983; Meyrick, 1986; Patrick et 
al., 1992). 
 Oxygen radical production and conjugated diene formation were associated with 
LPS-induced endothelial cell cytotoxicity, suggesting that injury to endothelial cells in 
vitro is mediated by oxygen radical-dependent lipid peroxidation (Brigham et al., 1987).  
Moreover, the cytotoxicity was attenuated by oxygen radical scavengers (Hewett and 
Roth, 1993).  Results from recent study suggest that a similar mechanism may contribute 
to LPS-induced injury to vascular endothelial cells in vivo (Matsuda et al., 1991). 
 In an in vitro study, and at very high concentrations (Hewett and Roth, 1993), 
LPS was cytotoxic to other cells as well, such as cultured macrophages (Glode et al., 
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1977) and fibroblasts (Ryan and McAdam, 1977).  However, the involvement of reactive 
oxygen metabolites in these instances has not been reported.  In contrast, at a low 
concentration of LPS, Jean and Roth (1993) determined that LPS was minimally 
cytotoxic to isolated hepatocytes.  It is yet to be determined how important this cytotoxic 
effect of LPS is in vivo.  It is likely that the most toxic effect of LPS in vivo is mediated 
indirectly by host-derived soluble mediators and cells such as PMNs (neutrophils). 
 In addition to its cytotoxic effects, LPS stimulates the release of a variety of 
inflammatory mediators from cultured cells.  These potent substances are implicated in 
the pathophysiological alterations associated with LPS exposure in vivo. 
Hewett and Roth (1993) reviewed LPS-induced injury on extrahepatic tissues, 
including the cardiovascular system, kidneys, gastrointestinal tract, and lungs as well as 
the hepatic changes.  LPS-induced injury on the cardiovascular system is characterized 
by a dramatic decrease in cardiac output within 1 h after a bolus intravenous dose of LPS 
(Hinshaw, 1979; Somani and Sairi, 1981, Olson, 1987; DOrio et al., 1987; Milligan et 
al., 1988) and is associated with a decrease in venous return (Hinshaw, 1979) .  In 
addition to alterations in cardiac output, there is a decrease in mean arterial blood 
pressure (DOrio et al., 1987; Olson, 1987; Wakabayashi et al., 1987) followed by a 
decrease in vascular contractility (Hewett and Roth, 1993).  As a result, blood flow is 
altered to most tissues, but the most affected organs are heart, kidney, pancreas, and 
spleen (Ferguson et al., 1978; Somani and Sairi, 1981; Breslow et al., 1987).   
In addition, in vitro experiments have demonstrated that LPS activates the 
coagulation system in both the extrinsic and intrinsic pathways, through the release of 
tissue factor from vascular cells (Rivers et al., 1975; Colucci et al., 1983), and promotes 
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disseminated intravascular coagulation (DIC) by antagonizing fibrinolysis (Hewett and 
Roth, 1993).  Disseminated intravascular coagulation is characterized by a reduction in 
circulating platelet numbers (Emerson et al., 1987; Smith et al., 1988; Sandset et al., 
1991), clotting factors, and fibrinogen (Emerson et al., 1987; Sandset et al., 1991), and 
by the deposition of fibrin in the microvasculature of various tissues, including the liver, 
kidney, and lung contributing to the LPS pathogenesis of these organs.  These changes 
are accompanied by increases in both prothrombin and partial prothrombin times 
(Lipinski et al., 1976; Emerson et al., 1987; Yoshikawa et al., 1981).  
 Kidneys are also affected by LPS exposure.  Lipopolysaccharide exposure causes 
renal tubular necrosis by a DIC-dependent pathway (Raij et al., 1977).  In addition,  and 
via a number of lipid mediators, LPS exposure indirectly causes marked decreases in 
renal blood flow (RBF), glomerular filtration rate (GFT), sodium reabsorption, and renal 
tissue potassium concentration (Badr et al., 1986; Cohen et al., 1990; Badr, 1992).  This 
is mediated by a number of lipid mediators (certain metabolites of arachidonic acid) 
(Hewett and Roth, 1993). 
 Furthermore, in the gastrointestinal tract (GIT) severe endotoxemia causes 
detachment of epithelial cells from the mucosal basement membrane, inflammatory cell 
infiltration, vascular congestion, and an increase in vascular permeability (Wallace et al., 
1987).  These changes accentuate the leak of further endotoxin, causing a loss of 
circulatory volume into interstitial tissue, promoting hypotension and increasing tissue 
ischemia (Ghosh et al., 1993). 
 In addition, pulmonary dysfunction is a hallmark of circulatory shock and sepsis 
(Ghosh et al., 1993).  The changes observed in acute respiratory distress characterized by 
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the adult respiratory distress syndrome (ARDS), frequently accompanies gram-negative 
infection (Fein et al., 1983) and the symptoms are similar to those seen in experimental 
endotoxemia (Esbenshade et al., 1982; Brigham and Meyrick, 1986): increased mean 
pulmonary arterial pressure, pulmonar vascular resistance, and alveolar-capillary 
membrane permeability together with decreased dynamic lung compliance and functional 
residual capacity leading to pulmonary edema, ventilation/perfusion mismatch, and 
hypoxia by impairment of gas exchange (Ghosh et al., 1993). 
 Particular attention should be given to the liver as liver dysfunction may trigger 
multiorgan failure because of overt failure of metabolic, synthetic, and phagocytic 
functions of the liver (Hewett and Roth, 1993).  The liver performs a number of 
important physiological functions such as carbohydrate metabolism, fat and cholesterol 
metabolism, and synthesis and excretion of bile constituents and plasma proteins.  It also 
plays an important role in the elimination and detoxification of xenobiotics agents 
(Hewett and Roth, 1993).    These functions are performed by hepatic parenchymal cells 
which comprise approximately 80% of the hepatic cells, and a heterogeneous population 
 the nonparenchymal cell fraction  consisting of fenestrated vascular endothelial cells, 
resident vascular macrophages (Kupffer cells), fat storage cells (Ito cells), and bile duct 
epithelial cells (Hewett and Roth, 1993). 
 The basic structural unit of the liver, in which hepatic cells come in close contact 
with the blood, is the liver lobule.   The lobule consists of cords of parenchymal cells 
radiating from a central vein through which blood exits the lobule and is transported to 
the inferior vena cava. Endothelial cells and Kupffer cells comprise the bulk of the 
sinusoid lining (Nolan, 1981).  Endothelial cells form the lining of the sinusoids and form 
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a sleeve-like plate that allows particles below a certain size to reach the hepatocytes.  
These cells ingest particles, such as endotoxin, by pinocitosis or absorptive endocytosis 
with vesicle formation and fluid incorporation (Nolan, 1981).  Kupffer cells are scattered 
throughout the sinusoids.  These cells remove dead blood cells as well as cell debris, and 
foreign substances, such as LPS, from the circulation.  Therefore, they are critical to the 
detoxification and action of LPS. 
 During exposure to LPS, morphological and functional alterations occur in the 
liver during septicemia (Levy et al., 1967; Utili et al., 1977; Hirata et al., 1980).  The 
earliest changes in morphological alterations are characterized by dilation of Kupffer cell 
endoplasmatic reticulum, and damage to the plasma and nuclear membranes.  This leads 
to injury to endothelial cells and appearance of fibrin clumps and platelet thrombin in the 
sinusoids, to swelling of the microvilli on the sinusoidal border, and dilation of bile 
canaliculi.  These alterations will culminate with hepatocellular degeneration and 
necrosis.  Lesions are multifocal, frequently involving parenchymal cells in the midzonal 
region of the liver lobule and are often infiltrated with PMNs.  In addition, there are 
increases in plasma activities of liver enzymes, such as aspartate and alanine 
aminotransferase, suggesting membrane cell damage to parenchymal cells (Sleeman and 
Hardaway, 1967; Shibayama, 1987; Hewett et al., 1992).   
 Among the functional changes in the liver after LPS exposure are changes in 
carbohydrate, lipid, and protein metabolism, cholesteasis, and circulatory alterations such 
as portal hypertension, and a disruption of hepatic blood flow (Hewett and Roth, 1993). 
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MECHANISM OF ACTION 
  
- Cell activation: 
Bacterial endotoxins initiate the syndrome of sepsis associated with gram-
negative rod infection (Wenzel et al., 1996).  This response is mediated by two 
biochemical elements known to recognize LPS (Figure 1.17): an LPS-binding protein 
(LPB), an acute phase reactant, and a membrane or soluble receptor known as CD14 
(Wenzel et al., 1996). 
CD14 is anchored in the cell membrane of monocytes and macrophages as a 
glycerophosphatidylinositol (GPI)-tailed protein.  Once LPS binds to it, the complex 
LPS-CD14 triggers an interaction of some portion of the CD14 protein with another cell 
membrane component (Tobias et al., 1986; Ulevitch and Tobias, 1995).  Both GPI-
anchored CD14 and soluble CD14 bind LPS resulting in cell activation to new gene 
expression.  In both cases, LPS-CD14 interactions are markedly facilitated by LBP; 
which acts as a transfer protein (Tobias et al., 1986; Han et al., 1994).  Binding of LPS to 
GPI-anchored CD14 also results in rapid translocation of LPS from the cell-membrane to 
intracellular locations (Gallay et al., 1993).  The treatment of macrophages with LPS 
resulted in increased protein tyrosine phosphorylation (Han et al., 1993; Weinstein et al., 
1991) targeting a new member of the mitogen activated protein (MAP) kinase family 
(Han et al., 1994): protein p38 which activates the biosynthesis of cytokines like IL-1 and 
TNF (Wenzel et al., 1996).  Besides signaling, CD14 functions as a surface protein 
mediating internalization of LPS (Hack et al., 1989) via a transmembrane protein which 
has been postulated but not yet identified (Ulevitch and Tobias, 1995).  
 49
- Cardiovascular system: 
Lipopolysaccharide reacts with leukocytes, platelets, the complement system, and 
other serum proteins to increase blood levels of proteolytic enzymes and of certain 
vasoactive substances, such as histamine, kinins, and serotonin (Hinshaw et al., 1965) 
resulting in pooling of blood, primarily in the pulmonary and splanchnic vasculature 
(Lillehei et al., 1965).  As a result, there is an increased peripheral vasoconstriction 
resulting in poor tissue perfusion.   
Cardiac output is diminished by the direct myocardial depressing action of LPS 
and by a decrease in venous return secondary to the pooling of blood (Cho, 1972).  As a 
consequence, a series of events is initiated beginning with a drop in blood pressure and 
peripheral perfusion.  Endogenous catecholamines are liberated to compensate for the 
falling blood pressure which will then lead to tissue acidosis and anoxia (Rosenberg and 
Rush, 1966).  This initiates capillary congestion and dilatation which accentuates the 
decreased venous return and cardiac output.  The cellular hypoxia results in lysosomal 
disruption, leading to cell lysis, propagation of tissue injury, and death (Christy, 1971).   
- Disseminated intravascular coagulation (DIC): 
The coagulation system comprises circulating proenzymes and factors that, when 
activated, result in a coordinated cascade of proteolytic events which culminate in the 
conversion of prothrombin to thrombin.  A major action of thrombin is the cleavage of 
circulating fibrinogen.  This leads to the consumption of fibrinogen and to the formation 
of insoluble fibrin clots.  Clot formation is normally regulated by endogenous 
anticoagulant and fibrinolytic systems which limit the actions to sites of damaged blood 
vessels.  However, under certain pathophysiological conditions such as sepsis and severe 
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endotoxemia, the coagulation system can become activated systemically, resulting in 
disseminated intravascular coagulation and consequent tissue injury (Hewett and Roth, 
1995). 
The coagulation system plays an important role in the pathogenesis of LPS on 
organ tissues, such as lung, liver, and kidney.  Supporting evidence for this was provided 
by studies with the anticoagulant, heparin, which attenuated the decrease in plasma 
fibrinogen concentration and afforded protection against liver injury (Hewett and Roth, 
1995).   
- Tissue injury: 
Kidneys:  A number of lipid mediators have been implicated in the effects of LPS 
on kidney function.  Among these are certain metabolites of arachidonic acid, including 
leukotrienes (potent vasoconstrictors), tromboxane, and platelet activating factor (PAF).  
The latter causes contraction of smooth muscle and glomerular mesangial cells in vitro 
(Schlondorff et al., 1984).  In addition, endothelin may also contribute to decrease in 
RBF and GFR during LPS exposure.  This potent vasoconstrictor is released from 
vascular endothelial cells in vitro, and its circulating concentration is elevated in vivo 
after exposure to LPS (Morel et al., 1991; Pernow et al., 1989; Sugiura et al., 1989).  
Endothelin induces contraction of renal blood vessels and glomerular mesangial cells in 
vitro (Edwards et al., 1990; Badr et al., 1989).  In contrast, IL-1 has been associated with 
increased Na excretion (Beasley et al., 1988), which was induced by prostaglandins, and 
the production of these prostaglandins were temporally related to alterations in sodium 
excretion after administration of IL-1 to rats (Hewett and Roth, 1993).  
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Gastrointestinal Tract:  The mechanism involved in the pathogenesis of 
gastrointestinal injury has not been clearly elucidated.  It is suggested (Hewett and Roth, 
1993) that, under severe endotoxemia, the effects of LPS are mediated by leukotrienes 
and PAF.  Leukotrienes induce vasoconstriction and promote increased vascular 
permeability promoting further leakage of endotoxin and hypotension.  Platelet 
Activating Factor contributes to LPS-induced GIT injury because a PAF concentration in 
the GIT is increased during LPS exposure (Whittle et al., 1987).  Platelet Activating 
Factor may mediate injury to the GIT in part by stimulating production of thromboxane 
A2 (Boughton-Smith et al., 1989).  In addition to leukotrienes and PAF, cytokines, most 
notably, TNF-α is also involved in the pathogenesis of gut injury during LPS exposure 
(Hewett and Roth, 1993).  In contrast, at low doses, LPS exposure causes perturbations in 
intestinal myoeletric activity.  These effects were attenuated by either cyclooxygenase 
inhibition or oxygen radical scavengers (Pons et al., 1991a, 1991b).  
Lungs:  Alterations in the lungs have been well characterized (Brigham and 
Meyrick, 1986).  It involves two phases.  Phase I occurs within the first hour after LPS 
exposure and is characterized by a marked increase in pulmonary arterial pressure and 
pulmonary vascular resistance. Phase I is mediated by thromboxane A2 (Olson et al. 
1985).  In addition to thromboxane, clotting factors are thought to be involved in lung 
injury as inhibitors of the clotting system attenuated the increase in pulmonary vascular 
resistance (Hoffman et al., 1990).  These early alterations are also accompanied by an 
increase in vascular permeability that is associated with polymorphonuclear neutrophil 
(PMN) infiltration, increased plasma protein leakage, and increased flow of protein rich 
lung lymph (Hewett and Roth, 1993).  Polymorphonuclear neutrophils (PMN) may cause 
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tissue injury by a mechanism that is dependent on oxygen radicals since oxygen 
metabolite scavengers (catalase and superoxide dismutase) provided protection against 
lung injury (Milligan et al., 1988; Koyama et al., 1992).  
In phase II, the pulmonary arterial pressure returns towards to normal, but still 
remains elevated.  Unlike the GIT, leukotrienes do not appear to mediate the LPS-
induced increase in vascular permeability in the lungs of rats (Cook et al., 1990; Koyama 
et al., 1992).  The second phase of lung injury may be mediated by PAF; however, the 
mechanism remains to be elucidated (Hewett and Roth, 1993).  Experiments have shown 
that PAF has a number of effects on PMN function in vitro, including priming and 
induction of reactive oxygen metabolite production, and adherence of PMNs to cell 
surfaces (Gay, 1990; Garcia et al., 1988; Tonnesen et al., 1989; Entman et al., 1990).  It 
has also been shown that PMN damage cells in vitro under certain circumstances 
(Entman et al., 1992).  However, if there is a relationship between PAF, PMN, and lung 
injury, it remains to be elucidated (Hewett and Roth, 1993). 
In addition, endothelin-1 has also been implicated as a potent vasoconstrictor 
because an increase in the circulation is seen under severe endotoxemia in certain 
animals, such as dogs and sheep (Morel et al., 1991; Nakamura et al., 1991).  However, 
as for PAF, the mechanisms are yet to be determined (Hewett and Roth, 1993). 
Liver: LPS acts indirectly on liver injury via the coagulation system and via 
mediated effects such as when endotoxin reacts with macrophages and releases several 
effector substances.  In addition, there is evidence that LPS may directly injure 
hepatocytes as well (Nolan, 1981).   
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The mechanisms by which the coagulation system mediates liver injury after LPS 
exposure remains unknown (Hewett and Roth, 1995).  However, the authors suggest that 
thrombin may play an important role on the expression of LPS-induced liver injury along 
with PMNs and TNF-α.   
Exposure to LPS is associated with the accumulation of large numbers of PMNs 
in the liver (Hewett et al., 1992) and PMNs have been implicated in the pathogenesis of 
liver injury.  In addition, Hewett et al. (1993) suggest that TNF-α is involved in liver 
injury by a PMN dependent mechanism.  Also, TNF-α is needed for activation of the 
coagulation system and is released under LPS exposure.  Therefore, Hewett and Roth et 
al., 1995 suggest that LPS-induced TNF-α enables PMNs to participate in the activation 
of the coagulation pathway, which in turn results in the generation of a factor (s) 
proximal in the pathway to fibrin formation that causes liver injury.  This factor is 
probably thrombin.  
Mediated effects result when endotoxin reacts with macrophages and releases 
several effector substances.  Some of the mediators which are released by endotoxin-
activated macrophages include lysosomal enzymes, procoagulants, collagenase, 
pyrogens, prostaglandins, colony-stimulating factor, and a tumoricidal substance (Nolan, 
1981). 
 Nolan (1981) reported that LPS may directly injure hepatocytes as well.  Either 
because of a failure of LPS detoxification or through effector release of lysosomal 
enzymes and other products from Kuppfer cells, the damaging substance reaches the 
parenchymal cell which possesses membrane receptors for both LPS and the toxic lipid A 
component.  Lysosomes are more fragile in hepatocytes from mice treated with 
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endotoxin, and LPS stimulates the degradation of cytochrome P-450 enzymes within 
hours (Nolan, 1981).  In addition, dye uptake and excretion is impaired after endotoxin 
exposure, and bile salt-independent flow is markedly reduced (Nolan, 1981). 
- Augmentation of hepatotoxicity by LPS:  Several inflammatory cells are 
stimulated during LPS exposure, e.g. Kupffer cells.  Considerable evidences suggest that 
activation of Kupffer cells amplifies the hepatotoxic response to several chemicals (Roth 
et al., 1997).  Activated Kupffer cells release reactive oxygen metabolites, and pre-
treatment of rats with scavengers of reactive oxygen species prevents the enhancement of 
some hepatotoxic responses (Roth et al., 1997).  In addition to release of reactive oxygen 
species, Kupffer cells when stimulated by LPS, releases the cytokine TNF.  Tumor 
Necrosis Factor can cause oxidative stress in hepatic parenchymal cells in vitro and 
render these cells more susceptible to injury (Roth et al., 1997). The cytokine-induced 
increase in hepatocellular sensitivity may be associated with damage to DNA (Roth et al., 
1997).  
Lipid mediators may also have important roles. Leukotriene C4, an inflammatory 
lipid released during Lipopolysaccharide exposure, can kill hepatocytes that have been 
stressed in vitro by hypoxia. LPS elicits the release of large amounts of prostaglandin D2 
from Kupffer cells, and this lipid metabolite alters hepatocellular homeostasis.  As a 
result, many products of activated Kupffer cells have actions that could render them 
important players in augmenting hepatotoxic responses (Roth et al., 1997).  
Other cell types activated by LPS exposure include platelets and neutrophils, both 
of which release mediators of inflammation when they are activated. Neutrophils release 
not only reactive oxygen species but also serine proteases such as cathepsin G and 
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elastase that can injure hepatocytes.  Neutrophil-derived proteases are important 
mediators of hepatocellular injury in rats co treated with LPS and galactosamine. 
Evidence in a model of LPS-induced liver injury suggests that TNF may act in part by 
activating these proteases or enhancing their release from neutrophils. Another serine 
protease that is involved critically in LPS-induced liver injury is thrombin arising from 
activation of the coagulation system. By altering cell membranes, changing intracellular 
signaling, influencing gene expression, etc., these and perhaps other inflammatory 
mediators produced during LPS exposure may render target cells more sensitive to injury 
from chemical insult.  
Finally, an in vivo LPS effect on xenobiotic metabolism is to decrease xenobiotic 
metabolizing capacity which can contribute to augmentation of hepatotoxicity (Roth et 
al., 1997). 
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CHAPTER III 
 
EFFECTS OF ENDOTOXIC LIPOPOLYSACCHARIDE ON PERFORMANCE,  
MORTALITY RATE, AND ORGAN WEIGHTS OF CHICKS AND POULTS FED 
AFLATOXIN 
 
ABSTRACT 
 
Aflatoxin B1 (AFB1) causes poor performance and is hepatotoxic in animals. 
Endotoxic lipopolysaccharide (LPS), a constituent of cell walls of gram negative bacteria, 
initiates an inflammatory response in animals. In rodents, nontoxic doses of LPS augment 
the effects of AFB1.  Two studies (Exp.1 and 2) were conducted to determine the effects 
of chronic exposure to low doses of E. coli LPS in chicks and poults fed diets 
contaminated with non toxic doses of aflatoxin B1.  Chicks were fed 0, 2, or 4 mg 
AFB1/kg diet, whereas poults were fed 0, 100, or 150 µg AFB1/kg diet for 21 days. 
Beginning on day 7, chicks were injected intraperitoneally with 0, 200, or 400 µg 
LPS/bird every other day, whereas poults were injected with 0, 100, or 150 µg LPS/bird 
on alternate days.  Due to high mortality in the chick study, the 4 mg/kg AFB1 treatment 
was not considered in the statistical analysis. AFB1 alone decreased (P < 0.05) feed 
intake (FI) and body weight gain (BWG) in chicks, whereas feed conversion (FDGN) 
was improved when chicks were given 400 µg LPS.  In contrast, LPS decreased (P < 
0.05) BWG and 150 µg LPS/bird worsened (P < 0.05) FDGN in poults.  AFB1 at 100 
µg/kg decreased (P < 0.05) FI and BWG in poults and a further decrease (P < 0.05) was 
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observed in BWG when poults were fed 150 µg AFB1/kg.  In addition, 150 µg AFB1/kg 
worsened (P < 0.05) FDGN in poults.  In poults, there was also an LPS x AFB1 
interaction (P < 0.05) for FDGN.  Co-treatment of 150 µg LPS/poult with 150 µg/kg 
AFB1 worsened FDGN compared with other combinations of LPS + AFB1.  With 
respect to relative organ weights, LPS increased (P < 0.05) thymus weight in chicks, 
whereas AFB1 increased (P < 0.05) liver and spleen weights and decreased (P < 0.05) 
thymus weight.  In poults, LPS increased (P < 0.05) spleen weight, whereas AFB1 
decreased (P < 0.05) liver and thymus weights and increased (P < 0.05) spleen weight.  
Mortality in chicks fed the control diet, 2 mg AFB1/kg, and 4 mg AFB1/kg, was 0, 0, and 
37%, respectively. In chicks injected with 200 and 400 µg LPS, mortality was 0 and 5%, 
respectively. Mortality was 35 and 75% in chicks fed 2 and 4 mg AFB1/kg and injected 
with 200 µg LPS, whereas mortality was 13 and 85% in chicks fed 2 and 4 mg AFB1/kg 
and injected with 400 µg LPS. Mortality in poults fed the control diet, 100 µg AFB1/kg, 
and 150 µg AFB1/kg, was 0, 0, and 7%, respectively. In poults injected with 100 and 150 
µg LPS, mortality was 7 and 10%, respectively. Mortality was 33 and 30% in poults fed 
100 and 150 µg AFB1/kg and injected with 100 µg LPS, whereas mortality was 23 and 
53% in poults fed 100 and 150 µg AFB1/kg and injected with 200 µg LPS. Based on 
these results, it can be concluded that at the levels chosen chronic exposure to low doses 
of LPS did not potentiate the effects of dietary non toxic doses of AFB1 on performance 
of chicks and poults fed from hatch to day 21.  However, for mortality rate, results 
suggest a toxic synergy between AFB1 and LPS in chicks and poults.  
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INTRODUCTION 
 
Mycotoxins are a group of structurally diverse secondary fungal metabolites that 
occur as contaminants of grain worldwide. It has been estimated that 25% of the worlds 
food crops are affected by mycotoxins (CAST, 1989). Many of these mycotoxins can 
cause serious health problems in animals and their presence in agricultural commodities 
may result in serious economic losses (estimated to be 1.4 billion dollars annually, 
CAST, 2003). Poultry producers have a continuous problem with low levels of 
mycotoxin-contaminated feedstuffs causing poorly defined syndromes.   
In the past, it was speculated that many of these unexplained syndromes were 
caused by synergism between mycotoxins. However, years of research have shown little 
or no synergy but only additive effects. Another potential explanation for the unexplained 
syndromes observed in poultry may be concomitant exposure to mycotoxins and stressors 
(e.g. ammonia, competition for feed and water, heat, disease, and endotoxin exposure) 
present in commercial poultry operations.  
Recent reports suggest that, one of these stressors, endotoxic lipopolysaccharides 
(LPS) a constituent of the outer membranes of the cell walls of gram-negative bacteria 
may augment the toxic effects of some mycotoxins (Barton et al., 2000a, 2000b; Zhou et 
al., 1999).  In rats given a non-toxic dose of aflatoxin (AF), intravenous injections of a 
non-toxic dose of LPS potentiated the effects of AF (four fold) causing hepatic lesions 
that were pronounced by 24 hours (Barton et al., 2000a, 2000b). In studies with mice, the 
trichothecene, deoxynivalenol (vomitoxin), became more toxic in the presence of LPS 
causing increased tissue injury and mortality (Zhou et al., 1999).  Results of a recent 
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study comparing nine different occupational settings for personal exposure to endotoxins 
indicates that the highest exposure occurred in poultry operations (Simpson et al., 1999). 
These results suggest poultry are exposed to high levels of LPS, and exposure may well 
potentiate the effects of low levels of mycotoxins that would normally be considered non-
toxic. The objective of these studies were to determine if LPS will potentiate the effects 
of AFB1 in broilers and turkeys fed dietary AFB1 from hatch to 21 days of age.  
 
MATERIAL AND METHODS 
 
For these trials, 180 day-old broilers (Exp.1) and 270 day-old turkeys (Exp.2) 
were obtained from a commercial hatchery, weighed, wing-banded, and randomly 
assigned to pens in stainless steel chick batteries.  Birds were maintained on a 24-h light 
schedule and allowed ad libitum access to feed and water.  Birds were monitored daily 
for signs of morbidity and mortality.  Post-mortem evaluation was performed for all birds 
that died throughout the experiment.  The animal care and use protocol was reviewed and 
approved by the University of Missouri-Columbia Animal Care and Use Committee.   
A 3 x 3 factorial design (three levels of LPS and three levels of AFB1) design was 
used with four replicates of five birds (chicks) or five replicates of six birds (poults) 
assigned to each of the nine treatments from day 1 to 21.  Treatments included: (A) 0 µg 
LPS/bird + 0 mg/kg AFB1; (B) 0 µg LPS/bird + 2 mg/kg AFB1 (chicks) or 100 µg/kg 
AFB1 (poults); (C) 0 µg LPS/bird + 4 mg/kg AFB1 (chicks) or 150 µg/kg AFB1 (poults); 
(D) 200 µg LPS/bird + 0 mg/kg AFB1 (chicks) or 100 µg LPS/bird + 0 µg/kg AFB1 
(poults); (E) 200 µg LPS/bird + 2 mg/kg AFB1 (chicks) or 100 µg LPS/bird + 100 µg/kg 
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AFB1 (poults); (F) 200 LPS/bird + 4 mg/kg AFB1 (chicks) or 100 µg LPS/bird + 150 
µg/kg AFB1 (poults); (G) 400 µg LPS/bird + 0 mg/kg of  AB1 (chicks) or 150 µg 
LPS/bird + 150 µg/kg AFB1 (poults); (H) 400 µg LPS/bird + 2 mg/kg AFB1 (chicks) or 
150 µg LPS/bird + 150 µg/kg AFB1 (poults); and (I) 400 µg LPS/bird + 4 mg/kg of 
AFB1 (chicks) or 150 µg LPS/bird + 150 µg/kg AFB1 (poults). 
Lipopolysaccharide (E. coli LPS; serotype 0127:B8) was purchased from Sigma 
Chemical (St. Louis, MO) and reconstituted in sterile and non-pyrogenic saline for 
injection.  The solution was then heated under low heat for approximately 5 minutes or 
until complete dissolution.  All glassware were made endotoxin-free by dry heating to 
250ûC for at least 3 hours.  Chicks and poults were injected intraperitoneally with the 
appropriate dose of LPS every other day from day 7 to 21. Chicks that did not receive 
LPS, were injected with sterile saline.  Dietary treatments were fed beginning day 1. 
Chicks and poults were injected intraperitoneally (IP) with the appropriate dose of LPS 
every other day from day 7 to 21.  
At 3 weeks of age (day 21), birds were euthanized with carbon dioxide and 
samples of liver, spleen, bursa, and thymus (three birds/pen) were collected for 
histopathologic evaluation as well as relative organ weight calculation (grams organ/100 
g body weight). 
Due to high mortality in groups fed 4 mg/kg AFB1, this treatment was not 
included in the statistical analysis in the chick study.  Data were analyzed as a 3 x 2 
factorial analysis (chicks) or a 3 x 3 factorial analysis (poults) by analysis of variance 
(ANOVA) using the General Linear Models procedure of SAS software (SAS Institute 
Inc., 1996).  Means showing significant differences in the ANOVA were compared using 
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Fishers protected least significant difference procedure (Snedecor and Cochran, 1989).  
Mortality data were transformed (Arcsin) prior to statistical analysis.  All statements of 
differences were based on a significance of P < 0.05. 
 
RESULTS 
 
 Experiment 1: Broiler Study:  Due to high mortality in the chick study, the 4 
mg/kg AFB1 treatment was not included in the statistical analysis of the performance 
data. AFB1 alone decreased (P < 0.05) feed intake (FI) and body weight gain (BWG) in 
chicks, whereas feed conversion (FDGN) was improved when chicks were given 400 µg 
LPS (Table 3.1).  Figure 3.3 shows treatment effects on final body weight of surviving 
broiler chicks fed 4 mg/kg AFB1.  With respect to relative organ weights (Tables 3.3, 
3.4), LPS increased (P < 0.05) thymus weight, whereas AFB1 increased (P < 0.05) liver 
and spleen weights and decreased (P < 0.05) thymus weight in chicks (Table 3.3).  
Mortality in chicks fed the control diet, 2 mg AFB1/kg, or 4 mg AFB1/kg, was 0, 0, and 
37%, respectively (Figure 3.1). In chicks injected with 200 and 400 µg LPS, mortality 
was 0 and 5%, respectively. Mortality was 35 and 75% in chicks fed 2 and 4 mg 
AFB1/kg and injected with 200 µg LPS, whereas mortality was 13 and 85% in chicks fed 
2 and 4 mg AFB1/kg and injected with 400 µg LPS. 
Experiment 2: Poult Study:  In contrast to chicks, LPS decreased (P < 0.05) 
BWG and 150 µg AFB1/kg worsened (P < 0.05) FDGN in poults (Table 3.2).  AFB1 at 
100 µg/kg decreased (P < 0.05) FI and BWG in poults and a further decrease (P < 0.05) 
was observed in BWG when poults were fed 150 µg AFB1/kg.  In addition, 150 µg 
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AFB1/kg worsened (P < 0.05) FDGN in poults.  In poults, there was also an LPS x AFB1 
interaction (P < 0.05) on FDGN.  Co-treatment of 150 µg LPS/poult with 150 µg/kg 
AFB1 worsened FDGN compared with other combinations of LPS + AFB1 (Table 3.2).  
In poults, LPS increased (P < 0.05) spleen weight, whereas AFB1 decreased (P < .05) 
liver and increased (P < .05) spleen weight (Table 3.4).  Mortality in poults fed the 
control diet, 100 µg AFB1/kg, or 150 µg AFB1/kg, was 0, 0, and 7%, respectively 
(Figure 3.2). In poults injected with 100 and 150 µg LPS, mortality was 7 and 10%, 
respectively. Mortality was 33 and 30% in poults fed 100 and 150 µg AFB1/kg and 
injected with 100 µg LPS, whereas mortality was 23 and 53% in poults fed 100 and 150 
µg AFB1/kg and injected with 150 µg LPS.   
 
DISCUSSION 
 
Due to high mortality in the chick study, the 4 mg/kg AFB1 treatment was not 
included in the statistical analysis of the performance data. Two mg/kg AFB1 alone 
decreased FI and BWG in chicks. Huff et al. (1988) showed that feeding 2.5 mg/kg 
AFB1 to broiler chickens caused a decrease in body weight and a further decrease was 
observed when birds were co-treated with AFB1 and 4 mg/kg T-2.  Verma et al. (2002) 
reported that AFB1 at 3 mg/kg AFB1 had no effect on body weight, serum protein and 
serum albumin, but increased the relative weights of liver, kidney, and proventriculus.  
Pimpukdee et al. (2004) reported that 5 mg/kg AFB1 decreased performance of 3-week-
old chickens.     
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Lipopolysaccharide at 400 µg/bird improved FDGN in chicks, whereas in poults 
LPS decreased BWG and 150 µg AFB1/kg worsened FDGN.  In addition, there was an 
LPS x AFB1 interaction on FDGN in poults.  The result of the chick study is not in 
agreement with the literature.  In contrast, the result of the poult study is consistent with 
the reports found in the literature.  Because of the diversion of nutrients away from 
growth in support of immune-related processes, immune challenge is considered a major 
obstacle to animals achieving their genetic potential for growth or efficiency of gain 
(Spurlock, 1997).  In addition, during periods of immune challenge, proinflammatory 
cytokines orchestrate a homeorhetic response in which nutrients are directed away from 
tissue growth in support of immune function (Spurlock, 1997).  Even when disease is 
subclinical in nature, the cumulative effect of the serial challenges is sufficient to cause 
significant alterations in metabolism with concurrent losses in performance (Spurlock, 
1997).  Koh et al. (1996) injected broiler chicks 100 µg/ml of S. typhymurium LPS on 
alternate days for 6 days and reported that activation of the acute phase reponse 
significantly decreased daily BWG, FI, and FDGN.  Shimizu et al. (1988) immunized 
chickens with whole cells of E.coli and observed elevated levels of anti-LPS activity, 
suggesting that LPS is a potent antigen in chickens.  In addition, a single injection of S. 
typhimurium in 3 week old male broiler chickens decreased body weight 12, 24, and 48 h 
after LPS challenge (Xie et al., 2000).    
Aflatoxin B1 at 100 µg/kg decreased FI and BWG in poults and a further decrease 
was observed in BWG when poults were fed 150 µg AFB1/kg.  In addition, AFB1 
worsened (P < 0.05) FDGN in poults.  In poults, these results are not in agreement with 
the literature.  Witlock and Wyatt (1981) reported that body weight gains of turkey poults 
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were only affected when 500 µg/kg AFB1 was fed.  However, Witlock et al. (1981) 
reported decreased body weights when turkey poults were fed 250 µg/kg AFB1 and a 
further decrease was observed in poults fed AFB1 and challenged with Eimeria 
adenoeides.  Giambrone et al. (1985a) reported no significant adverse effects on weight 
gain or feed conversion in turkey poults fed either 100, 150, or 200 µg/kg AFB1 for 5 
weeks.  In addition, Giambrone et al. (1985b) fed turkey poults 0, 100, 200, 400, or 800 
µg/kg AFB1 for 5 weeks and reported that levels greater than or equal to 400 µg/kg 
AFB1 were highly toxic to turkey poults. This toxicity was characterized by signs and 
lesions of aflatoxicosis as well as significant decreases in BWG and FDGN during 5 
weeks.  In addition, microscopic lesions, indicative of aflatoxicosis, were evident as low 
as 100 µg/kg AFB1, and significant decreases in cell-mediated immunity were noted in 
the 200 µg/kg AFB1 (Giambrone et al., 1985b). 
In this study, the means chosen to administer LPS may have been too invasive 
which may explain the increased susceptibility of the birds to levels of toxins otherwise 
considered non toxic.  From all the birds that died throughout the experimental period, 
approximately 50% of the broilers and 15% of the turkeys, independent of treatment, had 
signs of septicemia with pericarditis, perihepatitis, and retained yolk sack.  Interactions 
demonstrated between mycotoxins presence in the feed and infections, which manifests 
itself as increased mortality, has important implications for the poultry industry.  
Prabaharan and George (1999) fed 0.5 and 1.0 mg/kg AFB1 to Eimeria tenella infected 
birds.  The authors reported that mortality rate in the combined groups were higher than 
in the groups receiving either of the treatments alone.  Singh et al. (1999) reported 
mortality rate of approximately 50% in 3 week old chicks fed 800 µg/kg AFB1 and 
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infected with Salmonella gallinarum.  The authors reported that this increased mortality 
could be attributed to congestion and enlargement of liver due to aflatoxins and 
degeneration of liver due to Salmonella infection. Boonchuvit et al. (1975) reported 
chickens fed 16 mg/kg T-2 toxin and infected with Salmonella had mortality rate 
increased by 17.5% when compared to either factor alone. 
With respect to relative organ weights, AFB1 given alone increased spleen 
weights in chicks and poults.  In addition, AFB1 decreased relative thymus weight in 
chicks.  Also, LPS increased spleen weight in chicks and poults and increased thymus 
weight in chicks.  However, treatments had no effect on relative bursa weight in both 
species.  Hegazy and Adachi (2000) reported that feeding 2.6 mg/kg AFB1 to chicks 
decreased relative bursal and thymus weights, but spleen weight was increased.  The 
decrease in bursa and thymic weights represents the immunossupressive effect of the 
treatments.  However, the increase in spleen weight observed may be related to the health 
status of the birds.  Chang and Hamilton (1982) found a significant increase in relative 
spleen weights in chicks with infectious bursal disease virus, which may be enhanced by 
synergism with aflatoxicosis.  In the present study, birds that died during the 
experimental period were grossly necropsied.   From all the birds that died, 
approximately 50% of the chicks and 15% of the poults, independent of treatment, had 
signs of septicemia with pericarditis, perihepatitis, and retained yolk sack.   
In poults, AFB1 decreased liver, whereas in chicks, AFB1 increased relative liver 
weight.  In chicks, this result is in agreement with the literature.  Aflatoxin B1 causes 
fatty liver in poultry (Hamilton and Garlich, 1971; Carnaghan et al., 1966; Sawhney et 
al., 1973) leading to increased liver weight due to fat deposition in the liver.    In poults, 
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AFB1 decreased liver weight.  Bradley (1985) proposed that inhibition of protein 
synthesis impairs the ability of the animal to repair cellular damage leading to decreased 
relative organ weights.    
A prominent feature of septic shock is a severe and intractable hypotension 
coupled with a primary reduction in circulating blood volume, which leads ultimately to 
circulatory collapse and death (Andrew et al., 2000).  Co-treatment with LPS and AFB1 
markedly increased mortality rate in broilers compared with the LPS or AFB1 alone.  
Taylor et al. (1991) observed a similar response in mice exposed to LPS and T-2 toxin, 
with the combination treatment causing 100% mortality, compared with 20% for T-2 
alone, and no mortality for LPS alone. Taylor et al. (1991) concluded that increased LPS 
absorption accounted for the increase in mortality.  
AFB1 may well have enhanced the effect of LPS in broilers and turkeys in the 
current study. However, the mechanism of enhancement was probably different from that 
observed with T-2 toxin.  AFB1 is hepatotoxic and damage to the liver caused by AFB1 
may well have compromised the ability of the liver to metabolize LPS, resulting in 
reduced clearance of LPS from circulation, and increased mortality due to hypotension 
and circulatory collapse. 
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CONCLUSION 
 
Based on these results, it can be concluded that at the levels chosen, chronic 
exposure to low doses of LPS did not enhance the effects of dietary non toxic doses of 
AFB1 on performance of chicks and poults fed from hatch to day 21.  However, for 
mortality rate, results suggest a toxic synergy between AFB1 and LPS in both chicks and 
poults.  
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TABLE 3.1.  EFFECTS OF ENDOTOXIC LIPOPOLYSACCHARIDE ON 3 WEEK 
PERFORMANCE OF BROILER CHICKS FED AFLATOXIN B11,2 
 
LPS  AFB1 Feed Intake Body Weight  Feed 
     Gain Conversion 
(µg/bird)  (ppm) ---------------------(g)------------------ -----(g:g)----   
 
 
0  0 1047a 742a 1.414ab 
0  2   858ab  578b   1.482a 
200  0  1013ab  688ab   1.476a 
200  2     804b  580b   1.342ab 
400  0    878ab  667ab   1.303ab 
400  2    722b  576b   1.252b 
SEM      70.3   33.3    0.06 
                     -------------------------------Probability----------------------------- 
 
LPS 0.1561 0.5358 0.0490
AFB1 0.0111 0.0007 0.4843 
LPS X AFB1 0.9430 0.5499 0.3477 
 
1 Data are means of four replicates of five birds each. 
2 Because of excessive mortality, 4 mg/kg AFB1 treatment has not been included in the 
statistical analysis. 
a, b Values within columns with different superscripts differ significantly (P < 0.05). 
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TABLE 3.1:  EFFECTS OF ENDOTOXIC LIPOPOLYSACCHARIDE ON 3 WEEK 
PERFORMANCE OF BROILER CHICKS FED AFLATOXIN B11,2 
 
   Feed Intake Body Weight  Feed 
    Gain Conversion 
Main Effect Mean ---------------------(g)------------------ -----(g:g)----   
 
 
LPS, µg/bird 
 0   952 660 1.448a 
 200  908 634 1.409a 
 400  800 621 1.277b 
 
AFB1, mg/kg 
 0   980a 699a 1.398 
 2   794b 578b 1.359 
 
1 Data are main effect means. 
2 Because of excessive mortality, 4 mg/kg AFB1 treatment has not been included in the 
statistical analysis. 
a, b Values within columns, in main effect, with different superscripts differ significantly 
(P < 0.05). 
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TABLE 3.2.  EFFECTS OF ENDOTOXIC LIPOPOLYSACCHARIDE ON 3 WEEK 
PERFORMANCE OF TURKEY POULTS FED AFLATOXIN B11 
    
LPS  AFB1 Feed Intake Body Weight  Feed 
     Gain Conversion 
(µg/bird)  (ppb) ---------------------(g)------------------ -----(g:g)----   
 
 
0  0 792ab 435a 1.825b
0  100 733ab   406ab   1.806b 
0  150 721ab   385ab   1.869b 
100  0  736ab   387ab   1.909b 
100  100   693b   346b   2.028b 
100  150   647b   300bc   2.054b 
150  0  812a   398ab   2.068b 
150  100  725ab   311bc   1.875b 
150  150  692b   252c   2.768a 
SEM     36.58    24.94   0.102 
                     -------------------------------Probability------------------------------ 
 
LPS 0.1262 0.0004 0.0002
AFB1 0.0112 0.0002 0.0008 
LPS X AFB1 0.9479 0.4278 0.0011 
 
1 Data are means of five replicates of six birds each. 
a, b,c Values within columns with different superscripts differ significantly (P < 0.05). 
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TABLE 3.2 (CONT).  EFFECTS OF ENDOTOXIC LIPOPOLYSACCHARIDE ON 3 
WEEK PERFORMANCE OF TURKEY POULTS FED AFLATOXIN B11 
 
   Feed Intake Body Weight  Feed 
    Gain Conversion 
Main Effect Mean ---------------------(g)------------------ -----(g:g)----   
 
 
LPS, µg/bird 
 0   749 409a 1.833b
 100  692 344b 1.997b 
 150  743 322b 2.237a 
 
AFB1, µg/kg 
 0   780a 407a 1.934b 
 100  717b 354b 1.903b 
 150  686b 312c 2.230a 
 
1 Data are main effect means. 
a, b Values within columns, in main effect, with different superscripts differ significantly 
(P < 0.05). 
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TABLE 3.3.  EFFECTS OF ENDOTOXIC LIPOPOLYSACCHARIDE ON RELATIVE 
ORGAN WEIGHTS OF BROILER CHICKS FED AFLATOXIN B11,2 
 
LPS AFB1     LIVER SPLEEN BURSA  THYMUS 
(µg/bird) (ppm)  -------------------------------(%)-------------------------------   
 
 
0 0 2.814b 0.829b 0.233a 0.311ab
0 2    4.757a 1.324ab 0.225a  0.238c 
200 0    2.913b 0.948b 0.246a 0.369a
200 2    4.116ab 1.187ab 0.240a  0.303b
400 0    3.532b 0.945b 0.234a  0.301b 
400 2    4.468a 1.489a 0.226a 0.303b 
SEM      0.28  0.142 0.016     0.021 
 
                  -------------------------------Probability------------------------------ 
 
LPS  0.2533  0.5129 0.6161  0.0492
AFB1  <.0001  0.0018 0.5806  0.0134 
LPS X AFB1  0.2097  0.5277 0.9967  0.1728 
 
1 Data are means of 4 replicates of 3 birds each. 
2 Because of excessive mortality, 4 mg/kg AFB1 treatment has not been included. 
a, b, c Values within columns with different superscripts differ significantly (P < 0.05). 
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TABLE 3.3 (CONT).  EFFECTS OF ENDOTOXIC LIPOPOLYSACCHARIDE ON 
RELATIVE ORGAN WEIGHTS OF BROILER CHICKS FED AFLATOXIN B11,2 
 
Main Effect Mean  LIVER SPLEEN BURSA THYMUS  
           -------------------------------(%)------------------------------- 
 
 
LPS, µg/bird  
 0 3.785 1.076 0.229 0.275b  
 200 3.515 1.068 0.243 0.336a 
 400 4.000 1.217 0.230 0.302a 
 
AFB1, mg/kg 
 0 3.086b 0.907b 0.238a 0.327a 
 2 4.447a 1.333a 0.231a 0.281b 
 
1 Data are main effect means. 
2 Because of excessive mortality, 4 mg/kg AFB1 treatment has not been included. 
a, b Values within columns, in main effect, with different superscripts differ significantly 
(P < 0.05). 
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TABLE 3.4.  EFFECTS OF ENDOTOXIC LIPOPOLYSACCHARIDE ON RELATIVE 
ORGAN WEIGHTS OF TURKEY POULTS FED AFLATOXIN B11 
 
    
LPS AFB1     LIVER SPLEEN BURSA  THYMUS 
(µg/bird) (ppb) -----------------------------(%)---------------------------------   
 
 
0 0  3.048a 0.100c 0.153 0.128ab
0 100  2.586b  0.116b  0.156  0.099bc 
0 150  2.340c  0.117b  0.170 0.051c 
100 0  3.230a  0.121ab  0.155 0.143ab
100 100   2.567bc  0.135a  0.166  0.101bc 
100 150  2.472bc  0.123ab  0.148  0.075c 
150 0  3.127a  0.118b  0.150  0.157a 
150 100  2.590b  0.118b  0.149  0.120b 
150 150  2.490bc  0.135a  0.160  0.058c 
SEM    0.086  0.005  0.008   0.014
                     -------------------------------Probability---------------------------- 
 
LPS 0.3450 0.0024 0.5999 0.2610
AFB1 <.0001 0.0191 0.6136 <.0001 
LPS X AFB1 0.7456 0.0896 0.3040 0.7707 
 
1 Data are means of 4 replicates of 3 birds each. 
a, b, c Values within columns with different superscripts differ significantly (P < 0.05). 
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TABLE 3.4 (CONT).  EFFECTS OF ENDOTOXIC LIPOPOLYSACCHARIDE ON 
RELATIVE ORGAN WEIGHTS OF TURKEY POULTS FED AFLATOXIN B11 
 
Main Effect Mean  LIVER SPLEEN BURSA THYMUS  
           -------------------------------(%)------------------------------- 
 
 
LPS, µg/bird  
 0 2.658 0.111b 0.160 0.093 
 100 2.756 0.126a 0.156 0.107 
 150 2.735 0.123a 0.153 0.112 
 
AFB1, µg/kg 
 0 3.135a 0.113b 0.153 0.143a 
 100 2.581b 0.123a 0.157 0.107b 
 150 2.434b 0.125a 0.159 0.062c 
 
1 Data are main effect means. 
a, b Values within columns, in main effect, with different superscripts differ significantly 
(P < 0.05). 
 79
CHAPTER IV 
 
EFFECTS OF CONTINUOUS ADMINISTRATION OF LOW-DOSE OF 
ENDOTOXIC LIPOPOLYSACCHARIDE IN CHICKS AND POULTS FED NON 
TOXIC DOSES OF T-2 TOXIN 
 
ABSTRACT 
 
Two studies were conducted to determine the effects of chronic exposure to low 
doses of E. coli LPS in combination with feeding diets contaminated with non toxic doses 
of T-2 toxin in chicks and poults fed from hatch to day 21.  Chicks and poults were fed 0, 
1, or 2 mg T-2/kg diet.  Beginning on day 7, chicks and poults were injected 
intraperitoneally with 0, 100, or 150 µg LPS/bird every other day. At week two, 150 µg 
LPS/bird decreased (P < 0.05) feed intake (FI) and body weight gain (BWG) in chicks, 
but no T-2 effect or LPS x T-2 interaction was observed .  The mean values were 343, 
337, and 318g for FI; 277, 275, and 256 g for BWG for chicks given 0, 100, and 150 µg 
LPS/bird, respectively.  In poults, at week two, birds fed 2 mg T-2 toxin/kg diet showed a 
decrease (P < 0.05) in FI and BWG, but no LPS effect or LPS x T-2 interaction was 
observed.  The mean values were 244, 233, and 209 g for FI; 158, 145, and 126 g for 
BWG for poults fed 0, 1, and 2 mg/kg T-2, respectively.  In chicks, at week three, there 
was a significant (P < 0.05) LPS x T-2 interaction observed for BWG.  In poults, at week 
three, 2 mg/kg T-2 dramatically decreased (P < 0.05) FI, BWG, and increased FDGN.  
The mean values were 394, 383, and 324 g for FI; 198, 194, and 136 g for BWG; 2.05, 
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1.92, and 2.30 for FDGN for poults fed 0, 1, and 2 mg/kg of T-2, respectively.  No LPS 
effect and no LPS x T-2 interactions were observed.  With respect to oral lesions, chicks 
fed 2 mg/kg T-2 had a higher incidence of oral lesions when compared to chicks fed 1 
mg/kg T-2 (2 mg/kg T-2, 18%; 1 mg/kg T-2, 10%), but there was no difference in terms 
of severity of lesions.  At both levels, T-2 caused only mild lesions in chicks.  Poults fed 
2 mg/kg T-2 had a higher incidence (2 mg/kg T-2, 48%; 1 mg/kg T-2, 30%) and more 
severe oral lesions (2 mg/kg T-2, scored 1: 40%, scored between 2 and 3; 60%; 1 mg/kg 
T-2: scored 1, 56%; scored 2, 44%) than birds fed 1 mg/kg T-2.  Treatments had no effect 
on mortality rate of either species.  LPS increased relative spleen weight (P < .05) in 
chicks and poults.  There was no T-2 effect or LPS x T-2 interaction on relative organ 
weight in chicks or poults.   Based on these results, it can be concluded that, at the levels 
chosen, chronic exposure to LPS did not potentiate the effects of T-2 toxin in chicks and 
poults.  In poults, however, the decrease in performance observed in birds fed T-2 alone 
was atypical of a number of studies conducted, in which decrease in performance was 
only observed when poults were fed at least 5 mg/kg T-2. 
 
INTRODUCTION 
 
Mycotoxins are a group of structurally diverse secondary fungal metabolites that 
occur as contaminants of grain worldwide. It has been estimated that 25% of the worlds 
food crops are affected by mycotoxins (CAST, 1989). Many of these mycotoxins can 
cause serious health problems in animals and their presence in agricultural commodities 
may result in serious economic losses (estimated to be 1.4 billion dollars annually, 
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CAST, 2003). Poultry producers have a continuous problem with low levels of 
mycotoxin-contaminated feedstuffs causing poorly defined syndromes.   
In the past, it was speculated that many of these unexplained syndromes were 
caused by synergism between mycotoxins. However, years of research have shown little 
or no synergy but only additive effects. Another potential explanation for the unexplained 
syndromes observed in poultry may be concomitant exposure to mycotoxins and stressors 
(e.g. ammonia, competition for feed and water, heat, disease, and endotoxin exposure) 
present in commercial poultry operations.  
Recent reports suggest that, one of these stressors, endotoxic lipopolysaccharides 
(LPS) may augment the toxic effects of some mycotoxins (Barton et al., 2000a, 2000b; 
Zhou et al., 1999, 2000; Tai and Pestka, 1988).  Lipopolysaccharide is a component of 
the outer membrane of the cell walls of gram-negative bacteria.  Examples of gram-
negative bacteria include Escherichia coli and Salmonella typhymurium.  
Lipopolysaccharide has been extensively studied as an inflammagen and a major 
contributing factor to the pathogenesis of bacterial infections.  Exposure to LPS causes 
fever, circulatory shock, disseminated intravascular coagulation, and damage to 
numerous organs, including the liver (Barton et al., 2001).  
With respect to performance, exposure to LPS causes decrease in feed intake, 
which, in heifers, lasted for 4 hours (Steiger et al., 1999) and in pigs, 48 hours (Frank, 
2003) after LPS exposure before returning to control levels.  During an immunological 
challenge, animals undergo a series of physiological events known as the acute-phase 
response which is designed to help the animal to overcome the challenge (Baumann and 
Gauldie, 1994).  One resulting component of the acute-phase response is suppression in 
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feed intake (Kelley et al., 1994; Johnson, 1998).  Frank (2003) suggested that elevation in 
proinflammatory cytokines, e.g. TNF-α and IL-2, lead to an acute suppression in feed 
intake.  Warren et al. (1997) infused porcine TNF-α i.c.v. and reported dose-dependent 
reductions in feed intake over an 8-h period. 
Exposure to smaller doses of LPS initiates a more modest and noninjurious 
inflammatory response (Barton et al., 2001).  However, exposure to such doses can 
render the liver more sensitive to injury from xenobiotic agents, such as AFB1 and T-2 
toxin (Roth et al., 1997).  In addition to modifying the hepatotoxic responses of 
xenobiotic agents, it is possible that hepatotoxicity from some agents arises directly from 
primary damage to the GI tract which increases the translocation of LPS into the portal 
venous circulation (Roth et al., 1997).  The T-2 toxin damages the GI tract (Bratich et al., 
1990) increasing LPS translocation from the GI tract and causing liver lesion which 
resemble that produced by large, injurious doses of LPS (Roth et al., 1997; Taylor et al., 
1991).  
Animal exposure to bacterial endotoxin occurs through several mechanisms (Roth 
et al., 1997).  However, the two most important types of exposure are exposure to high 
concentrations of LPS via the respiratory tract from contaminated air, and gram-negative 
bacterial infections that lead to systemic LPS exposure.  Moreover, results of a recent 
study comparing nine different occupational settings for personal exposure to endotoxins 
indicates that the highest exposure occurred in poultry operations (Simpson et al., 1999). 
These results suggest poultry are exposed to high levels of LPS via contaminated air, and 
exposure may well potentiate the effects of low levels of mycotoxins that would normally 
be considered non-toxic.  
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The T-2 toxin (T-2) is a mycotoxin produced by the genera Fusarium and is a 
common contaminant of poultry feeds and feedstuffs and its adverse effects have been 
extensively studied (Leeson et al., 1995).  In poultry, exposure to T-2 induces gizzard 
erosions and oral lesions (Kubena et al., 1997, 1995; Neiger et al., 1994), and causes 
reduced body weight gain and feed intake.  The T-2 toxin is also a potent 
immunosuppressant (Moss, 2002).  Necrosis and depletion of the lymphoid organs has 
been reported in T-2 treated chickens and turkey poults (Wyatt et al., 1973; Boonchuvit 
et al., 1975; Richard et al., 1978a, 1978b; Hoerr et al., 1981).  
The immunosuppressive effects of T-2 on both cellular and antibody-mediated 
immunity decreases host resistance to infectious agents.  Mortality caused by paratyphoid 
infections was reported to be increased in chickens exposed to T-2 toxin (Boonchuvit et 
al., 1975; Ziprin and Elissalde, 1990).  In 1988, Tai and Pestka suggested a synergistic 
interaction between T-2 and S. typhimurium LPS in rats.  The authors found that a single 
sublethal oral dose of T-2 increased the acute toxicity of LPS and the LD50 values of LPS 
decreased upon co-administration of the toxin (Tai and Pestka, 1988).  In addition, 
combined treatment with subthreshold doses of S. typhimurium LPS and the tricothecene 
deoxynivalenol (vomitoxin) caused apoptosis in thymus, spleen, and Peyers patches after 
a 12-h exposure (Zhou et al., 2000).  Furthermore, in mice, acute, simultaneous exposure 
to T-2 and endotoxin resulted in increased mortality, hypothermia, TNF-α production, 
and thymic atrophy compared to treatment with either T-2 or endotoxin alone.  However, 
when animals were pretreated with endotoxin, a regime that renders the animals resistant 
to the effects of endotoxin, there was a reduction in the response to coadmnistration of T-
2 and endotoxin (Taylor et al., 1991). 
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Limited information is available on the chronic effects of a sublethal dose of LPS 
in combination with feeding subthreshold doses of T-2 toxin in chicks and poults.  The 
objectives of these studies were to determine if administration of low doses of E. coli 
LPS would potentiate the effects of non toxic doses of T-2 in chicks and poults fed 
dietary T-2 from hatch to 21 days of age.  
 
MATERIAL AND METHODS 
 
For these trials, 270 day-old broilers (Exp.1) and turkeys (Exp.2) were obtained 
from a commercial hatchery, weighed, wing-banded, and randomly assigned to pens in 
stainless steel chick batteries.  Birds were maintained on a 24-h light schedule and 
allowed ad libitum access to feed and water.  Birds were monitored daily for signs of 
morbidity and mortality.  Post-mortem evaluation was performed for all birds that died 
throughout the experiment.  The animal care and use protocol was reviewed and 
approved by the University of Missouri-Columbia Animal Care and Use Committee.   
For both experiments, a 3 x 3 factorial (three levels of T-2 and three levels of 
LPS) design was used with five replicates of six birds assigned randomly to each of the 
nine treatments from day 1 to day 21.  Treatments included: (A) 0 µg LPS/bird + 0 mg/kg 
T-2; (B) 0 µg LPS/bird + 1 mg/kg T-2; (C) 0 µg LPS/bird + 2 mg/kg T-2; (D) 100 µg 
LPS/bird + 0 mg/kg T-2; (E) 100 µg LPS/bird + 1 mg/kg T-2; (F) 100 µg LPS/bird + 2 
mg/kg T-2; (G) 150 µg LPS/bird + 0 mg/kg T-2; (H) 150 µg LPS/bird + 1 mg/kg T-2; 
and (I) 150 µg LPS/bird + 2 mg/kg T-2. 
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Lipopolyssacharide (E. coli LPS; serotype 0127:B8) was purchased from Sigma 
Chemical (St. Louis, MO) and reconstituted in sterile and non-pyrogenic saline for 
injection.  The solution was then heated under low heat for approximately 5 minutes or 
until complete dissolution.  All glassware was made endotoxin-free by dry heating to 
250ûC for at least 3 hours.  Chicks and poults were injected intraperitoneally (IP) with 
0.5 ml of sterile saline containing the appropriate quantity of LPS.  Birds were injected 
intraperitoneally (IP) with the appropriate dose of LPS every other day from day 7 to 21.  
Chicks and poults that did not receive LPS, were injected with sterile saline alone.  
Dietary treatments were fed beginning day 1.  
Birds were weighed weekly.  At 3 weeks of age (day 21), birds were then 
euthanized with carbon dioxide and samples of spleen and bursa (three birds/pen) 
(chicks) or splee, bursa, and thymus (three birds/pen) (poults) were collected for 
histopathologic evaluation as well as relative organ weight calculation (grams organ/100 
g body weight). 
Oral lesions were scored in a blind fashion using a 4-point scoring system, 
ranging from 0 to 4, with 0 = no lesion; 1 = one or two mouth lesions clearly visible on 
either the lower or upper mandible; 2 = lesions intermediate in appearance to lesions 
scored as 1 or 3; 3 = large lesions occurring at several sites within the mouth; 4 = large 
lesions occurring at several sites within the mouth, principally on the upper and lower 
mandible, the corners of the mouth, and the back of the tongue. 
Data were analyzed as a 3 x 3 factorial analysis by analysis of variance (ANOVA) 
using the General Linear Models procedure of SAS software (SAS Institute Inc., 1996).  
Means showing significant differences in ANOVA were compared using Fishers 
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protected least significant difference procedure (Snedecor and Cochran, 1989).  Mortality 
data were transformed (Arcsin) prior to statistical analysis.  All statements of differences 
were based on a significance of P < 0.05. 
 
RESULTS 
 
Experiment 1: Broiler Study:  At week two, 150 µg LPS/bird decreased (P < 
0.05) feed intake (FI) and body weight gain (BWG) in chicks, but no T-2 effect or LPS x 
T-2 interactions were observed (Table 4.1).  The mean values were 343, 337, and 318 g 
for FI; 277, 275, and 256 g for BWG for chicks given 0, 100, and 150 µg LPS/bird, 
respectively.  In chicks, at week three, there was a significant (P < 0.05) LPS x T-2 
interaction observed for BWG (Table 4.1).  With respect to oral lesions, chicks fed 2 
mg/kg T-2 had a higher incidence of oral lesions when compared to chicks fed 1 mg/kg 
T-2 (2 mg/kg T-2, 18%; 1 mg/kg T-2, 10%), but there was no difference in terms of 
severity of lesions (Table 4.3).  At both levels, T-2 caused only mild lesions.  Treatments 
had no effect on mortality rate of broilers.  LPS increased spleen weight in chicks (Table 
4.4).  There was no T-2 effect or LPS x T-2 interaction on relative organ. 
  Experiment 2: Poult Study:  In poults, at week two, birds fed 2 mg T-2 
toxin/kg diet showed a decrease (P < 0.05) in FI and BWG, but no LPS effect or LPS x 
T-2 interaction was observed (Table 4.2).  The mean values were 244, 233, and 209 g for 
FI; 158, 145, and 126 g for BWG for poults fed 0, 1, and 2 mg/kg T-2, respectively.  In 
poults, at week three, 2 mg/kg T-2 dramatically decreased FI, BWG, and increased 
FDGN (Table 4.2).  The mean values were 394, 383, and 324 g for FI; 198, 194, and 136 
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g for BWG; 2.05, 1.92, and 2.30 for FDGN for poults fed 0, 1, and 2 mg/kg of T-2, 
respectively.  No LPS effect or LPS x T-2 interaction was observed in turkey poults at 
week 3.  With respect to oral lesions, poults fed 2 mg/kg T-2 had a higher incidence (2 
mg/kg T-2, 48%; 1 mg/kg T-2, 30%) and more severe oral lesions (2 mg/kg T-2, scored 
1: 40%, scored between 2 and 3; 60%; 1 mg/kg T-2: scored 1, 56%; scored 2, 44%) than 
birds fed 1 mg/kg T-2 (Table 4.3 and Figure 4.1). Treatments had no effect on mortality 
rate of either species.  LPS increased spleen weight in poults (Table 4.4).  There was no 
T-2 effect or LPS x T-2 interaction on relative organ weight in poults. 
    
DISCUSSION 
 
At week two, 150 µg LPS/bird decreased FI and BWG in chicks; however, there 
was no LPS effect in week three.  Acute exposure to LPS decreases FI for a short period 
of time (Steiger et al., 1999; Frank, 2003).  Primary mediators of acute phase response 
are the cytokines TNF-α, IL-1, IL-2, and Il-6 (Klasing, 1998). Frank (2003) suggested 
that elevation in proinflammatory cytokines, e.g. TNF-α and IL-2, lead to an acute 
suppression in feed intake.  Warren et al. (1997) infused porcine TNF-α i.c.v. and 
reported dose-dependent reductions in feed intake over an 8-h period.  Xie et al. (2000) 
reported that LPS given to broiler chicks produced symptoms of drowsiness, lethargy, 
and withdrawal from feed and water within 1 hour of injection and that the symptoms 
persisted for up to 4 hours.  In addition, in 1994, Roth et al. evaluated the effects of 
repeated LPS challenges on the febrile and cytokine response of guinea-pigs; however, 
feed intake was not measured.  The febrile and cytokine responses were attenuated after 
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the third injection of LPS.  This phenomenon, known as endotoxin tolerance, was 
documented over 50 years ago by Beeson (1947).   
The state of endotoxin tolerance should not be confused with endotoxin resistance 
or resilience.  Tolerance is a state of a progressively diminishing response to an 
immunogen.  Resistance refers to the capability of physiological system to exclude a 
pathogen and resilience refers to the ability to maintain productivity during a challenge 
(Klasing, 1998).  Endotoxin tolerance was attributed to reduced TNF-α and IL-6-like 
activity (Roth et al., 1994); however, other mediators of food intake regulation cannot be 
eliminated (Frank, 2003). 
At week two, LPS caused decrease in performance in chicks.  The first LPS 
injection was administered on day 7 while the third injection was given on day 11 and 
throughout this period a reduction in FI and BWG was observed.  Therefore, the fact that 
LPS affected performance at 2 weeks of age and no or little effect was observed at week 
three is consistent with the endotoxin tolerance hypothesis described by Beeson (1947).  
The injections started at week two which suggest that the birds were adapting to the 
repeated LPS challenge and the responses to this exposure became less intense at week 
three.  At week two, lipopolysaccharide decreased performance in chicks when LPS-
treated group was compared to the birds receiving saline.  At week three, there was an 
LPS x T-2 effect on BWG in chicks; but no other significant difference between the LPS- 
and saline-treated groups was detected at week three.    
In chicks, T-2 had no effect on performance.  This result is in agreement with the 
literature.  For broiler chicks, decrease in performance was observed in birds fed 6 mg/kg 
of T-2 in combination with administration with Cryptosporidium bailey at 4 weeks of 
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age; furthermore, when chickens were fed 2 mg/kg of T-2 alone or combined with C. 
bailey challenge, there was no significant reduction in body weight gain (Békési et al., 
1997).  In addition, Kubena et al. (1997) reported an additive effect on body weight gain 
when broiler chicks were fed 5 mg/kg of T-2 combined with 300 mg/kg of Fumonisin B1 
(FB1) for 19 days.  However, no significant difference was observed for intake and feed 
conversion when 5 mg/kg T-2 was given alone Kubena et al. (1997).  In addition, Kubena 
et al. (2001) challenged broiler chicks with Salmonella typhimurium (ST) in combination 
with either 0, 7.5, or 15.0 mg T-2/kg of diet from day 3 to 11.  The authors determined an 
increase in susceptibility to ST colonization when chicks were fed the highest level of T-
2 (15.0 mg/kg).  Moreover, a decrease in body weight gain was only observed in birds 
fed 15.0 mg/kg of T-2 alone or in combination with ST. 
In poults, at week two, birds fed 2 mg T-2 toxin/kg diet showed a decrease in FI 
and BWG, but no LPS effect or LPS x T-2 interactions were observed.  At week three, 2 
mg/kg T-2 given alone dramatically decreased FI, BWG, and increased FDGN in poults.  
The decrease in performance observed in poults fed T-2 alone is atypical of a number of 
studies conducted in which decrease in performance was observed only when poults were 
fed at least 5 mg/kg T-2.  Kubena et al. (1995) reported that female turkey poults fed 5 
mg T-2/kg of feed for 21 days had body weight gain 26% lower than the control group 
and when T-2 treatment was combined with 300 mg FB1/kg of feed, a 47% reduction 
was observed.  In the present study, when 2 mg T-2/kg was given alone, there was a 21% 
reduction in body weight gain, an 11% reduction in feed intake, and 0.21 increase in feed 
efficiency.  In addition, Sklan et al. (2003) found oral lesions in poults fed 200 µg T-2/kg 
feed after 7 days of feeding which did not influence body weight or feed efficiency.   
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  With respect to oral lesions, chicks fed 2 mg/kg T-2 had a higher incidence of 
oral lesion when compared to chicks fed 1 mg/kg T-2, but no difference in terms of 
severity of lesions.  At both levels, T-2 caused only mild lesions in chicks.  Unlike 
chicks, poults fed 2 mg/T-2 had a higher incidence and more severe lesions than birds fed 
1 mg/kg T-2.  Treatments had no effect on mortality rate of either species.   
Lipopolysaccharide increased relative spleen weight in chicks and poults.  B 
lymphocytes attain full maturation in the bone marrow, and T lymphocytes mature in the 
thymus.  After the cells have matured, they leave the bone marrow or thymus and 
populate the peripheral lymphoid organs  e.g. spleen, where the immune responses to 
foreign antigens occur (Abbas and Lichtman, 2000).  In response to antigen and growth 
factors made by the antigen-stimulated lymphocytes and by other cells, the antigen-
specific lymphocytes undergo mitotic division.  This results in proliferation and increased 
size of antigen-specific cells (Abbas and Lichtman, 2000) resulting in enlargement of the 
spleen.  There was no T-2 effect or LPS x T-2 interaction on relative organ weight on 
chicks and poults.   Richard et al. (1978) fed broiler chicks diets containing 2 or 10 
mg/kg T-2 and found no significant effect of T-2 on relative organ weight of those birds.  
Ogunbo (1994) fed chicks and poults 4 mg/kg T-2 and found a decrease in absolute 
spleen weight in chicks, but not in poults.  In addition, there was no effect on relative 
bursa weight for both species.  
The T-2 toxin damages the GI tract (Bratich et al., 1990) increasing LPS 
translocation from the GI tract (Roth et al., 1997; Taylor et al., 1991), suggesting that the 
natural barriers to systemic LPS exposure via GI tract is more easily broken during T-2 
toxicosis (Perry et al., 1972).  Therefore, the lack of combined effects between T-2 and 
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LPS may be due to the fact that the T-2 levels chosen were too low for broiler chicks and 
turkey poults to cause significant GI tract damage to cause increase in translocation of 
LPS into the portal blood.  In turkey poults, however, the decrease in performance 
observed in birds fed T-2 alone is atypical of a number of studies conducted in which 
decrease in performance was only observed when poults were fed at least 5 mg/kg T-2. 
 
CONCLUSION 
 
Based on these results, it can be concluded that LPS did not enhance the effects of 
T-2 toxin in poults and chicks.  In poults, however, a decrease in performance observed 
in birds T-2 alone was atypical of a number of studies conducted in which decrease in 
performance was only observed when poults were fed at least 5 mg/kg T-2. 
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TABLE 4.1.  EFFECTS OF ENDOTOXIC LIPOPOLYSACCHARIDE IN BROILER 
CHICKS FED T-2 TOXIN1 
 
  2ND WEEK  3RD WEEK 
 
LPS T-2 FI BWG FDGN FI BWG FDGN 
(µg/bird) (ppm) --------(g)--------   (g:g) -------(g)--------   (g:g) 
 
 
0 0 346a 281a 1.2362 477 363a 1.3152 
0 1 346a 275a 1.2579 456 330b 1.3848 
0 2 336a 276a 1.2198 472 354ab 1.3348 
100 0 331a 272a 1.2171 443 327b 1.3517 
100 1 336a 280a 1.2008 470 351ab 1.3392 
100 2 343a 272a 1.2629 469 326b 1.4391 
150 0 325ab 267a 1.2163 449 336b 1.3377 
150 1 298b 234b 1.2472 447 343ab 1.3026 
150 2 331a 267a 1.2405 483 331b 1.3807 
SEM   10.52 8.83   0.02  10.03 8.42   0.03 
 
   -----------------------------------Probability------------------------------ 
 
LPS  0.0322 0.0217 0.7479 0.5766 0.1308 0.2595 
T-2  0.5450 0.3935 0.4765 0.0847 0.7750 0.0948 
LPS X T-2  0.3618 0.2017 0.0970 0.1374 0.0377 0.0922 
 
1 Data are means of five replicates of six birds each. 
a, b Values within column with different superscript differ significantly (P < 0.05). 
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TABLE 4.1 (CONT).  EFFECTS OF ENDOTOXIC LIPOPOLYSACCHARIDE IN 
BROILER CHICKS FED T-2 TOXIN1 
 
  2ND WEEK  3RD WEEK 
 
  FI BWG FDGN FI BWG FDGN 
Main Effect Mean --------(g)--------   (g:g) -------(g)--------   (g:g) 
 
 
LPS, µg/bird 
 0 343a 277a 1.2380 468 349 1.3449 
 100 337a 275a 1.2269 460 335 1.3767 
 150 318b 256b 1.2347 460 337 1.3403 
 
T-2 toxin, ppm 
 0 334 273 1.2232 456 342 1.3349 
 1 327 263 1.2353 457 341 1.3422 
 2 337 271 1.2411 474 337 1.3849 
 
1 Data are means of 5 replicates of 6 birds each. 
a, b Values within column with different superscript differ significantly (P < 0.05). 
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TABLE 4.2.  EFFECTS OF ENDOTOXIC LIPOPOLYSACCHARIDE IN TURKEY 
POULTS FED T-2 TOXIN1 
 
   2ND WEEK   3RD WEEK 
 
LPS T-2 FI BWG FDGN FI BWG FDGN 
(µg/kg) (ppm) ------- (g) -------  (g:g) ------- (g) ---------  (g:g) 
 
 
0 0 242ab 150ab 1.6268 395a 208a 1.9210b 
0 1 244ab 147ab 1.6660 391a 182a 1.9510ab 
0 2 217b 126b 1.7378 350ab 164ab 2.1320ab 
100 0 254a 167a 1.5222 390a 205a 1.9152b 
100 1 212b 131b 1.6731 370a 194a 1.9206b 
100 2 211b 131b 1.6366 295b 110b 2.2300ab 
150 0 237ab 156ab 1.5163 397a 181a 2.3291ab 
150 1 243ab 157ab 1.5552 388a 205a 1.8911b 
150 2 199b 120b 1.6631 327b 134b 2.4778a 
SEM  9.55 8.35   0.06  16.68   14.03   0.16  
  
  -----------------------------------Probability-------------------------------- 
 
LPS  0.5272 0.9048 0.2096 0.2009 0.4688 0.2573 
T-2  0.0007 0.0005 0.0940 <.0001 <.0001 0.0470 
LPS X T-2 0.1170 0.2055 0.8312 0.7394 0.1229 0.6365 
 
1 Data are means of five replicates of six birds each. 
a, b Values within column with different superscript differ significantly (P < 0.05). 
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TABLE 4.2 (CONT).  EFFECTS OF ENDOTOXIC LIPOPOLYSACCHARIDE IN 
TURKEY POULTS FED T-2 TOXIN1 
  
 2ND WEEK  3RD WEEK 
 
  FI BWG FDGN FI BWG FDGN 
Main Effect Mean --------(g)--------   (g:g) -------(g)--------   (g:g) 
 
 
LPS, µg/bird 
 0 235 141 1.6769 379 185 2.0013 
 100 226 143 1.6106 352 170 2.0452 
 150 226 144 1.5782 370 174 2.2327 
 
T-2 toxin, ppm 
 0 244a 158a 1.5551 394a 198a 2.0551b 
 1 233a 145a 1.6314 383a 194a 1.9209a 
 2 209b 126b 1.6792 324b 136b 2.3031a 
 
1 Data are means of 5 replicates of 6 birds each. 
a, b Values within column with different superscript differ significantly (P < 0.05). 
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TABLE 4.3.  EFFECTS OF ENDOTOXIC LIPOPOLYSACCHARIDE ON MOUTH 
LESION1 OF BROILER CHICKS AND TURKEY POULTS FED T-2 TOXIN 
 
    
LPS  T-2      ORAL LESION SCORE 
(µg/bird) (ppm)  BROILERS  TURKEYS  
 
 
0  0 0.00b  0.00c  
0  1  0.27ab    0.67b 
0   2  0.40ab    2.07a 
100   0   0.13b    0.07c 
100   1  0.13b    0.73b 
100   2  0.73a    1.67a 
150   0  0.07b    0.13bc 
150   1  0.27ab    1.20ab 
150   2  0.27ab    1.43a 
SEM      0.16     0.23 
                     -------------------------------Probability------------------------------ 
 
LPS  0.5683 0.8405  
T-2  0.0170 <.0001  
LPS X T-2  0.4250 0.1567 
 
1 Data are means of five replicates of three birds each. 
a, b,c Values within columns with different superscripts differ significantly (P < 0.05). 
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TABLE 4.3 (CONT).  EFFECTS OF ENDOTOXIC LIPOPOLYSACCHARIDE ON 
HEMATOCRIT1, MORTALITY RATE2, AND MOUTH LESION1 OF POULTS FED 
T-2 TOXIN AND AFLATOXIN B1 
 
    ORAL LESION SCORE 
Main effect mean   BROILERS  TURKEYS  
 
 
LPS, µg/bird 
 0   0.22  0.91  
 100   0.33    0.82 
 150    0.20    0.92 
 
T-2, mg/kg 
 0      0.07b    0.07c 
 1     0.22ab    0.87b 
 2     0.47a    1.72a 
 
1 Data are main effect means. 
a, b Values within columns, in main effect, with different superscripts differ significantly 
(P < 0.05). 
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Figure 4.1. Incidence and severity of oral lesions in turkey poults fed T-2 toxin 
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TABLE 4.4.  EFFECTS OF ENDOTOXIC LIPOPOLYSACCHARIDE ON RELATIVE 
ORGAN WEIGHTS OF BROILER CHICKS FED T-2 TOXIN1 
 
   BROILERS  TURKEYS 
 
LPS T-2    SPLEEN BURSA SPLEEN BURSA THYMUS 
(µg/bird) (ppm) ----------------------------------------(%)---------------------------------   
 
 
0 0  0.104 0.287 0.099 0.176 0.125
0 1  0.092 0.273  0.092  0.160   0.120  
0 2  0.108 0.294  0.094  0.182  0.110
100 0  0.167 0.289  0.111  0.165   0.124
100 1  0.165 0.304  0.120  0.172   0.132
100 2  0.154 0.289  0.115  0.191   0.108
150 0  0.166 0.263  0.110  0.167   0.123 
150 1  0.145 0.272  0.115  0.184   0.120 
150 2  0.143 0.300  0.109  0.175   0.116 
SEM   0.01 0.02  0.008  0.005    0.009 
    ----------------------------------Probability------------------------------ 
 
LPS  <.0001 0.6042  <.0001  0.8748   0.9190
T-2  0.3177 0.6147  0.6726  0.1277   0.1290
LPS X T-2  0.5724 0.7293  0.5692  0.1979   0.7844 
 
1 Data are means of five replicates of three birds each. 
a, b, c Values within columns with different superscripts differ significantly (P < 0.05). 
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TABLE 4.4 (CONT).  EFFECTS OF ENDOTOXIC LIPOPOLYSACCHARIDE ON 
RELATIVE ORGAN WEIGHTS OF BROILER CHICKS AND TURKEY POULTS 
FED AFLATOXIN B11 
 
   BROILERS  TURKEYS 
 
LPS T-2    SPLEEN BURSA SPLEEN BURSA THYMUS 
(µg/bird) (ppm) ----------------------------------------(%)---------------------------------   
 
 
LPS, µg/bird  
 0 0.101b 0.284 0.229b 0.173 0.119 
 100 0.162a 0.294 0.243a 0.176 0.121 
 150 0.151a 0.278 0.240a 0.176 0.120 
 
T-2, mg/kg 
 0 0.145 0.279 0.107 0.169 0.124 
 1 0.134 0.282 0.109 0.172 0.124 
 2 0.135 0.294 0.106 0.183 0.111 
 
1 Data are main effect means. 
a, b Values within columns, in main effect, with different superscripts differ significantly 
(P < 0.05). 
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CHAPTER V 
 
EFFECTS OF CONTINOUS ADMINISTRATION OF LOW-DOSE ENDOTOXIC 
LIPOPOLYSACCHARIDE IN CHICKS AND POULTS FED NON TOXIC DOSES 
OF AFLATOXIN B1 AND T-2 TOXIN 
 
ABSTRACT 
 
Two studies were conducted to determine the effects of chronic exposure to low 
doses of E. coli lipopolysaccharide (LPS) in chicks and poults fed diets contaminated 
with non toxic doses of aflatoxin B1 (AFB1) and T-2 toxin (T-2) from hatch to day 21.  
Birds were fed diets containing 0 or 2 mg T-2/kg diet singly or in combination with 0 or 2 
mg AFB1/kg (chicks) or 0 or 0.15 mg/kg AFB1 (poults).  Beginning on day 7, chicks and 
poults were injected intraperitoneally with 0 or 150 µg LPS/bird every other day. At 
week 2, LPS, T-2 and AFB1 decreased (P < 0.05) feed intake (FI) and body weight gain 
(BWG) in both chicks and poults.  Feed efficiency (FDGN) was increased (P < 0.05) by 
T-2 in both species, by AFB1 in chicks, and by LPS in poults.  In chicks, when T-2 was 
combined with AFB1, there was a further decrease (P < 0.05) in FI and BWG whereas in 
poults, there was a further increase (P < 0.05) in FDGN when T-2 was combined with 
LPS.  In chicks, at week three, FI was affected (P < 0.05) by AFB1 and T-2, BWG by 
AFB1, T-2, and LPS, and FDGN by AFB1.  Similar to week two, when T-2 was 
combined with AFB1, there was a further decrease (P < 0.05) in FI and BWG of those 
chicks compared to chicks fed AFB1.  In poults, FI was decreased (P < 0.05) by T-2, 
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BWG by T-2 and AFB1, and FDGN was increased by T-2.  In chicks, mortality rate at 
the end of the 3-week period was higher (P < 0.05) for the AFB1-fed groups.  In poults, 
LPS increased (P < 0.05) mortality rate and poults given the combination of LPS and T-2 
had a higher mortality rate compared to those fed T-2 alone or only injected with LPS 
(LPS, 0; T-2, 0; LPS x T-2, 12%).  In chicks, there was an additive interaction (P < 0.05) 
among LPS, AFB1, and T-2 on mortality rate after the first LPS injection (LPS, 6; AFB1, 
0; T-2, 0; LPS x T-2, 0; LPS x AFB1, 8; LPS x T-2 x AFB1, 16%); however, in poults, 
there was no LPS effect (P > 0.05) on mortality rate after the first LPS injection.  In 
chicks and poults, LPS decreased FI which lasted for 6 hours after the first LPS injection.  
Based on these results, it can be concluded that at the levels chosen chronic exposure to 
low doses of LPS did not potentiate the effects of dietary non toxic doses of T-2 and 
AFB1 on performance of chicks and poults fed from hatch to day 21.  However, LPS did 
potentiate the effects of T-2 on mortality rate and oral lesions in poults and, after the first 
LPS injection, decreased feed intake for 6 hours.  LPS also enhanced mortality rate in 
broiler chicks after the first LPS injection and decreased feed intake for 6 hours after the 
first injection containing LPS. 
 
INTRODUCTION 
 
Mycotoxins are a group of structurally diverse secondary fungal metabolites that 
occur as contaminants of grain worldwide. It has been estimated that 25% of the worlds 
food crops are affected by mycotoxins (CAST, 1989). Many of these mycotoxins can 
cause serious health problems in animals and their presence in agricultural commodities 
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may result in serious economic losses (estimated to be 1.4 billion dollars annually; 
CAST, 2003). Poultry producers have a continuous problem with low levels of 
mycotoxin-contaminated feedstuffs causing poorly defined syndromes.   
In the past, it was speculated that many of these unexplained syndromes were 
caused by synergism between mycotoxins. However, years of research have shown little 
or no synergy but only additive effects. Another potential explanation for the unexplained 
syndromes observed in poultry may be concomitant exposure to mycotoxins and stressors 
(e.g. ammonia, competition for feed and water, heat, disease, and endotoxin exposure) 
present in commercial poultry operations.   
Recent reports suggest that, one of these stressors, endotoxic lipopolysaccharides 
(LPS) may augment the toxic effects of some mycotoxins (Barton et al., 2000b; Zhou et 
al., 1999, 2000; Tai and Pestka, 1988).  Bacterial lipopolysaccharide is a component of 
the outer membrane of the cell walls of gram-negative bacteria.  Exposure to high doses 
of LPS causes fever, circulatory shock, disseminated intravascular coagulation, and 
damage to numerous organs, including the liver (Barton et al., 2001).  Acute exposure to 
LPS causes decrease in feed intake, which, in heifers, lasted for 4 hours (Steiger et al., 
1999) and in pigs for 48 hours (Frank, 2003) after LPS exposure before returning to 
control levels.  During an immunological challenge, an animal undergoes a series of 
physiological events known as the acute-phase response which is designed to help the 
animal to overcome the challenge (Baumann and Gauldie, 1994).  One resulting 
component of the acute-phase response is suppression in feed intake (Kelley et al., 1994; 
Johnson, 1998).  Frank (2003) suggested that elevation in proinflammatory cytokines, 
e.g. TNF-α and IL-2, lead to an acute suppression in feed intake.  Warren et al. (1997) 
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infused porcine TNF-α i.c.v. and reported dose-dependent reductions in feed intake over 
an 8-h period. 
Exposure to smaller doses of LPS initiates a more modest and noninjurious 
inflammatory response (Barton et al., 2001).  However, exposure to such doses can 
render the liver more sensitive to injury from xenobiotic agents, such as AFB1 and T-2 
toxin (Roth et al., 1997).  In addition, T-2 damages the GI tract (Bratich et al., 1990) 
increasing the LPS translocation from the GI tract and causing liver lesions which 
resemble that produced by large, injurious doses of LPS (Roth et al., 1997; Taylor et al., 
1991).  
Moreover, results of a recent study comparing nine different occupational settings 
for personal exposure to endotoxins indicates that the highest exposure occurred in 
poultry operations (Simpson et al., 1999). These results suggest poultry are exposed to 
high levels of LPS via contaminated air, and exposure may well potentiate the effects of 
low levels of mycotoxins that would normally be considered non-toxic.  
Aflatoxin B1 (AFB1), the most toxic of the aflatoxins, causes a variety of adverse 
effects in different animal species, especially in poultry which includes retarded growth 
rate, impaired feed conversion, increased liver weights, liver damage, 
immunosuppression, negative effects on serum chemistry and hematological parameters, 
and histopathological lesions.  Huff et al. (1986) showed that the most sensitive 
indicators of aflatoxicosis in young broiler chickens are the reduction in serum albumin 
and total protein levels.  Aflatoxin B1 also inhibits protein synthesis and lipid synthesis, 
depresses glucose metabolism and blood clotting-factor synthesis (Busby and Wogan, 
1981).  Rastogi et al. (2001) reported a decrease in the activities of succinate 
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dehydrogenase and glucose-6-phosphatase, increased levels of lipid peroxides, and 
decline in the activities of enzymatic antioxidants levels, such as glutathione-S-
transferase, glutathione reductase, and glutathione peroxidase. 
The T-2 toxin (T-2) is a mycotoxin produced by the genera Fusarium and is a 
common contaminant of poultry feeds and feedstuffs (Leeson et al., 1995).  In poultry, 
exposure to T-2 induces gizzard erosions and oral lesions (Kubena et al., 1997, 1995; 
Neiger et al., 1994), reduced body weight gain and feed intake, necrosis and depletion of 
the lymphoid organs (Wyatt et al., 1973; Boonchuvit et al., 1975; Richard et al., 1978; 
Hoerr et al., 1981).   
The T-2 is also a potent immunosuppressant (Moss, 2002) decreasing host 
resistance to infectious agents.  Mortality caused by paratyphoid infections was reported 
to be increased in chickens exposed to T-2 (Boonchuvit et al., 1975; Ziprin and Elissalde, 
1990).  Tai and Pestka 1988s results suggest a synergistic interaction between T-2 and S. 
typhimurium LPS in rats.  In addition, T-2 inhibits protein synthesis (Sudakin, 2003) and 
may stimulate lipid peroxidation (Karppanen et al., 1989). 
In the literature, only the acute effects of LPS alone or in combination with high 
doses of xenobiotics are described.  Therefore, there is limited information available on 
the chronic effects of a sublethal dose of LPS in combination with feeding subtoxic doses 
of T-2 toxin in chicks and poults.  The objective of these studies was to determine the 
chronic effects of continuous administration of low doses of E. coli LPS every other day 
in chicks and poults fed non toxic doses of AFB1 and T-2 from hatch to 21 days of age.  
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MATERIAL AND METHODS 
 
For these trials, 200 day-old broilers (Exp.1) and turkeys (Exp.2) were obtained 
from a commercial hatchery, weighed, wing-banded, and randomly assigned to pens in 
stainless steel chick batteries.  Birds were maintained on a 24-h light schedule and 
allowed ad libitum access to feed and water.  Birds were monitored daily for signs of 
morbidity and mortality.  Post-mortem evaluation was performed on all birds that died 
during the experiment.  The animal care and use protocol was reviewed and approved by 
the University of Missouri-Columbia Animal Care and Use Committee.   
For both experiments, a 2 x 2 x 2 factorial (two levels of LPS, two levels of T-2 
and two levels of AFB1) design was used with five replicates of five birds assigned 
randomly to each of the eight treatments from day 1 to 21.  Treatments included: (A) 0 
µg LPS/bird + 0 mg/kg T-2 + 0 mg/kg AFB1; (B) 0 µg LPS/bird + 2 mg/kg T-2 + 0 
mg/kg of AFB1; (C) 0 µg LPS/bird + 0 mg/kg of T-2 + 2 mg/kg AFB1 (chicks) or 0.15 
mg/kg AFB1 (poults); (D) 0 µg LPS/bird + 2 mg/kg T-2 + 2 mg/kg AFB1 (chicks) or 
0.15 mg/kg AFB1 (poults); (E) 150 µg LPS/bird + 0 mg/kg T-2 + 0 mg/kg AFB1; (F) 150 
µg LPS/bird + 2 mg/kg T-2 + 0 mg/kg AFB1; (G) 150 µg LPS/bird + 0 mg/kg T-2 + 2 
mg/kg AFB1 (chicks) or 0.15 mg/kg AFB1 (poults); and (H) 150 µg LPS/bird + 2 mg/kg 
of T-2 + 2 mg/kg AFB1 (chicks) or 0.15 mg/kg AFB1 (poults). 
Lipopolysaccharide (E. coli LPS; serotype 0127:B8) was purchased from Sigma 
Chemical (St. Louis, MO) and reconstituted in sterile and non-pyrogenic saline for 
injection.  The solution was then heated under low heat for approximately 5 minutes or 
until complete dissolution.  All glassware were made endotoxin-free by dry heating to 
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250ûC for at least 3 hours.  Chicks were injected intraperitoneally with 0.5 ml of sterile 
saline containing the appropriate quantity of LPS.  Chicks that did not receive LPS, were 
injected with sterile saline.  Dietary treatments were fed beginning day 1. Chicks and 
poults were injected intraperitoneally (IP) with the appropriate dose of LPS every other 
day from day 7 to 21.  
Feed intake (FI) was measured at 1, 2, 4, 6, 12, 18, and 24 hours after the first 
three injections for Experiments 1 and 2 to determine LPS effect on FI. Birds and feed 
consumption were weighed weekly.  At 3 weeks of age (day 21), birds were then 
euthanized with carbon dioxide, bled via cardiac puncture for whole blood and serum 
collection.  Whole blood was collected for hematocrit determination and serum for 
determination of glucose, calcium, uric acid, aspartate aminotransferase, creatine kinase, 
total protein, albumin, and globulin concentrations.  Liver, spleen, bursa, and thymus 
(three birds/pen) were sampled for histopathologic evaluation as well as relative organ 
weight calculation.  Organ weights are expressed as relative weights (grams organ/100 g 
body weight). 
Liver samples (two birds/rep; eight/trt) were also collected for measurement of 
hepatic glutathione (GSH).  Briefly, 1 g of liver tissue was immediately homogenized in 
PBS solution (pH 7.0).  Homogenates were then centrifuged at 2,800 g for 10 min and 
stored at - 80ºC until analysis.  Hepatic glutathione level in the supernatant was 
determined using a spectrophotometric assay kit (Calbiochem, Cat. No. 354102) 
according to the manufacturers instructions. 
Oral lesions were scored in a blind fashion using a 4-point scoring system, 
ranging from 0 to 4, with 0 = no lesion; 1 = one or two mouth lesions clearly visible on 
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either the lower or upper mandible; 2 = lesions intermediate in appearance to lesions 
scored as 1 or 3; 3 = large lesions occurring at several sites within the mouth; 4 = large 
lesions occurring at several sites within the mouth, principally on the upper and lower 
mandible, the corners of the mouth, and the back of the tongue. 
Data were analyzed as a 2 x 2 x 2 factorial by analysis of variance (ANOVA) 
using the General Linear Models procedure of SAS software (SAS Institute Inc., 1996).  
Means showing significant differences in ANOVA were compared using Fishers 
protected least significant difference procedure (Snedecor and Cochran, 1989). Mortality 
data were transformed (Arcsin) prior to statistical analysis.  All statements of differences 
were based on a significance of P < 0.05. 
 
RESULTS 
 
Experiment 1: Broiler Study:  At week one, there was an AFB1 effect (P < 
0.05) on feed intake (FI) (Table 5.1).  At week two, LPS, T-2 and AFB1 decreased (P < 
0.05) FI and BWG, whereas feed efficiency (FDGN) was increased (P < 0.05) by T-2 and 
AFB1.  In chicks, when T-2 was combined with AFB1, there was a further decrease (P < 
0.05) in FI (T-2, 291; AFB1, 286; T-2 x AFB1, 228 g) and BWG (T-2, 242; AFB1, 229; 
T-2 x AFB1, 170 g).  Lipopolysaccharide injections affected (P < 0.05) feed intake (FI).  
Independent of the dietary treatments, chicks given LPS did not returne to eating until 6 
hours after the first injection (Figure 5.3).  In birds given saline alone, these signs were 
absent.  At week three, in chicks, BWG was affected (P < 0.05) by AFB1, T-2, and LPS, 
FI by T-2 and AFB1, and FDGN by AFB1 only.  As in week two, when T-2 was 
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combined with AFB1, there was a further decrease (P < 0.05) in FI (T-2, 583; AFB1, 
542; T-2 x AFB1, 453 g) and BWG (T-2, 432; AFB1, 385; T-2 x AFB1, 293 g) in chicks 
(Table 5.1).  In chicks, mortality rate at the end of the 3-week period was higher (P < 
0.05) in the AFB1-fed groups (Table 5.3).  In addition, exposure to LPS increased 
mortality rate measured within 24 hours after the first LPS injection.  In chicks, T-2 
caused (P < 0.05) mild oral lesions in birds fed T-2 singly or in combination with LPS or 
AFB1 or both (Table 5.3).  With respect to relative organ weights of chicks (Tables 5.5), 
AFB1 increased (P < 0.05) liver and spleen weights and decreased thymus weight.  
Lipopolysaccharide increased spleen weight and decreased bursa weight (P < 0.05).  T-2 
had no effects on relative organ weights of chicks; however, when T-2 was combined 
with AFB1, there was a further decrease (P < 0.05) in thymus weight (T-2, 0.337; AFB1, 
0.300; T-2 x AFB1, 0.231 g:100 g BW).  In chicks, LPS and AFB1 decreased (P < 0.05) 
serum total protein (TP) and albumin (ALB) concentrations, whereas T-2 decreased only 
ALB concentrations (P < 0.05).  There was an LPS x T-2 interaction on TP (LPS, 2.17; 
T-2, 2.21; LPS x T-2, 2.25 g/100 ml) and ALB (LPS, 1.18; T-2, 1.13; LPS x T-2, 2.25 
g/100 ml) (Table 5.7).  For serum chemistry, in chicks, AFB1 caused a decrease (P < 
0.05) in serum concentrations of glucose (GLU) and calcium (Ca) (Table 5.9).  In 
addition, co-treatment with AFB1 and T-2 or AFB1 and LPS decreased (P < .05) Ca 
when compared to LPS and T-2 given alone (LPS, 9.7; T-2, 9.9; AFB1, 8.6; LPS x 
AFB1, 8.6; T-2 x AFB1, 8.7 mg/dL).  There was also an LPS x T-2 interaction (P < 0.05) 
observed in Ca in chicks (LPS, 9.7; T-2, 9.9; LPS x T-2, 9.9).  LPS decreased aspartate 
aminotransferase (AST) in chicks (Table 5.9).  In chicks, there were no treatment effects 
(P > 0.05) on hematocrit (HCT) (Table 5.3).  In chicks, AFB1 increased (P < 0.05) GLUT 
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(Table 5.11).  In addition, a three-way interaction in GLUT was found (P > 0.05) in 
chicks (LPS, 6.24; T-2, 6.70; AFB1, 8.41; LPS x T-2 x AFB1, 6.92 mmol/100 µL).          
Experiment 2: Poult Study:  At week one, there was a T-2 effect (P < 0.05) on 
FI, body weight gain (BWG), and feed conversion (FDGN) (Table 5.2).  At week two, 
LPS, T-2 and AFB1 decreased (P < 0.05) FI and BWG (Tables 5.1 and 5.2).  Feed 
efficiency (FDGN) was increased (P < 0.05) by T-2 and by LPS in poults (Tables 5.2).  
In poults, there was a further increase (P < 0.05) on FDGN when T-2 was combined with 
LPS (LPS, 1.23; T-2, 1.32; LPS x T-2, 1.42 g:g).  Lipopolysaccharide injections affected 
(P < 0.05) feed intake (FI).  Independent of the dietary treatments, birds given LPS 
returned to eating 6 hours after the first injection (Figure 5.3).  In poults, at week three, FI 
was increased and FDGN decreased (P < 0.05) by T-2, whereas BWG was decreased (P < 
0.05) by T-2 and AFB1 (Tables 5.2).  In poults, LPS increased (P < 0.05) mortality rate 
during the 3 week long study (0 LPS, 2; 150 LPS, 9%).  In addition, an LPS x T-2 
interaction was also found in poults (P < 0.05) (LPS, 0; T-2, 0; LPS x T-2, 12%) (Table 
5.4 and Figure 5.2).  In poults, T-2 had an effect (P < 0.05) on incidence of oral lesions.  
The incidence of oral lesion in poults fed T-2 was 93%, whereas in poults fed no T-2, no 
oral lesions were detected (Table 5.4).  Lipopolysaccharide increased (P < 0.05) the 
severity of the oral lesions of birds fed T-2 when compared to birds fed T-2 alone.  Birds 
fed T-2 and given LPS had 50% of the oral lesions scored either 3 or 4, whereas birds fed 
T-2 singly had 93% of the birds scored between 0 and 2 and only 7% scored 3.    
With respect to organ weight, in contrast to chicks, T-2 increased liver weight and 
spleen weight (P < 0.05) in poults (Table 5.6), whereas AFB1 increased (P < 0.05) spleen 
weight and decreased liver and thymus weights in poults (Tables 5.6).  In poults, LPS 
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increased (P < 0.05) TP (Table 5.8).  LPS x T-2 interactions were observed for TP and 
globulin (GLOB) concentrations (TP: LPS, 3.06; T-2, 2.83; LPS x T-2, 3.36 g/100 ml; 
GLOB: LPS, 1.65; T-2, 1.47; LPS X T-2, 1.96 g/100 ml).  Aflatoxin B1 caused (P < 
0.05) almost a 2-fold decrease in TP, ALB, and GLOB when compared to the control 
group.  There was also a less than additive AFB1 x T-2 interaction (P < 0.05) on ALB (T-
2, 1.36; AFB1, 0.78; T-2 x AFB1, 0.81 g/100 ml) (Table 5.8). In poults, AFB1 decreased 
GLU and Ca and decreased AST (P < 0.05) (Table 5.10).  In addition, T-2 decreased Ca 
and LPS decreased creatine kinase (CK) (P < 0.05).  In poults, no interactions among the 
factors were observed.  In either species, no affects (P > 0.05) on uric acid (UA) were 
observed (Tables 5.9 and 5.10).  In poults, T-2 x AFB1 and LPS X T-2 X AFB1 
interactions were found (LPS, 35.13; T-2, 34.13; AFB1, 35.33; T-2 X AFB1, 34.23; LPS 
X T-2 X AFB1, 38.67%) (Table 5.4).  Finally, treatments had no effect (P > 0.05) on 
hepatic glutathione (GLUT) concentration (Table 5.12).  
 
DISCUSSION 
 
A prominent feature of septic shock is a severe and intractable hypotension 
coupled with a primary reduction in circulating blood volume, which leads ultimately to 
circulatory collapse and death (Andrew et al., 2000).  In the present study, at the end of 3 
weeks, LPS caused increased mortality in poults, but had no effect in mortality on chicks.  
In addition, there was a synergistic interaction between T-2 and LPS in poults increasing 
mortality rate.  Furthermore, in poults, T-2 had an effect on incidence of oral lesions.  
The incidence of oral lesion in poults fed T-2 was 93% whereas in poults fed no T-2, no 
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oral lesion was detected.  Lipopolysaccharide increased the severity of the oral lesions 
compared to the birds fed T-2 alone.  Birds fed T-2 and given LPS had 50% of oral 
lesions with a score between 3 and 4, whereas birds fed T-2 alone had 93% of the birds 
with lesion score between 0 and 2 and only 7% with lesion score of 3.  These results are 
in agreement with the literature.  The T-2 toxin damages the GI tract (Bratich et al., 
1990) increasing LPS translocation from the GI tract (Roth et al., 1997; Taylor et al., 
1991), suggesting that the natural barriers to LPS systemic exposure via the GI tract is 
more easily broken during T-2 toxicosis (Perry et al., 1972).  In addition, tricothecenes 
become more toxic in the presence of LPS, thereby causing markedly elevated tissue 
injury and mortality (Tai and Pestka, 1988; Taylor et al., 1991; Zhou et al., 1999). 
By contrast, in chicks, 2 mg T-2/kg diet, with or without LPS, caused only mild 
oral lesions suggesting that 2 mg T-2/kg diet may have been too low a concentration to 
cause significant GI tract damage to allow translocation of LPS into the portal blood and 
therefore increase mortality when chicks were co-treated with LPS and T-2.  However, in 
chicks, LPS had more of an acute effect.  Chicks given LPS had an increase of 12% in 
mortality after the first injection containing LPS which was not seen in poults.  This 
result suggests that chicks may be more susceptible to an initial dose of LPS when 
compared to poults.   
Acute exposure to LPS decreases FI for a short period of time (Steiger et al., 
1999; Frank, 2003).  Primary mediators of acute phase response are the cytokines TNF-α, 
IL-1, IL-2, and IL-6 (Klasing, 1998). Frank (2003) suggested that elevation in 
proinflammatory cytokines, e.g. TNF-α and IL-2, lead to an acute suppression in feed 
intake.  Warren et al. (1997) infused porcine TNF-α i.c.v. and reported dose-dependent 
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reductions in feed intake over an 8-h period.  In the present study, LPS injections affected 
feed intake immediately.  Exposure to LPS caused lethargy and withdrawal from feed and 
water for at least 4 hours.  Birds also presented signs of ruffled feathers and moderate 
diarrhea.  Independent of the dietary treatments, birds given LPS resumed eating 6 hours 
after the first injection containing LPS.  In birds given saline alone, these signs were 
absent.  After the second and third injections, however, LPS had no effect on feed intake.  
These results are in agreement with the results of Xie et al. (2000) who reported that LPS 
given to broiler chicks produced symptoms of drowsiness, lethargy, and withdrawal from 
feed and water within 1 hour of injection and that the symptoms persisted for up to 4 
hours.  In addition, in 1994, Roth et al. evaluated the effects of repeated LPS challenges 
on the febrile and cytokine response of guinea-pigs; however, feed intake was not 
measured.  The febrile and cytokine responses were attenuated after the third injection of 
LPS.  This phenomenon, known as endotoxin tolerance, was documented over 50 years 
ago by Beeson (1947).   
The state of endotoxin tolerance should not be confused with endotoxin resistance 
or resilience.  Tolerance is a state of a progressively diminishing response to an 
immunogen.  Resistance refers to the capability of physiological system to exclude a 
pathogen and resilience refers to the ability to maintain productivity during a challenge 
(Klasing, 1998).  Endotoxin tolerance was attributed to reduced TNF-α and IL-6-like 
activity (Roth et al., 1994); however, other mediators of food intake regulation cannot be 
eliminated (Frank, 2003). 
At week two, LPS caused decrease in performance in both species.  The first LPS 
injection was administered on day 7 while the third injection was given on day 11 and 
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throughout this period a reduction in FI was observed.  Therefore, the fact that LPS 
affected performance at 2 weeks of age and no or little effect was observed at week three 
is consistent with the endotoxin tolerance hypothesis described by Beeson (1947).  The 
injections started at week 2 which suggest that the birds were adapting to the repeated 
LPS challenge and the responses to this exposure became less intense at week three.  At 
week two, lipopolysaccharide decreased performance in both species when LPS-treated 
group was compared to the birds receiving saline.  At week three, there was a LPS effect 
on BWG in chicks; but no other significant difference between the LPS- and saline-
treated groups was detected at week three.    
The T-2 toxin at 2 mg T-2/kg diet caused a decrease in performance in both 
species.  In chicks, this result is consistent with the literature as the reports are rather 
controversial.  The T-2 toxin reduced growth in chicks fed 4 mg T-2/ kg of diet (Wyatt et 
al., 1973; Ademoyero and Hamilton, 1991; Leeson et al., 1995).  In broiler chicks, 
decrease in performance at four weeks of age was observed in birds fed 6 mg T-2/kg of 
diet.  In chicks fed 2 mg T-2/kg, there was no significant reduction in body weight gain 
(Békési et al., 1997).   However, Richard et al. (1978) reported depression in feed intake 
and feed efficiency when chickens were fed 2 and 10 mg/kg T-2.  Kubena et al. (1997) 
reported an additive effect on body weight gain when broiler chicks were fed 5 mg/kg of 
T-2 combined with 300 mg/kg of Fumonisin B1 (FB1) for 19 days, but no significant 
difference was observed for intake and feed conversion when T-2 was given alone.  In 
addition, when Hoehler and Marquardt (1996) fed 4 ppm T-2/kg of diet, only a slight 
decrease in performance was observed.  In contrast, T-2 concentrations as low as 0.9 mg 
T-2/kg of diet have been reported to cause decreased FI and BWG (Garcia et al., 2003).  
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In poults, Sklan et al. (2003) reported that addition of up to 1 mg/kg T-2 caused no effect 
on poults performance; however, the authors reported an increase in the severity of oral 
lesions as the levels of T-2 in the diet increased.  Kubena et al. (1995) reported that 
female turkey poults fed 5 mg T-2/kg of feed for 21 days had body weight gain 26% 
lower than the control group and when T-2 treatment was combined with 300 mg FB1/kg 
of feed, a 47% reduction was observed.  Richard et al. (1978) fed turkey poults either 2 or 
10 mg/kg T-2 for 4 weeks.  Poults fed 10 mg/kg T-2 were a third lighter than the control 
group, whereas poults fed 2 mg/kg T-2 were slightly lighter the control only at week four 
(Richard et al., 1978).   
In chicks, 2 mg/kg AFB1 caused depressed performance at both two and three 
weeks of age.  In addition, there was a synergistic interaction between T-2 and AFB1 
resulting in further decrease in FI and BWG.  Verma et al. (2002) reported that AFB1  
(~3 mg/kg AFB1) co-treatment with OA significantly decreased body weight, serum 
protein and serum albumin, and increased the relative weights of liver, kidney, and 
proventriculus.  Pimpukdee et al. (2004) reported that 5 mg/kg AFB1 had decreased 
performance of 3-week-old chickens.  In addition, Huff et al. (1988) showed that feeding 
2.5 mg/kg AFB1 to broiler chickens caused a decrease in body weight and a further 
decrease was observed when birds were co-treated with AFB1 and 4 mg/kg T-2.  
In this study, the means chosen to administer LPS may have been too invasive 
which may explain the increased susceptibility of the birds to levels of toxins otherwise 
considered non toxic.   
Independent of the dietary treatments, LPS significantly increased relative spleen 
weight and decreased relative bursa weight when compared to chicks receiving saline, 
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whereas in poults, LPS increased spleen and liver weights compared to the saline-treated 
groups.  Stress-induced bursal atrophy has been suggested to be caused by an increased 
corticosteroid production (Riddell, 1987).  Lipopolysaccharide is an immunological 
stressor that increases the production of corticosteroid, which may account for the 
decrease in bursa weight observed in the present study.  Xie et al. (2000) reported 
increase in liver weights of chicken exposed to Salmonella typhimurium LPS.  The 
increase in the relative weights of liver in LPS-treated birds illustrates the importance of 
the liver in the acute phase response (Xie et al., 2000).  The liver is the site for the 
synthesis of acute phase proteins and detoxification of xenobiotics.  It is likely that the 
apparent changes in liver weight may be due to an increase in its metabolic function 
coupled with loss of body weight.   
In poults, T-2 increased liver and spleen weights.  Friend et al. (1983) reported 
that liver was affected by feeding T-2 in rats.  Richard et al. (1978) reported decreased 
relative thymus weight when poults were fed 10 mg/kg T-2, but no effect was observed 
when poults were fed 2 mg/kg T-2.  In addition, the authors reported no effect on spleen 
and bursa weights when poults were fed either 2 or 10 mg/kg T-2 (Richard et al., 1978).  
The T-2 toxin induced inhibition of cell proliferation in the murine spleen is a transient 
effect (Cooray and Lindahl-Kiessling, 1987).  During chronic exposure of Swiss mice to 
T-2 toxin, the spleen decreased in size initially, but subsequently increased in size until it 
became much larger than that of the control mice (Hayes et al., 1980).  Cooray and 
Lindahl-Kiessling (1987) reported that mice given T-2 toxin for 3 weeks had enlarged 
spleens and that the increase was dose dependent.  In addition, the authors also reported 
that T-2 treatment increased the metabolic capacity of mouse peritoneal cells and the 
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number of mature macrophages in the murine spleen which in turn may have been 
capable of stimulating antibody synthesis in the mouse spleen resulting in increases of its 
size.  In addition, T-2 toxin selectively destroys T suppressor cells (Otakawa et al., 1979; 
Rosenstein et al., 1981) which may have contributed to enhancement of spontaneous 
antibody synthesis in the murine spleen as well. In chicks, T-2 had no effect on relative 
organ weight.  Richard et al. (1978) fed broiler chicks diets containing 2 or 10 mg/kg T-2 
and found no significant effect of T-2 on relative organ weight of those birds.  In contrast, 
Ogunbo (1994) found decreased absolute spleen weights when broilers were fed diets 
containing 4 mg/kg T-2. 
In chicks and poults, AFB1 given alone increased spleen and decreased thymus 
weight.  In addition, a synergistic interaction between T-2 and AFB1 on thymus relative 
weight was observed in chicks.  Hegazy and Adachi (2000) reported that feeding 2.6 
mg/kg AFB1 to chicks decreased relative bursal and thymus weights, but spleen weight 
was increased.  The decrease in bursa and thymic weights represents the 
immunossupressive effect of the treatments.  However, the increase in spleen weight 
observed may be related to the health status of the birds.  Chang and Hamilton (1982) 
found a significant increase in relative spleen weights in chicks with infectious bursal 
disease virus, which may be enhanced by synergism with aflatoxicosis.  In the present 
study, at the end of the third week, birds were euthanized and grossly necropsied.   Some 
birds (approximately 15%) presented signs of septicemia with perihepatitis and 
pericarditis.  In poults, AFB1 decreased liver and thymus weights and increased spleen 
weights.  AFB1 increased relative liver weight in chicks.  In chicks, this result is in 
agreement with the literature.  AFB1 causes fatty liver in poultry (Hamilton and Garlich, 
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1971; Carnaghan et al., 1966; Sawhney et al., 1973) causing increased liver weight due to 
fat deposition in the liver.    In poults, AFB1 decreased liver weight.  Bradley (1985) 
proposed that inhibition of protein synthesis impairs the ability of the animal to repair 
cellular damage leading to decreased relative organ weights.   In contrast, Ogunbo (1994) 
fed turkey poults 4 mg/kg T-2 and found no significant difference in liver weight. 
In chicks, AFB1 decreased serum Ca.  In addition, LPS x T-2, LPS x AFB1, and 
T-2 x AFB1 interactions were found in serum Ca.  In poults, AFB1 and T-2 decreased 
serum Ca.  Sergeev et al. (1988) reported that rats exposed to T-2 were hypocalcemic and 
this condition was accompanied with decreases in the activities of alkaline phosphatase 
on the intestinal mucosa, the hepatic concentration of 25-OH-D3, and renal 24,25-OH.  In 
laying hens, the presence of the toxin in the diet resulted in decreased egg production and 
quality of the egg shell (Chi et al., 1977, 1978).  Chan and Tarnawski (2002) suggested 
that tissue injury may stimulate serum response factor (SRF) which activate genes to 
promote healing and that Ca2+/calmodulin-dependent kinase (Cam) may be involved in 
the process of SRF activation by cytoplasmatic Ca2+ elevation.   
Shen et al. (1994) have shown that AFB1 causes lipid peroxidation in rat liver and 
that pretreatment with vitamin E, selenium, or deferoxamine, an iron chelator, 
significantly inhibited lipid peroxidation as well as liver cell damage.  The tricothecenes 
deoxynivalenol (DON) and T-2 have also been shown to stimulate lipid peroxidation in 
rat liver along with depletion of hepatic glutathione (Rizzo et al., 1994).  In the present 
experiment, treatments did not affect GLUT in poults, whereas in chicks there was an 
increase in GLUT.  Hoehler and Marquardt (1996) showed that feeding either 4 mg/kg or 
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5 mg/kg T-2 did not affect malondialdehyde (MDA), a product from lipid peroxidation, 
in liver homogenates of chickens.   
The results obtained regarding T-2 as a promoter of lipid peroxidation in this 
study reflect the findings by other authors, as they are rather contradictory.  Schuster et 
al. (1987) suggested that lipid peroxidation is not involved in the toxicity of T-2.  Segal et 
al. (1983), in contrast, reported that T-2 and another tricothecene, DON, stimulated lipid 
peroxidation in the livers of rats.  Hoehler and Marquardt (1996) suggested that the 
assays utilized (TBARS) are not always accurate because of their lack of specificity.  In 
addition, the vitamin E status of the animal may also affect the degree of lipid 
peroxidation.   
In chicks fed AFB1, there was an increase in GLUT.  Rastogi et al. (2001) 
reported a decrease in the activities of succinate dehydrogenase and glucose-6-
phosphatase, increased levels of lipid peroxides, and decline in the activities of enzymatic 
antioxidants levels, such as glutathione-S-transferase, glutathione reductase, and 
glutathione peroxidase.  This may explain the increase in the concentration of GLUT in 
chicks fed AFB1.  The low activities of the glutathione enzymes probably resulted in an 
increase in the concentration of the substrate.  In addition, one important route of AFB1 
8,9-epoxide detoxification is via conjugation to glutathione (GSH) (Degen and Neumann, 
1978; Eaton et al., 1994) which may increase the concentration of this compound.  
Furthermore, a three-way interaction in glutathione concentration was found in chicks, 
but not in poults.  Glutathione concentration was depressed in the treatments receiving 
LPS and fed T-2 and AFB1.  Luyendyk et al. (2002) reported that it is conceivable that 
LPS might decrease liver GSH concentration, thereby decreasing capacity to detoxify the 
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AFB1 8,9 epoxide, and resulting in enhanced hepatotoxicity.  Unfortunately, it is beyond 
the scope of this study to suggest that GSH may have been decreased by LPS. 
 
CONCLUSION 
 
Based on these results, it can be concluded that at the levels chosen chronic 
exposure to low doses of LPS did not potentiate the effects of dietary non toxic doses of 
T-2 and AFB1 on performance of chicks and poults fed from hatch to day 21.  However, 
LPS did potentiate the effects of T-2 on mortality rate and oral lesion in poults.  In 
addition, acute exposure to LPS also enhanced mortality rate in broiler chicks and cause a 
decrease in feed intake in chicks and poults, independent of dietary treatments. 
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TABLE 5.3.  EFFECTS OF ENDOTOXIC LIPOPOLYSACCHARIDE ON 
HEMATOCRIT1, MORTALITY RATE2, AND MOUTH LESION1 OF BROILER 
CHICKS FED T-2 TOXIN AND AFLATOXIN B1 
 
    
LPS T-2    AFB1 HEMATOCRIT MORTALITY LESION  
(µg/bird) (ppm) (ppm) ---------------------(%)--------------------   
 
 
0 0 0 31.47a   4b 0.00b
0 2 0  31.80a    0c  0.60a 
0 0  2  33.40a  20ab  0.00b 
0 2  2   31.90a  12b  0.60a 
150 0  0  31.40a    8b  0.00b 
150 2  0  30.63a    0c  0.73a 
150 0  2  29.93a  12b  0.00b 
150 2  2  31.07a  32a  0.53a 
SEM        1.49    ---   0.10 
                     -------------------------------Probability------------------------------ 
       
LPS 0.1975  0.3052 0.8223
T-2 0.8503  0.6993 <.0001
AFB1 0.8135  <.0001 0.5018
LPS X T-2 0.7177  0.1762 0.8223
LPS X AFB1 0.4711  0.7465 0.5018
T-2 X AFB1 0.9874  0.0883 0.5018
LPS X T-2 X AFB1 0.3812  0.0438 0.5018
 
1 Data are means of five replicates of three birds each. 
2 Mortality data were transformed (Arcsin) prior to statistical analysis. 
a, b Values within columns with different superscripts differ significantly (P < 0.05). 
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TABLE 5.3 (CONT).  EFFECTS OF ENDOTOXIC LIPOPOLYSACCHARIDE ON 
HEMATOCRIT1, MORTALITY RATE2, AND MOUTH LESION1 OF BROILER 
CHICKS FED T-2 TOXIN AND AFLATOXIN B1 
 
Main Effect Mean  HEMATOCRIT MORTALITY LESION  
             --------------------(%)--------------------- 
 
 
LPS, µg/bird  
 0 32.14a   9a 0.30a  
 150 30.76a 13a 0.32a 
 
T-2 toxin, ppm 
 0 31.55a 11a 0.00b 
 2 31.35a 11a 0.62a 
 
AFB1, ppm 
 0 31.32a   3b 0.33a 
 2 31.57a 19a 0.28a 
 
1 Data are main effect means. 
2 Mortality data were transformed (Arcsin) prior to statistical analysis. 
a, b Values within columns, in main effect, with different superscripts differ significantly 
(P < 0.05). 
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TABLE 5.4.  EFFECTS OF ENDOTOXIC LIPOPOLYSACCHARIDE ON 
HEMATOCRIT1, MORTALITY RATE2, AND MOUTH LESION1 OF TURKEY 
POULTS FED T-2 TOXIN AND AFLATOXIN B1 
 
    
LPS T-2    AFB1 HEMATOCRIT MORTALITY LESION  
(µg/bird) (ppm) (ppb) ---------------------(%)--------------------   
 
 
0 0 0 35.40b  0b 0.00c
0 2 0  34.13b   0b   1.60b 
0 0  150  35.33b   8a   0.20c 
0 2  150  34.23b   0b   2.00ab 
150 0  0  35.13b   0b   0.20c 
150 2  0  33.43b  12a   2.40a 
150 0  150  34.47b   8a   0.20c 
150 2  150  38.67a  16a   2.33a 
SEM      0.96   ---2    0.50 
                     -------------------------------Probability------------------------------ 
 
LPS 0.3436 0.0177 0.0446
T-2 0.9610 0.3460 <.0001
AFB1 0.0987 0.0934 0.4092 
LPS X T-2 0.0814 0.0177 0.1531 
LPS X AFB1 0.1034 0.8551 0.3037 
T-2 X AFB1 0.0319 0.1831 0.8357 
LPS X T-2 X AFB1 0.0419 0.8551 0.6786 
 
1 Data are means of five replicates of three birds each. 
2 Mortality data were transformed (Arcsin) prior to statistical analysis. 
a, b,c Values within columns with different superscripts differ significantly (P < 0.05). 
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TABLE 5.4 (CONT).  EFFECTS OF ENDOTOXIC LIPOPOLYSACCHARIDE ON 
HEMATOCRIT1, MORTALITY RATE2, AND MOUTH LESION1 OF POULTS FED 
T-2 TOXIN AND AFLATOXIN B1 
 
Main Effect Mean  HEMATOCRIT MORTALITY LESION  
             --------------------(%)--------------------- 
 
 
LPS, µg/bird  
 0 34.77a    2b 0.95a  
 150 35.42a    9a 1.28a 
 
T-2 toxin, ppm 
 0 35.08a   4a 2.08b 
 2 35.12a   7a 0.15a 
 
AFB1, ppb 
 0 34.52a  3a 1.05a 
 150 35.67a  8a 1.18a  
 
1 Data are main effect means. 
2 Mortality data were transformed (Arcsin) prior to statistical analysis. 
a, b Values within columns, in main effect, with different superscripts differ significantly 
(P < 0.05). 
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TABLE 5.5.  EFFECTS OF ENDOTOXIC LIPOPOLYSACCHARIDE ON RELATIVE 
ORGAN WEIGHTS OF BROILER CHICKS FED T-2 TOXIN AND AFLATOXIN B11 
 
    
LPS T-2    AFB1  LIVER SPLEEN BURSA  THYMUS 
(µg/bird) (ppm) (ppm) -------------------------------(%)------------------------------   
 
 
0 0 0 3.279c 0.086d 0.250ab 0.300ab
0 2 0 2.850c  0.089c  0.278a  0.337a 
0 0  2 4.600b  0.153bc  0.259ab 0.300ab 
0 2  2  5.243a  0.162b  0.282a  0.231b 
150 0  0 3.158c  0.119c  0.237ab  0.298ab 
150 2  0 3.360c  0.125c  0.252ab  0.312ab 
150 0  2 4.878ab  0.179b  0.200b  0.268b 
150 2  2 5.266a  0.227a  0.209b  0.232b 
SEM    0.182  0.013  0.019   0.019
                     -------------------------------Probability------------------------------ 
 
LPS 0.1889 <.0001 0.0040 0.2904
T-2 0.1268 0.0719 0.1818 0.3282 
AFB1 <.0001 <.0001 0.2284 0.0003 
LPS X T-2 0.4737 0.2556 0.6493 0.8810 
LPS X AFB1 0.8674 0.5245 0.0973 0.9432 
T-2 X AFB1 0.0200 0.1803 0.8641 0.0068 
LPS X T-2 X AFB1 0.0940 0.3175 0.9904 0.2960 
 
1 Data are means of five replicates of three birds each. 
a, b, c Values within columns with different superscripts differ significantly (P < 0.05). 
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TABLE 5.5 (CONT).  EFFECTS OF ENDOTOXIC LIPOPOLYSACCHARIDE ON 
RELATIVE ORGAN WEIGHTS OF BROILER CHICKS FED T-2 TOXIN AND 
AFLATOXIN B11 
 
Main Effect Mean  LIVER SPLEEN BURSA THYMUS  
           -------------------------------(%)------------------------------- 
 
 
LPS, µg/bird  
 0 3.993a 0.123b 0.267a 0.292a 
 150 4.165a 0.162a 0.225b 0.277a 
 
T-2 toxin, ppm 
 0 3.978a 0.134a 0.237a 0.291a 
 2 4.180a 0.151a 0.255a 0.278a 
 
AFB1, ppm 
 0 3.162b 0.105b 0.255a 0.312a  
 2 4.996a 0.180a 0.238a 0.257b 
 
1 Data are main effect means. 
a, b Values within columns, in main effect, with different superscripts differ significantly 
(P < 0.05). 
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TABLE 5.6.  EFFECTS OF ENDOTOXIC LIPOPOLYSACCHARIDE ON RELATIVE 
ORGAN WEIGHTS OF TURKEY POULTS FED T-2 TOXIN AND AFLATOXIN B11 
    
LPS T-2    AFB1  LIVER SPLEEN BURSA  THYMUS 
(µg/bird) (ppm) (ppb) -------------------------------(%)------------------------------   
 
 
0 0 0 2.407bc 0.117bc 0.188a 0.135a
0 2 0 2.443b  0.114c  0.200a  0.134a 
0 0  150 2.257c  0.157ab  0.181a 0.115a
0 2  150 1.933d  0.125bc  0.196a  0.117a 
150 0  0 2.739a  0.139ab  0.188a  0.128a 
150 2  0 2.495b  0.138b  0.202a  0.130a 
150 0  150 2.366bc  0.160a  0.187a  0.118a 
150 2  150 2.222c  0.146ab  0.200a  0.118a 
SEM    0.057  0.007  0.014   0.008 
                     -------------------------------Probability------------------------------ 
 
LPS <.0001 0.0025 0.7642  0.6793
T-2 0.0002 0.0231 0.1758  0.9310
AFB1 <.0001 0.0006 0.7329   0.0114 
LPS X T-2 0.5382 0.3354 0.9991  0.9184 
LPS X AFB1 0.9297 0.3006 0.8247  0.5031 
T-2 X AFB1 0.1199 0.0623 0.9638  0.9893 
LPS X T-2 X AFB1 0.0075 0.4732 0.9115  0.8156 
 
1 Data are means of five replicates of three birds each. 
a, b, c Values within columns with different superscripts differ significantly (P < 0.05). 
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TABLE 5.6 (CONT).  EFFECTS OF ENDOTOXIC LIPOPOLYSACCHARIDE ON 
RELATIVE ORGAN WEIGHTS OF TURKEY POULTS FED T-2 TOXIN AND 
AFLATOXIN B11 
 
Main Effect Mean  LIVER SPLEEN BURSA THYMUS  
           -------------------------------(%)------------------------------- 
 
 
LPS, µg/bird  
 0 3.993b 0.123b 0.267a 0.292a  
 150 4.165a 0.162a 0.225a 0.277a 
 
T-2 toxin, ppm 
 0 3.978b 0.134b 0.237a 0.291a 
 2 4.180a 0.151a 0.255a 0.280a 
 
AFB1, ppb 
 0 2.521a 0.127b 0.195a 0.132a 
 150 2.195b 0.147a 0.191a 0.117b 
 
1 Data are main effect means. 
a, b Values within columns, in main effect, with different superscripts differ significantly 
(P < 0.05). 
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TABLE 5.7.  EFFECTS OF ENDOTOXIC LIPOPOLYSACCHARIDE ON SERUM 
CONCENTRATIONS OF TOTAL PROTEIN, ALBUMIN, AND GLOBULIN OF 
BROILER CHICKS FED T-2 TOXIN AND AFLATOXIN B11 
 
    
       TOTAL 
LPS T-2    AFB1 PROTEIN ALBUMIN GLOBULIN 
(µg/bird) (ppm) (ppm) --------------------------(g/100 ml)----------------------------- 
 
 
0 0 0 2.51a  1.40a 0.92a
0 2 0  2.21ab   1.13b  1.09a 
0 0  2  1.92b   0.82c  1.10a 
0 2  2   1.59c   0.61d  0.91a 
150 0  0  2.17b   1.18b  0.99a 
150 2  0  2.25ab   1.14b  1.11a 
150 0  2  1.57c   0.73cd  0.82a 
150 2  2  1.52c   0.60d  0.91a 
SEM      0.11    0.05    0.12 
                     -------------------------------Probability------------------------------ 
 
LPS 0.0232 0.0287 0.5688
T-2 0.0530 <.0001 0.5759
AFB1 <.0001 <.0001 0.2820 
LPS X T-2 0.0417 0.0243 0.5025 
LPS X AFB1 0.6830 0.4714 0.2849 
T-2 X AFB1 0.5812 0.7632 0.2494 
LPS X T-2 X AFB1 0.7665 0.2807 0.3153 
 
1 Data are means of four replicates of three birds each. 
a, b,c, d Values within columns with different superscripts differ significantly (P < 0.05). 
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TABLE 5.7 (CONT).  EFFECTS OF ENDOTOXIC LIPOPOLYSACCHARIDE ON 
SERUM CONCENTRATIONS OF TOTAL PROTEIN, ALBUMIN, AND GLOBULIN 
OF BROILER CHICKS FED T-2 TOXIN AND AFLATOXIN B11 
 
       TOTAL 
Main Effect Mean           PROTEIN   ALBUMIN   GLOBULIN 
                                                     --------------------------(g/100 ml)----------------------------- 
 
LPS, µg/bird  
 0 2.06a   0.99a     1.00a  
 150 1.88b 0.91b     0.96a 
 
T-2 toxin, ppm 
 0 2.05a 1.03a     0.96a 
 2 1.89a 0.87b     1.00a 
 
AFB1, ppm 
 0 2.29a 1.21a     1.03a 
 2 1.65b 0.69b     0.93a  
 
1 Data are main effect means. 
a, b Values within columns, in main effect, with different superscripts differ significantly 
(P < 0.05). 
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TABLE 5.8.  EFFECTS OF ENDOTOXIC LIPOPOLYSACCHARIDE ON SERUM 
CONCENTRATIONS OF TOTAL PROTEIN, ALBUMIN, AND GLOBULIN OF 
TURKEY POULTS FED T-2 TOXIN AND AFLATOXIN B11 
 
    
       TOTAL 
LPS T-2    AFB1 PROTEIN ALBUMIN GLOBULIN 
(µg/bird) (ppm) (ppb) --------------------------(g/100 ml)----------------------------- 
 
 
0 0 0 3.16ab  1.43a 1.80ab
0 2 0  2.83b   1.36a  1.47b 
0 0  150  1.75c   0.78c  0.92c 
0 2  150  1.71c   0.81c  0.92c 
150 0  0  3.06ab   1.41a  1.65ab 
150 2  0  3.36a   1.40a  1.96a 
150 0  150  1.73c   0.81c  0.95c 
150 2  150  2.00c   0.97b  1.12c 
SEM      0.12    0.04    0.12 
                     -------------------------------Probability------------------------------ 
 
LPS 0.0433 0.0687 0.0891
T-2 0.5451 0.3647 0.6669
AFB1 <.0001 <.0001 <.0001 
LPS X T-2 0.0099 0.0728 0.0211 
LPS X AFB1 0.6405 0.1258 0.7400 
T-2 X AFB1 0.4279 0.0131 0.5740 
LPS X T-2 X AFB1 0.3359 0.4655 0.1496 
 
1 Data are means of four replicates of three birds each. 
a, b,c Values within columns with different superscripts differ significantly (P < 0.05). 
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TABLE 5.8 (CONT).  EFFECTS OF ENDOTOXIC LIPOPOLYSACCHARIDE ON 
SERUM CONCENTRATIONS OF TOTAL PROTEIN, ALBUMIN, AND GLOBULIN 
OF TURKEY POULTS FED T-2 TOXIN AND AFLATOXIN B11 
 
       TOTAL 
Main Effect Mean           PROTEIN   ALBUMIN   GLOBULIN 
                                                     --------------------------(g/100 ml)----------------------------- 
 
LPS, µg/bird  
 0 2.37b 1.10a     1.28a  
 150 2.54a 1.14a     1.42a 
 
T-2 toxin, ppm 
 0 2.43a 1.11a     1.33a 
 2 2.48a 1.13a     1.37a 
 
AFB1, ppb 
 0 3.10a 1.40a     1.72a 
 150 1.80b  0.84b     0.98b  
 
1 Data are main effect means. 
a, b Values within columns, in main effect, with different superscripts differ significantly 
(P < 0.05). 
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TABLE 5.9.  EFFECTS OF ENDOTOXIC LIPOPOLYSACCHARIDE ON SERUM 
CHEMISTRY PARAMETERS OF BROILER CHICKS FED T-2 TOXIN AND 
AFLATOXIN B11 
 
        Uric   
LPS T-2    AFB1  Glucose Calcium Acid AST2
(µg/bird) (ppm) (ppm)      -------------------(mg/dL)----------------        (U/L)   
 
0 0 0 297a 10.6a 6.1a 178ab
0 2 0 291a   9.9ab 4.9a 163a
0 0  2 228b   8.6c 6.7a 182ab
0 2  2  223b   8.7c 4.8a  195a
150 0  0 312a   9.7b 5.6a  170ab
150 2  0 281a   9.9ab 5.3a  143b
150 0  2 223b   8.6c  5.9a  153b
150 2  2 243b   9.5b 6.2a  133b
SEM    12.7  0.25 0.67   11.3
 
                     -------------------------------Probability------------------------------ 
 
LPS  0.5869 0.8092 0.7799 0.0010
T-2  0.5606 0.5588 0.1233 0.1318
AFB1  <.0001 <.0001 0.3500 0.7908
LPS X T-2  0.9698 0.0268 0.1334 0.1686
LPS X AFB1  0.7561 0.0281 0.7404 0.0596
T-2 X AFB1  0.1638 0.0460 0.9879 0.2859
LPS X T-2 X AFB1  0.1731 0.8630 0.4940 0.5261
 
1 Data are means of four replicates of three birds each. 
2 AST = aspartate aminotransferase. 
a, b, c Values within columns with different superscripts differ significantly (P < 0.05). 
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TABLE 5.9 (CONT).  EFFECTS OF ENDOTOXIC LIPOPOLYSACCHARIDE ON 
SERUM CHEMISTRY PARAMETERS OF BROILER CHICKS FED T-2 TOXIN AND 
AFLATOXIN B11 
 
Uric                    
Main Effect Mean  Glucose Calcium Acid AST2 
                                     --------------------(mg/dL)----------------            (U/L)   
 
LPS, µg/bird  
 0 260a 9.4a  5.6a  180a  
 150 265a 9.4a  5.8a  150b  
 
T-2 toxin, ppm 
 0 265a 9.4a  6.1a  171a  
 2 260a 9.5a  5.3a  159a  
 
AFB1, ppb 
 0 295a 10.0a  5.5a  164a  
 2 230b   8.9b  5.9a  166a  
 
1 Data are main effect means. 
2 AST = Aspartate aminotransferase 
a, b Values within columns, in main effect, with different superscripts differ significantly 
(P < 0.05). 
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TABLE 5.10.  EFFECTS OF ENDOTOXIC LIPOPOLYSACCHARIDE ON SERUM 
CHEMISTRY PARAMETERS OF TURKEY POULTS FED T-2 TOXIN AND 
AFLATOXIN B11 
 
        Uric  Creatine  
LPS T-2    AFB1  Glucose Calcium Acid AST2 Kinase
(µg/bird) (ppm) (ppb) -------------(mg/dL)------------         ----------(U/L)---------   
 
 
0 0 0 332a 10.9a 5.5a 264b 1600b
0 2 0 318ab 10.4a 5.2a 255b 1571b  
0 0  150 273b  9.2b 6.2a 277ab 1800ab
0 2  150 293ab  8.7b 5.6a 296a 2115a
150 0  0 289ab 10.7a 7.1a 245b 1379b
150 2  0 298ab 10.2a 5.7a 252b 1340b
150 0  150 268b  8.8b  5.7a 274ab 1333b
150 2  150 267b  8.6b 6.0a 283ab 1442b
SEM    18.5 0.26 0.88  8.16    148
 
                     -------------------------------Probability------------------------------ 
 
LPS 0.0822 0.2542 0.4152 0.1181 0.0009
T-2 0.8043 0.0228 0.4190 0.2551 0.4057
AFB1 0.0153 <.0001 0.9828 <.0001 0.0683
LPS X T-2 0.9610 0.7931 0.9274 0.8331 0.6105
LPS X AFB1 0.5532 0.8890 0.3722 0.7616 0.1139
T-2 X AFB1 0.6421 0.6597 0.6118 0.2098 0.2532
LPS X T-2 X AFB1 0.4018 0.7505 0.4456 0.2727 0.6446
 
1 Data are means of four replicates of three birds each. 
2 AST = aspartate aminotransferase. 
a, b Values within columns with different superscripts differ significantly (P < 0.05). 
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TABLE 5.10 (CONT).  EFFECTS OF ENDOTOXIC LIPOPOLYSACCHARIDE ON 
SERUM CHEMISTRY PARAMETERS OF TURKEY POULTS FED T-2 TOXIN AND 
AFLATOXIN B11 
        
Uric         Creatine  
Main Effect Mean  Glucose Calcium Acid AST2 Kinase
                             -------------(mg/dL)------------                ----------(U/L)---------    
 
 
LPS, µg/bird   
 0 304a  9.8a  5.6a  273a  1772a  
 150 280a  9.6a  6.1a  264a  1374b  
 
T-2 toxin, ppm 
 0 291a  9.9a  6.1a  265a  1528a  
 2 294a  9.5b  5.6a  272a  1617a  
 
AFB1, ppb 
 0 309a 10.6a  5.9a  254a  1472a  
 150 275b   8.8b  5.9a  282b  1673a  
 
1 Data are main effect means. 
2 AST = Aspartate aminotransferase 
a, b Values within columns, in main effect, with different superscripts differ significantly 
(P < 0.05). 
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TABLE 5.11: EFFECTS OF ENDOTOXIC LIPOPOLYSACCHARIDE ON 
GLUTATHIONE (GSH) CONCENTRATION OF LIVER HOMOGENATES OF 
BROILER CHICKS FED T-2 TOXIN AND AFLATOXIN B11 
  
 LPS T-2 AFB1 GLUTATHIONE 
   (µg/bird)  (ppm) (ppm)  (mmol/100 uL) 
 
 
 0 0 0   7.89ab 
 0 2 0   6.70b 
 0 0 2   8.41a 
 0 2 2   8.29a 
 150 0 0   6.24b 
 150 2 0   7.55ab 
 150 0 2   8.10ab 
 150 2 2   6.92ab 
 SEM     0.49 
 
         Probability 
  
 LPS    0.0950 
 T-2    0.4201 
 AFB1    0.0280 
 LPS X T-2    0.3220 
 LPS X AFB1    0.5435 
 T-2 X AFB1    0.3288 
 LPS X T-2 X AFB1   0.0200 
1 Data are means of four replicates of two birds each. 
a, b Values within columns with different superscripts differ significantly (P < 0.05). 
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TABLE 5.11 (CONT).  EFFECTS OF ENDOTOXIC LIPOPOLYSACCHARIDE ON 
GLUTATHIONE (GSH) CONCENTRATION OF LIVER HOMOGENATES OF 
BROILER CHICKS FED T-2 TOXIN AND AFLATOXIN B11 
  
   GLUTATHIONE 
 Main Effect Mean  (mmol/100 uL) 
 
 LPS, µg/bird  
  0   7.82a 
  150   7.20a 
 
 T-2, ppm 
  0   7.66a 
  2   7.37a 
 
 AFB1, ppm 
  0   7.10b 
  2   7.93a 
1 Data are main effect means. 
a, b Values within columns, in main effect, with different superscripts differ significantly 
(P < 0.05) 
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TABLE 5.12. EFFECTS OF ENDOTOXIC LIPOPOLYSACCHARIDE ON 
GLUTATHIONE (GSH) CONCENTRATION OF LIVER HOMOGENATES OF 
TURKEY POULTS FED T-2 TOXIN AND AFLATOXIN B11 
  
 LPS T-2 AFB1 GLUTATHIONE 
   (µg/bird)  (ppm) (ppb)  (mmol/100 uL) 
 
 
 0 0 0   2.58  
 0 2 0   2.40 
 0 0 150   2.43 
 0 2 150   2.51 
 150 0 0   2.48 
 150 2 0   2.56 
 150 0 150   2.25 
 150 2 150   2.38 
 SEM     0.12 
 
         Probability 
  
 LPS    0.4271 
 T-2    0.7367 
 AFB1    0.1893 
 LPS X T-2    0.3537 
 LPS X AFB1    0.2767 
 T-2 X AFB1    0.3511 
 LPS X T-2 X AFB1   0.5477 
 1 Data are means of four replicates of two birds each. 
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TABLE 5.12 (CONT).  EFFECTS OF ENDOTOXIC LIPOPOLYSACCHARIDE ON 
GLUTATHIONE (GSH) CONCENTRATION OF LIVER HOMOGENATES OF 
TURKEY POULTS FED T-2 TOXIN AND AFLATOXIN B11 
  
   GLUTATHIONE 
 Main Effect Mean  (mmol/100 uL) 
 
 LPS, µg/bird  
  0   2.48    
  150   2.42 
 
 T-2, ppm 
  0   2.44 
  2   2.46 
 
 AFB1, ppb 
  0   2.51 
  150   2.39 
    1 Data are main effect means. 
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Figure 5.1.  Mortality of broiler chicks after the first injection containing endotoxic 
LPS 
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Figure 5.2.  Interaction of endotoxic lipopolysaccharide and T-2 on mortality rate of 
turkey poults 
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Feed Intake of broiler chicks after the second LPS 
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Feed intake of broiler chicks after the third LPS 
injection
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Figure 5.3. Effect of three consecutive LPS injections on feed intake of chicks and poults.  
Orthogonal contrasts were designed to compare LPS- to saline-treated groups. 
P > 0.05
P > 0.05
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CHAPTER VI 
 
CONCLUSION 
 
Aflatoxin B1 (AFB1) causes poor performance and is hepatotoxic in animals. 
Endotoxic lipopolysaccharide (LPS), a constituent of cell walls of gram negative bacteria, 
initiates an inflammatory response in animals. In rodents, nontoxic doses of LPS augment 
the effects of AFB1.  Two studies (Exp.1 and 2) were conducted to determine the effects 
of chronic exposure to low doses of E. coli LPS in chicks and poults fed diets 
contaminated with non toxic doses of aflatoxin B1.  Chicks were fed 0, 2, or 4 mg 
AFB1/kg diet, whereas poults were fed 0, 100, or 150 µg AFB1/kg diet for 21 days. 
Beginning on day 7, chicks were injected intraperitoneally with 0, 200, or 400 µg 
LPS/bird every other day, whereas poults were injected with 0, 100, or 150 µg LPS/bird 
on alternate days.  Based on the results obtained, it can be concluded that at the levels 
chosen chronic exposure to low doses of LPS did not potentiate the effects of dietary non 
toxic doses of AFB1 on performance of chicks and poults fed from hatch to day 21.  
However, for mortality rate, results suggest a toxic synergy between AFB1 and LPS in 
chicks and poults.  
In Exp. 3 and 4, the effects of chronic exposure to low doses of E. coli LPS in 
combination with feeding diets contaminated with non toxic doses of T-2 toxin were 
determined in chicks and poults fed from hatch to day 21.  Chicks and poults were fed 0, 
1, or 2 mg T-2/kg diet.  Beginning on day 7, chicks and poults were injected 
intraperitoneally with 0, 100, or 150 µg LPS/bird every other day. Based on the results 
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from these experiments, it can be concluded that, at the levels chosen, chronic exposure 
to LPS did not potentiate the effects of T-2 toxin in chicks and poults.  In poults, 
however, the decrease in performance observed in birds fed T-2 alone was atypical of a 
number of studies conducted in which decrease in performance was only observed when 
poults were fed at least 5 mg/kg T-2. 
Finally, Exp. 5 and 6 were conducted to determine the effects of chronic exposure 
to low doses of E. coli lipopolysaccharide (LPS) in chicks and poults fed diets 
contaminated with non toxic doses of aflatoxin B1 (AFB1) and T-2 toxin (T-2) from 
hatch to day 21.  Birds were fed diets containing 0 or 2 mg T-2/kg diet singly or in 
combination with 0 or 2 mg AFB1/kg (chicks) or 0 or 0.15 mg/kg AFB1 (poults).  
Beginning on day 7, chicks and poults were injected intraperitoneally with 0 or 150 µg 
LPS/bird every other day. In chicks and poults, LPS decreased FI which lasted for 6 
hours after the first LPS injection.  Based on the results obtained, it can be concluded that 
at the levels chosen chronic exposure to low doses of LPS did not potentiate the effects of 
dietary non toxic doses of T-2 and AFB1 on performance of chicks and poults fed from 
hatch to day 21.  However, LPS did potentiate the effects of T-2 on mortality rate and 
oral lesions in poults and, after the first LPS injection, decreased feed intake for 6 hours.  
LPS also enhanced mortality rate in broiler chicks after the first LPS injection and 
decreased feed intake for 6 hours after the first injection containing LPS.
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